[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 9926
1. Zuma AV, Lima DF, Assef AP, Marques EA, Leão RS: Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from blood in Rio de Janeiro displaying susceptibility profiles to non-β-lactam antibiotics. Braz J Microbiol; 2017 Apr - Jun;48(2):237-241
MedlinePlus Health Information. consumer health - Staphylococcal Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The distinction between healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) infections has become increasingly blurred.
  • [MeSH-major] Anti-Bacterial Agents / pharmacology. Bacteremia / microbiology. Drug Resistance, Bacterial. Methicillin-Resistant Staphylococcus aureus / drug effects. Multilocus Sequence Typing. Staphylococcal Infections / microbiology

  • MedlinePlus Health Information. consumer health - Antibiotic Resistance.
  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - MRSA.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. All rights reserved.
  • [Cites] Diagn Microbiol Infect Dis. 2013 Aug;76(4):518-20 [23719088.001]
  • [Cites] Epidemiol Infect. 2012 Aug;140(8):1372-5 [22008212.001]
  • [Cites] Clin Microbiol Infect. 2007 Jul;13(7):725-7 [17403127.001]
  • [Cites] Rev Bras Enferm. 2015 Jan-Feb;68(1):128-35, 136-43 [25946506.001]
  • [Cites] Infection. 2013 Aug;41(4):851-4 [23456477.001]
  • [Cites] Diagn Microbiol Infect Dis. 2014 Jan;78(1):59-62 [24211217.001]
  • [Cites] Antimicrob Agents Chemother. 2008 Sep;52(9):3315-20 [18591266.001]
  • [Cites] F1000 Med Rep. 2012;4:4 [22312414.001]
  • [Cites] Int J Antimicrob Agents. 2012 Apr;39(4):273-82 [22230333.001]
  • [Cites] BMC Microbiol. 2009 May 28;9:113 [19476638.001]
  • [Cites] J Cyst Fibros. 2011 Sep;10(5):377-82 [21636331.001]
  • [Cites] Lab Invest. 2007 Jan;87(1):3-9 [17146447.001]
  • [Cites] BMC Res Notes. 2014 Oct 25;7:759 [25344770.001]
  • [Cites] J Antimicrob Chemother. 2012 Apr;67(4):837-40 [22240400.001]
  • [Cites] J Infect Dev Ctries. 2013 Jan 15;7(1):10-6 [23324815.001]
  • [Cites] Rev Soc Bras Med Trop. 2013 Jan-Feb;46(1):34-8 [23563822.001]
  • [Cites] Diagn Microbiol Infect Dis. 2007 Nov;59(3):339-45 [17662563.001]
  • [Cites] J Am Board Fam Med. 2010 Nov-Dec;23(6):714-9 [21057066.001]
  • [Cites] Diagn Microbiol Infect Dis. 2009 Aug;64(4):434-41 [19631097.001]
  • [Cites] N Engl J Med. 2014 Apr 17;370(16):1524-31 [24738669.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2013 May;32(5):613-20 [23232976.001]
  • [Cites] Braz J Med Biol Res. 2012 Jul;45(7):637-43 [22527128.001]
  • [Cites] Braz J Med Biol Res. 2009 Aug;42(8):756-60 [19578704.001]
  • [Cites] BMC Microbiol. 2016 Jun 21;16(1):115 [27325108.001]
  • [Cites] J Clin Microbiol. 2000 Mar;38(3):1008-15 [10698988.001]
  • [Cites] Am J Infect Control. 2013 Mar;41(3):e21-6 [23261682.001]
  • [Cites] Infect Control Hosp Epidemiol. 2006 Oct;27(10):1041-50 [17006810.001]
  • [Cites] Lancet Infect Dis. 2005 May;5(5):275-86 [15854883.001]
  • [Cites] Int J Med Microbiol. 2016 Sep;306(6):367-80 [27265234.001]
  • (PMID = 28108350.001).
  • [ISSN] 1678-4405
  • [Journal-full-title] Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
  • [ISO-abbreviation] Braz. J. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Keywords] NOTNLM ; MLST / MRSA / USA1100 / USA400 / USA800
  •  go-up   go-down


2. Saunders-Hastings P, Quinn Hayes B, Smith R, Krewski D: Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada. PLoS One; 2017;12(6):e0179315
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths.
  • Associated estimates of economic burden ranged from CAD $115 million to over $2 billion when extended mass school closure was implemented.
  • DISCUSSION: Children accounted for a disproportionate number of pandemic infections, particularly in household settings.
  • The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Influenza Other Respir Viruses. 2013 Nov;7(6):1316-27 [23560537.001]
  • [Cites] Biomed Pharmacother. 2000 May;54(4):188-95 [10872717.001]
  • [Cites] J Appl Microbiol. 2001 Oct;91(4):572-9 [11576290.001]
  • [Cites] Zhonghua Jie He He Hu Xi Za Zhi. 2011 Jul;34(7):509-14 [22041776.001]
  • [Cites] BMC Public Health. 2011 Feb 25;11 Suppl 1:S1 [21356128.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001169 [16625539.001]
  • [Cites] Math Biosci. 2002 Nov-Dec;180:29-48 [12387915.001]
  • [Cites] BMC Public Health. 2009 Dec 24;9:488 [20034405.001]
  • [Cites] Prev Med. 2012 Jun;54(6):434-9 [22548868.001]
  • [Cites] Science. 2009 Oct 30;326(5953):729-33 [19745114.001]
  • [Cites] Am J Epidemiol. 2009 Sep 15;170(6):679-86 [19679750.001]
  • [Cites] Lancet Infect Dis. 2012 Jan;12(1):36-44 [22032844.001]
  • [Cites] Epidemiol Infect. 2007 Apr;135(3):372-85 [16928287.001]
  • [Cites] Nat Rev Microbiol. 2005 Aug;3(8):591-600 [16064053.001]
  • [Cites] Proc Biol Sci. 2011 Sep 22;278(1719):2753-60 [21288945.001]
  • [Cites] Biosecur Bioterror. 2009 Sep;7(3):265-73 [19656012.001]
  • [Cites] Science. 2009 Jun 19;324(5934):1557-61 [19433588.001]
  • [Cites] Nature. 2004 Dec 16;432(7019):904-6 [15602562.001]
  • [Cites] CMAJ. 2010 Feb 9;182(2):131-6 [19959592.001]
  • [Cites] BMC Public Health. 2011 Jan 03;11:2 [21199571.001]
  • [Cites] Pathogens. 2016 Dec 06;5(4):null [27929449.001]
  • [Cites] Infect Control Hosp Epidemiol. 2011 Dec;32(12):1149-57 [22080652.001]
  • [Cites] PLoS Med. 2013 Nov;10(11):e1001558 [24302890.001]
  • [Cites] MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60 [18685555.001]
  • [Cites] J Virol. 2015 Oct;89(19):9920-31 [26202246.001]
  • [Cites] J Clin Virol. 2011 Mar;50(3):235-9 [21195022.001]
  • [Cites] N Engl J Med. 2014 Aug 28;371(9):796-7 [25162885.001]
  • [Cites] Emerg Themes Epidemiol. 2013 May 07;10(1):3 [23651557.001]
  • [Cites] Vaccine. 2012 May 2;30(21):3209-22 [22387221.001]
  • [Cites] Am J Epidemiol. 2008 Dec 15;168(12):1343-52 [18974084.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44 [18332436.001]
  • [Cites] Influenza Other Respir Viruses. 2012 Sep;6(5):313-7 [22151080.001]
  • [Cites] Influenza Other Respir Viruses. 2013 May;7(3):466-71 [23078163.001]
  • [Cites] J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9 [10877456.001]
  • [Cites] J Theor Biol. 2015 Sep 7;380:60-73 [25981631.001]
  • [Cites] PLoS Med. 2010 Apr 06;7(4):e1000256 [20386727.001]
  • [Cites] Eur J Epidemiol. 1994 Aug;10(4):471-4 [7843359.001]
  • [Cites] Science. 2005 Aug 12;309(5737):1083-7 [16079251.001]
  • [Cites] J Theor Biol. 2006 Jul 21;241(2):193-204 [16387331.001]
  • [Cites] Int J Environ Res Public Health. 2015 Aug 18;12(8):9750-67 [26295248.001]
  • [Cites] PLoS One. 2013 Jun 21;8(6):e67253 [23805303.001]
  • [Cites] Phys Life Rev. 2016 Sep;18:66-97 [27451336.001]
  • [Cites] J Virol. 2011 Dec;85(24):13432-8 [21976646.001]
  • [Cites] Nature. 2007 Jan 18;445(7125):237 [17230157.001]
  • [Cites] PLoS Comput Biol. 2010 Jan 29;6(1):e1000656 [20126529.001]
  • [Cites] Value Health. 2009 Mar-Apr;12(2):226-33 [18671770.001]
  • [Cites] Cochrane Database Syst Rev. 2014 Apr 10;(4):CD008965 [24718923.001]
  • [Cites] BMC Infect Dis. 2014 Sep 18;14:509 [25234544.001]
  • [Cites] Proc Biol Sci. 2007 Feb 22;274(1609):599-604 [17476782.001]
  • [Cites] Am J Infect Control. 2010 Jun;38(5):374-80 [20569849.001]
  • [Cites] Am J Epidemiol. 2011 May 15;173(10):1121-30 [21427173.001]
  • [Cites] Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S168-72 [21342890.001]
  • [Cites] J Gen Intern Med. 1998 Oct;13(10):716-7 [9798822.001]
  • [Cites] J Theor Biol. 2008 Jul 7;253(1):118-30 [18402981.001]
  • [Cites] J R Soc Interface. 2006 Jun 22;3(8):453-7 [16849273.001]
  • [Cites] N Engl J Med. 2009 Nov 12;361(20):1945-52 [19745214.001]
  • [Cites] BMC Med. 2009 Jun 22;7:30 [19545404.001]
  • [Cites] PLoS One. 2013 Nov 27;8(11):e80481 [24312225.001]
  • [Cites] CMAJ. 2009 Nov 10;181(10):673-80 [19825923.001]
  • [Cites] BMC Public Health. 2013 Mar 08;13:211 [23496898.001]
  • [Cites] BMC Infect Dis. 2009 Aug 12;9:129 [19674455.001]
  • [Cites] Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Dec;44(12):1075-8 [21215106.001]
  • [Cites] BMC Public Health. 2015 Jun 09;15:543 [26055522.001]
  • [Cites] Influenza Other Respir Viruses. 2013 May;7(3):418-25 [22804954.001]
  • [Cites] PLoS One. 2010 May 06;5(5):e10520 [20463898.001]
  • [Cites] J Hosp Infect. 2010 Mar;74(3):271-7 [20061056.001]
  • [Cites] Theor Biol Med Model. 2006 Nov 30;3:38 [17137517.001]
  • [Cites] Vaccine. 2010 Aug 31;28(38):6210-20 [20643091.001]
  • [Cites] Clin Infect Dis. 2010 Jan 15;50(2):165-74 [20021259.001]
  • [Cites] Value Health. 2012 Sep-Oct;15(6):982-6 [22999151.001]
  • [Cites] Ann Intern Med. 2009 Oct 6;151(7):464-73 [19652173.001]
  • [Cites] BMC Infect Dis. 2012 Jan 26;12:26 [22280120.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5935-40 [16585506.001]
  • [Cites] BMC Infect Dis. 2010 Apr 19;10:99 [20403201.001]
  • [Cites] Emerg Infect Dis. 2007 Apr;13(4):581-9 [17553273.001]
  • [Cites] Vaccine. 2006 Nov 10;24(44-46):6701-7 [16806596.001]
  • [Cites] Math Biosci Eng. 2013 Oct-Dec;10(5-6):1475-97 [24245626.001]
  • [Cites] Influenza Other Respir Viruses. 2013 Sep;7(5):799-808 [23122189.001]
  • [Cites] Clin Infect Dis. 2007 Apr 15;44(8):1084-8 [17366454.001]
  • [Cites] Math Biosci. 2006 Oct;203(2):301-18 [16540129.001]
  • [Cites] Protein Cell. 2010 Jan;1(1):9-13 [21203993.001]
  • [Cites] Lancet Infect Dis. 2012 Sep;12(9):687-95 [22738893.001]
  • [Cites] MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62 [20689501.001]
  • [Cites] Am J Epidemiol. 2004 Apr 1;159(7):623-33 [15033640.001]
  • (PMID = 28614365.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Choi JY, Sung YB, Kim JH: Comparative Study of Bipolar Hemiarthroplasty for Femur Neck Fractures Treated with Cemented versus Cementless Stem. Hip Pelvis; 2016 Dec;28(4):208-216

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among the 180 patients, 115 were treated with cemented stems and 65 patients with cementless stems.
  • Selective use of cemented stem in bipolar hemiarthroplasty may be a desirable treatment method for patients with poor bone quality and higher risk of infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Indian J Orthop. 2011 Jan;45(1):15-22 [21221218.001]
  • [Cites] BMJ. 2007 Dec 15;335(7632):1251-4 [18056740.001]
  • [Cites] J Bone Joint Surg Am. 2006 Feb;88(2):249-60 [16452734.001]
  • [Cites] J Bone Joint Surg Am. 2006 Dec;88(12):2583-9 [17142407.001]
  • [Cites] J Bone Joint Surg Am. 2005 Sep;87(9):2122-30 [16140828.001]
  • [Cites] Int Orthop. 2002;26(4):229-32 [12185525.001]
  • [Cites] PLoS One. 2013 Jul 23;8(7):e68903 [23935902.001]
  • [Cites] Arthritis Rheum. 2008 Dec 15;59(12):1713-20 [19035425.001]
  • [Cites] J Orthop Surg (Hong Kong). 2014 Apr;22(1):92-5 [24781623.001]
  • [Cites] Bone. 1993 May-Jun;14 (3):231-42 [8363862.001]
  • [Cites] Clin Orthop Relat Res. 2009 Sep;467(9):2426-35 [19130162.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001708 [17054139.001]
  • [Cites] J Bone Joint Surg Am. 1990 Feb;72 (2):161-8 [2303502.001]
  • [Cites] J Bone Joint Surg Am. 1999 Jun;81(6):831-43 [10391548.001]
  • [Cites] Acta Reumatol Port. 2009 Jul-Sep;34(3):475-85 [19820671.001]
  • [Cites] J Arthroplasty. 2014 Feb;29(2 Suppl):19-25 [24360487.001]
  • [Cites] Injury. 2005 Mar;36(3):424-9 [15710161.001]
  • [Cites] J Bone Joint Surg Am. 2012 Apr 4;94(7):577-83 [22488613.001]
  • [Cites] J Arthroplasty. 2001 Jun;16(4):521-3 [11402421.001]
  • [Cites] Arch Orthop Trauma Surg. 2012 Apr;132(4):455-63 [22160512.001]
  • [Cites] Can J Anaesth. 2001 Jul-Aug;48(7):626-9 [11495867.001]
  • [Cites] Instr Course Lect. 2015;64:51-60 [25745894.001]
  • [Cites] J Orthop Surg (Hong Kong). 2014 Aug;22(2):186-9 [25163952.001]
  • [Cites] Orthopedics. 1994 Sep;17(9):789-92 [7800601.001]
  • [Cites] Clin Orthop Relat Res. 1994 May;(302):75-82 [8168326.001]
  • [Cites] Injury. 1993 Mar;24(3):185-6 [8509191.001]
  • [Cites] J Bone Joint Surg Br. 1991 Mar;73(2):322-4 [2005165.001]
  • (PMID = 28097110.001).
  • [ISSN] 2287-3260
  • [Journal-full-title] Hip & pelvis
  • [ISO-abbreviation] Hip Pelvis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Bipolar hemiarthroplasty / Cemented stem / Cementless stem / Femoral neck fractures
  •  go-up   go-down


Advertisement
4. Stenger M, Behr-Rasmussen C, Klein K, Grønnemose RB, Andersen TE, Klitgaard JK, Kolmos HJ, Lindholt JS: Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity. PLoS One; 2017;12(3):e0173362

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Drug Metab Dispos. 2008 Aug;36(8):1689-97 [18505790.001]
  • [Cites] J Bacteriol. 2004 Jul;186(14):4486-91 [15231780.001]
  • [Cites] Appl Environ Microbiol. 2008 Dec;74(23):7376-82 [18836028.001]
  • [Cites] Semin Vasc Surg. 2002 Dec;15(4):268-74 [12478501.001]
  • [Cites] PLoS One. 2015 Aug 12;10(8):e0135571 [26267376.001]
  • [Cites] J Med Microbiol. 2014 Sep;63(Pt 9):1174-80 [24913562.001]
  • [Cites] Vasc Endovascular Surg. 2004 Jan-Feb;38(1):75-82 [14760481.001]
  • [Cites] J Pharmacol Exp Ther. 1984 Mar;228(3):636-9 [6707914.001]
  • [Cites] Intern Med J. 2005 Dec;35 Suppl 2:S72-8 [16271063.001]
  • [Cites] J Antibiot (Tokyo). 2008 Jan;61(1):7-10 [18305353.001]
  • [Cites] Am J Surg. 2010 Jul;200(1):47-52 [20074700.001]
  • [Cites] Eur J Vasc Endovasc Surg. 2010 Apr;39(4):472-7 [20060756.001]
  • [Cites] Semin Vasc Surg. 2011 Dec;24(4):199-204 [22230674.001]
  • [Cites] Nat Chem Biol. 2011 Jun;7(6):348-50 [21516114.001]
  • [Cites] Eur J Pharmacol. 2015 Jan 15;747:7-12 [25449032.001]
  • [Cites] Eur J Vasc Endovasc Surg. 2012 May;43(5):582-7 [22421376.001]
  • [Cites] PLoS One. 2013;8(3):e57493 [23505431.001]
  • [Cites] Forensic Sci Int. 1994 Feb;64(2-3):165-70 [8175087.001]
  • [Cites] Eur J Pharm Sci. 2011 Jun 14;43(3):89-98 [21447389.001]
  • [Cites] PLoS One. 2013 May 17;8(5):e64518 [23691239.001]
  • [Cites] Expert Rev Anti Infect Ther. 2007 Apr;5(2):305-15 [17402845.001]
  • [Cites] JAMA. 2015 Jul 21;314(3):296-7 [26197191.001]
  • [Cites] J Control Release. 2016 Nov 10;241:125-134 [27663229.001]
  • [Cites] PLoS One. 2012;7(11):e48981 [23166602.001]
  • [Cites] In Vivo. 2014 Jan-Feb;28(1):33-8 [24425833.001]
  • [Cites] APMIS. 1988 Dec;96(12):1079-84 [3214583.001]
  • [Cites] Vasc Endovascular Surg. 2006 Jan-Feb;40(1):1-10 [16456600.001]
  • [Cites] Int J Antimicrob Agents. 2003 Sep;22(3):250-3 [13678829.001]
  • [Cites] Int J Antimicrob Agents. 2010 Apr;35(4):322-32 [20149602.001]
  • [Cites] FEMS Microbiol Lett. 2011 May;318(2):168-76 [21375577.001]
  • [Cites] Eur J Vasc Endovasc Surg. 2008 Jan;35(1):41-5 [17719807.001]
  • [Cites] Drug Metab Dispos. 2006 Mar;34(3):471-6 [16272405.001]
  • [Cites] In Vivo. 2004 Nov-Dec;18(6):787-94 [15646821.001]
  • [Cites] Adv Surg. 1996;29:33-9 [8719993.001]
  • [Cites] Toxicol Appl Pharmacol. 1999 Jul 15;158(2):115-24 [10406926.001]
  • [Cites] Int J Antimicrob Agents. 2010 Feb;35(2):174-6 [20005679.001]
  • [Cites] In Vivo. 2007 Sep-Oct;21(5):771-5 [18019410.001]
  • [Cites] J Antimicrob Chemother. 2008 Dec;62(6):1215-21 [18836185.001]
  • [Cites] J Infect. 2000 Mar;40(2):184-7 [10841097.001]
  • [Cites] J Med Chem. 2013 Jun 27;56(12):4975-89 [23710549.001]
  • [Cites] Res Microbiol. 2013 Feb-Mar;164(2):181-8 [23089256.001]
  • [Cites] J Vasc Surg. 2006 Jul;44(1):38-45 [16828424.001]
  • [Cites] In Vivo. 2006 May-Jun;20(3):361-6 [16724671.001]
  • (PMID = 28278183.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Jancel T, Shaw PA, Hallahan CW, Kim T, Freeman AF, Holland SM, Penzak SR: Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review. J Clin Pharm Ther; 2017 Feb;42(1):75-79
MedlinePlus Health Information. consumer health - Fungal Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients were included if they were initiated on posaconazole for prophylaxis or treatment for fungal infections from September 2006 through March 2013 with at least one trough concentration collected after at least 7 days of therapy.
  • Until studies are conducted to determine the appropriate dosing of posaconazole in this patient population, therapeutic drug monitoring should be considered to ensure adequate posaconazole exposure.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
  • [Cites] Ann Pharmacother. 2013 Jul-Aug;47(7-8):976-83 [23737511.001]
  • [Cites] Pediatr Infect Dis J. 2015 Jun;34(6):604-6 [25973938.001]
  • [Cites] Clin Infect Dis. 2008 Jun 15;46(12):1813-21 [18462102.001]
  • [Cites] Clin Pharmacokinet. 2011 Nov 1;50(11):725-34 [21973269.001]
  • [Cites] Antimicrob Agents Chemother. 2014 Nov;58(11):6879-85 [25199779.001]
  • [Cites] Pediatr Infect Dis J. 2011 Sep;30(9):794-7 [21772229.001]
  • [Cites] Pediatr Blood Cancer. 2009 Jul;52(7):872-4 [19127570.001]
  • [Cites] Mycoses. 2009 May;52(3):276-9 [18643916.001]
  • [Cites] BMC Infect Dis. 2012 Oct 19;12:263 [23082876.001]
  • [Cites] Pediatr Infect Dis J. 2010 Jun;29(6):578 [20508483.001]
  • [Cites] Antimicrob Agents Chemother. 2009 Mar;53(3):958-66 [19075045.001]
  • [Cites] J Clin Microbiol. 2009 Jun;47(6):1969-72 [19386841.001]
  • [Cites] Antimicrob Agents Chemother. 2007 Mar;51(3):812-8 [17210771.001]
  • [Cites] Clin Infect Dis. 2007 Jan 1;44(1):2-12 [17143808.001]
  • [Cites] Antimicrob Agents Chemother. 2012 Aug;56(8):4196-201 [22615291.001]
  • [Cites] Antimicrob Agents Chemother. 2009 Jul;53(7):2960-4 [19433558.001]
  • [Cites] J Antimicrob Chemother. 2014 May;69(5):1162-76 [24379304.001]
  • [Cites] Antimicrob Agents Chemother. 2003 Sep;47(9):2788-95 [12936975.001]
  • [Cites] Pediatr Infect Dis J. 2016 Feb;35(2):183-8 [26544987.001]
  • [Cites] Med Mycol. 2016 Feb;54(2):128-37 [26483433.001]
  • [Cites] Clin Pharmacol Ther. 2010 Jul;88(1):115-9 [20505665.001]
  • [Cites] Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15 [16723559.001]
  • [Cites] Pharmacotherapy. 2013 Jan;33(1):e1-8 [23307552.001]
  • [Cites] Ann Pharmacother. 2012 Sep;46(9):e22 [22872751.001]
  • (PMID = 27982447.001).
  • [ISSN] 1365-2710
  • [Journal-full-title] Journal of clinical pharmacy and therapeutics
  • [ISO-abbreviation] J Clin Pharm Ther
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 CL006002-01
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antifungal Agents; 0 / Suspensions; 0 / Triazoles; 6TK1G07BHZ / posaconazole
  • [Keywords] NOTNLM ; paediatric (major topic) / pharmacokinetics (major topic) / posaconazole (major topic) / therapeutic drug monitoring (major topic)
  •  go-up   go-down


6. Montaner Ramón A, Murillo Sanjuán L, Martínez Faci C, Guerrero Laleona C, Rodríguez-Vigil Iturrate C: [Serratia infections, should we think about primary immunodeficiencies?]. Arch Argent Pediatr; 2017 Apr 01;115(2):e108-e111

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Serratia infections, should we think about primary immunodeficiencies?]
  • CGD is characterized by sensitivity to recurrent and severe bacterial and fungal infections, with formation of granulomas due to the inability of phagocytes to generate reactive oxygen compounds, necessary for the intracellular death of phagocytic microorganisms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Sociedad Argentina de Pediatría.
  • (PMID = 28318195.001).
  • [ISSN] 1668-3501
  • [Journal-full-title] Archivos argentinos de pediatria
  • [ISO-abbreviation] Arch Argent Pediatr
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract
  • [Publication-country] Argentina
  • [Keywords] NOTNLM ; Serratia marcescens / granuloma / pediatrics / phagocytes / primary immunodeficiencies
  •  go-up   go-down


7. Ortegón L, Puentes-Herrera M, Corrales IF, Cortés JA: Colonization and infection in the newborn infant: Does chlorhexidine play a role in infection prevention? Arch Argent Pediatr; 2017 02 01;115(1):65-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Healthcare-associated infections are a major problem in newborn infants, considering their high morbidity, mortality, and long-term sequelae.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Sociedad Argentina de Pediatría.
  • (PMID = 28097843.001).
  • [ISSN] 1668-3501
  • [Journal-full-title] Archivos argentinos de pediatria
  • [ISO-abbreviation] Arch Argent Pediatr
  • [Language] eng; spa
  • [Publication-type] Journal Article
  • [Publication-country] Argentina
  • [Keywords] NOTNLM ; chlorhexidine / nosocomial infection / preterm infant / primary prevention / sepsis
  •  go-up   go-down


8. Zu J, Zhuang G, Liang P, Cui F, Wang F, Zheng H, Liang X: Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model. Sci Rep; 2017 Jun 06;7(1):2912

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model.
  • The age-specific seroclearance pattern of hepatitis B surface antigen (HBsAg) in chronic hepatitis B virus (HBV) infections of China remains unclear.
  • In this study, based on three national serosurvey data of hepatitis B in China, we propose an age- and time-dependent discrete model and use the method of non-linear least squares to estimate the age-specific annual rate of HBsAg seroclearance.
  • We found that the HBsAg seroclearance in chronic HBV infections of China aged 1-59 years occurred at an average annual rate of 1.80% (95% CI, 1.54-2.06%) from 1993 to 2006.
  • It also prevented 9.30% of new HBV infections (about 7.43 million people) and 9.95% of HBV-related deaths (about 0.25 million people) from 1993 to 2006.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:7-10 [23855289.001]
  • [Cites] Antivir Ther. 2010;15(2):133-43 [20386068.001]
  • [Cites] Gastroenterology. 2004 Sep;127(3):756-63 [15362032.001]
  • [Cites] Hepatology. 2004 Jun;39(6):1694-701 [15185311.001]
  • [Cites] Sci Rep. 2016 Nov 07;6:36186 [27819332.001]
  • [Cites] Hepatogastroenterology. 2008 Mar-Apr;55(82-83):578-81 [18613411.001]
  • [Cites] Science. 1993 Oct 15;262(5132):369-70 [8211155.001]
  • [Cites] Vaccine. 2009 Nov 5;27(47):6550-7 [19729084.001]
  • [Cites] Int J Epidemiol. 2005 Dec;34(6):1329-39 [16249217.001]
  • [Cites] Zhonghua Liu Xing Bing Xue Za Zhi. 1991 Dec;12(6):325-6 [1811889.001]
  • [Cites] Gastroenterology. 2002 Oct;123(4):1084-9 [12360470.001]
  • [Cites] Hepatology. 1997 Nov;26(5):1338-42 [9362381.001]
  • [Cites] Int J Epidemiol. 2000 Aug;29(4):744-52 [10922354.001]
  • [Cites] Science. 1999 Dec 24;286(5449):2453-4 [10636808.001]
  • [Cites] Nat Commun. 2015 Mar 25;6:6588 [25807344.001]
  • [Cites] J Infect Dis. 2009 Jul 1;200(1):39-47 [19469708.001]
  • [Cites] Lancet. 2009 Feb 14;373(9663):582-92 [19217993.001]
  • [Cites] Sci Rep. 2016 Jun 21;6:27251 [27324884.001]
  • [Cites] Hepatology. 1992 Mar;15(3):382-6 [1544619.001]
  • [Cites] Nature. 2001 May 17;411(6835):390-5 [11357148.001]
  • [Cites] Hepatology. 2001 Jul;34(1):139-45 [11431745.001]
  • [Cites] Nat Med. 2001 May;7(5):619-24 [11329065.001]
  • [Cites] Sci Rep. 2016 Aug 22;6:31349 [27546197.001]
  • [Cites] Pediatr Infect Dis J. 2003 Feb;22(2):157-63 [12586980.001]
  • [Cites] Hepatology. 1992 May;15(5):770-6 [1568717.001]
  • [Cites] J Hyg (Lond). 1985 Oct;95(2):419-36 [4067297.001]
  • [Cites] N Engl J Med. 1996 May 30;334(22):1422-7 [8618580.001]
  • [Cites] Hepatol Int. 2007 Mar;1(1):267-73 [19669348.001]
  • [Cites] J Gastroenterol. 2000;35(3):201-5 [10755689.001]
  • [Cites] Sci Rep. 2016 Dec 01;6:38180 [27905528.001]
  • [Cites] Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Sep;26(9):655-8 [16471211.001]
  • [Cites] Hepatology. 2007 May;45(5):1187-92 [17465003.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):1848-56 [12454842.001]
  • [Cites] Am J Epidemiol. 1997 Jun 1;145(11):1039-47 [9169913.001]
  • [Cites] J Theor Biol. 2015 Dec 7;386:115-21 [26375372.001]
  • [Cites] Hum Vaccin Immunother. 2015;11(6):1534-9 [25881006.001]
  • (PMID = 28588249.001).
  • [ISSN] 2045-2322
  • [Journal-full-title] Scientific reports
  • [ISO-abbreviation] Sci Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. Thomas K, Vassilopoulos D: Immunization in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol; 2016 Oct;30(5):946-963

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Immunization represents the most efficient and simplest intervention to prevent certain viral and bacterial infections in the general population as well as in the vulnerable population of patients with inflammatory rheumatic diseases treated with immunosuppressives.
  • Here, we present an updated review of literature data regarding the safety and efficacy of immunizations against different pathogens in rheumatic patients treated with conventional immunosuppressives or the newer biologic agents while at the same time we provide practical guidance for the appropriate vaccine administration in this patient population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier Ltd. All rights reserved.
  • (PMID = 27964798.001).
  • [ISSN] 1532-1770
  • [Journal-full-title] Best practice & research. Clinical rheumatology
  • [ISO-abbreviation] Best Pract Res Clin Rheumatol
  • [Language] eng
  • [Publication-type] Review; Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Biologics / Corticosteroids / Disease modifying anti-rheumatic drugs / Hepatitis B virus / Herpes zoster / Human papilloma virus / Influenza / Pneumococcal / Vaccines
  •  go-up   go-down


10. Absinta M, Cortese IC, Vuolo L, Nair G, de Alwis MP, Ohayon J, Meani A, Martinelli V, Scotti R, Falini A, Smith BR, Nath A, Jacobson S, Filippi M, Reich DS: Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology; 2017 Apr 11;88(15):1439-1444
Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: On 3T postcontrast T2-FLAIR images, the presence of focal gadolinium enhancement was evaluated in the leptomeningeal compartment in 254 people with non-MS neurologic conditions or neurotropic viral infections.
  • [MeSH-minor] Adult. Aged. Cohort Studies. Cross-Sectional Studies. Female. HIV Infections / cerebrospinal fluid. HIV Infections / diagnostic imaging. Humans. Imaging, Three-Dimensional. Leukocyte Count. Linear Models. Male. Middle Aged. Multiple Sclerosis, Relapsing-Remitting / cerebrospinal fluid. Multiple Sclerosis, Relapsing-Remitting / diagnostic imaging. Nervous System Diseases / cerebrospinal fluid. Nervous System Diseases / diagnostic imaging. Oligoclonal Bands / cerebrospinal fluid. Young Adult

  • MedlinePlus Health Information. consumer health - Encephalitis.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 American Academy of Neurology.
  • [Cites] J Neurotrauma. 2017 Jan 1;34(1):23-30 [27215444.001]
  • [Cites] J Neuropathol Exp Neurol. 1998 Sep;57(9):839-49 [9737547.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):435-7 [7561926.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 Apr;24(4):719-23 [12695212.001]
  • [Cites] Neuroimage. 2010 Jan 15;49(2):1524-35 [19766196.001]
  • [Cites] Clin Lab. 2006;52(3-4):115-24 [16584057.001]
  • [Cites] Neurology. 2015 Jul 7;85(1):18-28 [25888557.001]
  • [Cites] Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e164 [26516629.001]
  • [Cites] J Neurol. 1988 Jan;235(3):129-30 [2896763.001]
  • [Cites] J Neuropathol Exp Neurol. 1997 Apr;56(4):403-13 [9100671.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Jan;21(1):105-11 [10669233.001]
  • [Cites] JAMA Neurol. 2017 Jan 1;74(1):100-109 [27893883.001]
  • [Cites] Mult Scler. 2016 Nov 1;:1352458516678083 [27811339.001]
  • [Cites] Acta Neurol Scand. 1989 May;79(5):361-5 [2741667.001]
  • (PMID = 28283598.001).
  • [ISSN] 1526-632X
  • [Journal-full-title] Neurology
  • [ISO-abbreviation] Neurology
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oligoclonal Bands; AU0V1LM3JT / Gadolinium
  •  go-up   go-down


11. Zilm PS, Butnejski V, Rossi-Fedele G, Kidd SP, Edwards S, Vasilev K: D-amino acids reduce Enterococcus faecalis biofilms in vitro and in the presence of antimicrobials used for root canal treatment. PLoS One; 2017;12(2):e0170670

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Enterococcus faecalis is the most frequent species present in post-treatment disease and plays a significant role in persistent periapical infections following root canal treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Microbiol Immunol. 1992 Oct;7(5):257-62 [1494447.001]
  • [Cites] Trends Microbiol. 2001 Jan;9(1):9-10 [11252255.001]
  • [Cites] Aust Dent J. 2007 Mar;52(1 Suppl):S64-82 [17546863.001]
  • [Cites] Science. 2009 Sep 18;325(5947):1552-5 [19762646.001]
  • [Cites] Int Endod J. 2006 Apr;39(4):249-81 [16584489.001]
  • [Cites] World J Microbiol Biotechnol. 2012 Oct;28(10):3067-74 [22806745.001]
  • [Cites] Int J Antimicrob Agents. 2007 Sep;30(3):236-41 [17574822.001]
  • [Cites] J Microbiol Methods. 2011 Feb;84(2):167-73 [21081140.001]
  • [Cites] Int Endod J. 2015 Mar;48(3):210-9 [24749689.001]
  • [Cites] Appl Environ Microbiol. 2001 Oct;67(10):4538-45 [11571153.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Jun;46(6):1845-50 [12019099.001]
  • [Cites] J Bacteriol. 2013 Dec;195(23):5391-5 [24097941.001]
  • [Cites] J Microbiol Methods. 2008 Feb;72 (2):157-65 [18155789.001]
  • [Cites] Science. 1988 Jun 3;240(4857):1302-9 [3287616.001]
  • [Cites] Int Endod J. 1998 Jan;31(1):1-7 [9823122.001]
  • [Cites] BMC Microbiol. 2006 Jul 11;6:60 [16834772.001]
  • [Cites] World J Microbiol Biotechnol. 2012 Apr;28(4):1641-6 [22805946.001]
  • [Cites] Oral Microbiol Immunol. 2000 Oct;15(5):309-12 [11154422.001]
  • [Cites] J Dent Res. 1987 Aug;66(8):1375-9 [3114347.001]
  • [Cites] Int Endod J. 2003 Jan;36(1):1-11 [12656508.001]
  • [Cites] Int Endod J. 2014 Nov;47(11):1003-11 [25298127.001]
  • [Cites] APMIS. 2007 Aug;115(8):891-9 [17696944.001]
  • [Cites] FEBS Open Bio. 2016 May 19;6(6):586-93 [27419061.001]
  • [Cites] Science. 2010 Apr 30;328(5978):627-9 [20431016.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):502-4 [11561809.001]
  • [Cites] J Microbiol Methods. 2000 Apr;40(2):175-9 [10699673.001]
  • [Cites] J Microbiol Methods. 2004 Sep;58(3):351-60 [15279939.001]
  • [Cites] Front Microbiol. 2016 Jun 13;7:896 [27379039.001]
  • [Cites] Int Endod J. 1997 Sep;30(5):297-306 [9477818.001]
  • [Cites] PLoS One. 2015 Feb 06;10(2):e0117613 [25658642.001]
  • [Cites] Int Endod J. 2001 Sep;34(6):429-34 [11556508.001]
  • [Cites] Infect Immun. 2015 Feb;83(2):470-81 [25385795.001]
  • [Cites] J Med Microbiol. 2014 Oct;63(Pt 10):1369-76 [25001104.001]
  • (PMID = 28151960.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Nukui A, Masuda A, Abe H, Arai K, Yoshida KI, Kamai T: Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy. BMC Cancer; 2017 May 25;17(1):372
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Soluble interleukin-2 receptor (sIL-2R) has a role in T cell activation and may be important for immune regulation in various conditions, including infections, transplantation rejection, autoimmune inflammatory states, and cancer.
  • METHODS: We monitored the serum level of sIL-2R over time and examined phosphorylated Akt expression by the primary tumor in 47 patients with metastatic clear cell RCC (ccRCC) undergoing cytoreductive nephrectomy followed by first-line adjuvant therapy with IFN-alpha plus sequential VEGF-targeting therapy as second- or third-line adjuvant therapy.
  • RESULTS: A preoperative increase of the serum level of sIL-2R was correlated with a higher preoperative serum level of programmed cell death 1 (PD-1)-ligand 1 (PD-L1), increased expression of phosphorylated Akt by the primary tumor, and a worse response to IFN-alpha/sequential VEGF-targeting therapy, as well as being an independent prognostic factor for a shorter overall survival time by multivariate analysis.
  • Over time, the serum sIL-2R level largely reflected the tumor response to therapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4275-80 [20160101.001]
  • [Cites] Nat Rev Immunol. 2012 Feb 17;12(3):180-90 [22343569.001]
  • [Cites] Int J Biol Markers. 2008 Apr-Jun;23(2):121-2 [18629785.001]
  • [Cites] Cancer Immunol Immunother. 2011 Jun;60(6):793-808 [21350947.001]
  • [Cites] J Biol Chem. 2008 Dec 12;283(50):34495-9 [18945681.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16 [10655437.001]
  • [Cites] Immunity. 2013 Jan 24;38(1):13-25 [23352221.001]
  • [Cites] Cancer Res. 1998 Jul 15;58(14):3078-86 [9679974.001]
  • [Cites] Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12526-34 [23852728.001]
  • [Cites] Br J Cancer. 2003 Nov 17;89(10):1906-8 [14612901.001]
  • [Cites] Nature. 2005 Dec 8;438(7069):820-7 [16341007.001]
  • [Cites] Nat Rev Immunol. 2008 Jun;8(6):467-77 [18500231.001]
  • [Cites] Science. 2011 Mar 25;331(6024):1565-70 [21436444.001]
  • [Cites] Immunity. 2010 Aug 27;33(2):153-65 [20732639.001]
  • [Cites] Cell. 2011 Mar 4;144(5):646-74 [21376230.001]
  • [Cites] BMC Cancer. 2015 ;15:1097 [25784113.001]
  • [Cites] Nat Rev Immunol. 2009 Mar;9(3):162-74 [19197294.001]
  • [Cites] J Clin Oncol. 2006 Mar 1;24(7):1169-77 [16505437.001]
  • [Cites] Clin Cancer Res. 2013 Jul 1;19(13):3345-52 [23633457.001]
  • [Cites] Cell. 2015 Sep 10;162(6):1217-28 [26321681.001]
  • [Cites] Cancer. 2010 Jan 1;116(1):57-65 [19862815.001]
  • [Cites] Int J Urol. 2013 Oct;20(10):944-55 [23692504.001]
  • [Cites] J Clin Oncol. 2009 Jun 1;27(16):2697-704 [19380450.001]
  • [Cites] Cancer Cell. 2002 Oct;2(4):289-300 [12398893.001]
  • [Cites] J Clin Invest. 2005 Dec;115(12):3623-33 [16308572.001]
  • [Cites] BMC Cancer. 2015 Oct 09;15:667 [26452347.001]
  • [Cites] Cell. 2015 Sep 10;162(6):1229-41 [26321679.001]
  • [Cites] Cell. 2008 May 30;133(5):775-87 [18510923.001]
  • [Cites] PLoS One. 2013 Nov 13;8(11):e78730 [24236041.001]
  • [Cites] Cell. 2010 Apr 2;141(1):39-51 [20371344.001]
  • [Cites] Cancer Immunol Res. 2014 Oct;2(10):926-36 [25281320.001]
  • (PMID = 28545581.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Axitinib / Interferon / Renal cell carcinoma / Soluble interleulin-2 receptor / Sorafenib
  •  go-up   go-down


13. Girardi A, Galletti S, Raschi E, Koci A, Poluzzi E, Faldella G, De Ponti F: Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit. Ital J Pediatr; 2017 Apr 17;43(1):37

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Drug use in preterm neonates admitted to Neonatal Intensive Care Unit (NICU) has been investigated, so far, in terms of unauthorized or off-label use; very little is known on the use of combinations of different active substances, which is frequently required in this population (prophylaxis of infections, treatment of concomitant diseases).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2007 Jun 14;356(24):2483-95 [17568029.001]
  • [Cites] Pediatrics. 2015 May;135(5):826-33 [25896845.001]
  • [Cites] Acta Paediatr. 2014 Apr;103(4):e139-42 [24397831.001]
  • [Cites] Pediatr Int. 2014 Feb;56(1):57-9 [23937449.001]
  • [Cites] Semin Fetal Neonatal Med. 2005 Apr;10(2):115-22 [15701577.001]
  • [Cites] Int J Clin Pharm. 2015 Aug;37(4):645-55 [25832676.001]
  • [Cites] Int J Risk Saf Med. 2015;27 Suppl 1:S9-S10 [26639729.001]
  • [Cites] J Perinatol. 2011 Mar;31(3):199-205 [20651693.001]
  • [Cites] Drug Saf. 2015 Jun;38(6):535-51 [25863473.001]
  • [Cites] Acta Paediatr. 2013 Nov;102(11):1067-74 [23855971.001]
  • [Cites] Clin Dev Immunol. 2013;2013:586076 [23762094.001]
  • [Cites] Pediatrics. 2015 May;135(5):928-9 [25896842.001]
  • [Cites] Arch Dis Child. 2015 Apr;100(4):394-8 [25628457.001]
  • [Cites] Pediatr Res. 2011 Apr;69(4):354-8 [21178824.001]
  • [Cites] Early Hum Dev. 2011 Mar;87 Suppl 1:S31-3 [21251768.001]
  • [Cites] Pediatr Crit Care Med. 2013 Mar;14(3):318-22 [23392363.001]
  • [Cites] Eur J Clin Pharmacol. 2010 Jan;66(1):87-95 [19756556.001]
  • [Cites] Eur J Clin Pharmacol. 2016 Jan;72 (1):117-23 [26490354.001]
  • [Cites] N Engl J Med. 2001 Dec 6;345(23):1660-6 [11759644.001]
  • [Cites] Pharmaceuticals (Basel). 2013 Sep 05;6(9):1094-129 [24276421.001]
  • [Cites] Pediatr Nephrol. 2013 Mar;28(3):477-84 [23070277.001]
  • [Cites] Pediatrics. 2006 Jun;117(6):1979-87 [16740839.001]
  • [Cites] Pediatrics. 2013 Aug;132(2):e372-80 [23878051.001]
  • [Cites] Eur J Clin Pharmacol. 2014 Apr;70(4):445-52 [24398969.001]
  • [Cites] Eur J Pediatr. 2012 Mar;171(3):439-45 [21912893.001]
  • [Cites] Pediatr Nephrol. 2013 Apr;28(4):661-6 [23224224.001]
  • [Cites] BMC Pediatr. 2013 Jan 07;13:5 [23294560.001]
  • [Cites] Arch Dis Child Fetal Neonatal Ed. 2011 Jul;96(4):F290-5 [21173011.001]
  • [Cites] J Clin Pharm Ther. 2016 Dec;41(6):612-620 [27578606.001]
  • [Cites] Expert Opin Drug Saf. 2008 Nov;7(6):679-90 [18983215.001]
  • [Cites] Pediatr Nephrol. 2012 Sep;27(9):1575-82 [22532328.001]
  • (PMID = 28412957.001).
  • [ISSN] 1824-7288
  • [Journal-full-title] Italian journal of pediatrics
  • [ISO-abbreviation] Ital J Pediatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Drug use / Neonatal intensive care unit / Nephrotoxicity / Preterm neonates
  •  go-up   go-down


14. Crawford G, Lobo R, Brown G, Macri C, Smith H, Maycock B: HIV, Other Blood-Borne Viruses and Sexually Transmitted Infections amongst Expatriates and Travellers to Low- and Middle-Income Countries: A Systematic Review. Int J Environ Res Public Health; 2016 Dec 16;13(12)
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] HIV, Other Blood-Borne Viruses and Sexually Transmitted Infections amongst Expatriates and Travellers to Low- and Middle-Income Countries: A Systematic Review.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Travel Med. 2004 May-Jun;11(3):171-4 [15710059.001]
  • [Cites] J Community Health. 2015 Aug;40(4):725-35 [25618578.001]
  • [Cites] J Travel Med. 2006 Sep-Oct;13(5):300-17 [16987130.001]
  • [Cites] Travel Med Infect Dis. 2006 Mar;4(2):86-93 [16887730.001]
  • [Cites] J Community Health. 2016 Apr;41(2):424-41 [26499822.001]
  • [Cites] BMJ. 2004 Jul 24;329(7459):214-7 [15271833.001]
  • [Cites] Occup Med (Lond). 2000 Nov;50(8):572-8 [11220025.001]
  • [Cites] J Travel Med. 2009 Mar-Apr;16(2):79-83 [19335805.001]
  • [Cites] J Travel Med. 2000 Jul-Aug;7(4):170-4 [11003727.001]
  • [Cites] AIDS. 2001 Jul 27;15(11):1442-5 [11504969.001]
  • [Cites] Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):750-6 [25457304.001]
  • [Cites] Lancet Infect Dis. 2013 Mar;13(3):205-13 [23182931.001]
  • [Cites] Scand J Public Health. 2013 Jun;41(4):392-7 [23470474.001]
  • [Cites] Sex Transm Dis. 2013 Oct;40(10):797-800 [24275731.001]
  • [Cites] HIV Med. 2012 May;13(5):315-7 [22276810.001]
  • [Cites] Health Promot J Austr. 2016 Apr 04;:null [27040978.001]
  • [Cites] Int Marit Health. 2015 ;66(4):238-46 [26726895.001]
  • [Cites] Travel Med Infect Dis. 2012 Mar;10(2):59-68 [22459635.001]
  • [Cites] Open Med. 2014 Feb 11;8(1):e20-32 [25009682.001]
  • [Cites] Int J Antimicrob Agents. 2003 Feb;21(2):131-4 [12615376.001]
  • [Cites] Southeast Asian J Trop Med Public Health. 2013 Jul 4;44(4):690-6 [24050104.001]
  • [Cites] Bioethics. 2009 Feb;23(2):97-111 [19531163.001]
  • [Cites] J Travel Med. 2009 Nov-Dec;16(6):382-90 [19930377.001]
  • [Cites] Occup Med (Lond). 2007 Aug;57(5):313-21 [17656496.001]
  • [Cites] PLoS One. 2015 Dec 08;10(12):e0143304 [26646541.001]
  • [Cites] Travel Med Infect Dis. 2007 Sep;5(5):287-94 [17870633.001]
  • [Cites] Int J Environ Res Public Health. 2014 Aug 20;11(8):8552-66 [25141001.001]
  • [Cites] Sex Transm Infect. 2007 Dec;83(7):517-22 [17991687.001]
  • [Cites] J Travel Med. 2014 Jan-Feb;21(1):45-51 [24354921.001]
  • [Cites] Scand J Infect Dis. 2014 Jun;46(6):447-53 [24694214.001]
  • [Cites] J Travel Med. 2006 Nov-Dec;13(6):345-50 [17107427.001]
  • [Cites] Sex Health. 2014 Dec;11(6):547-55 [25355061.001]
  • [Cites] Curr Infect Dis Rep. 2005 Mar;7(2):132-137 [15727741.001]
  • [Cites] BMJ Open. 2013 Feb 26;3(2):null [23444449.001]
  • [Cites] J Travel Med. 2008 Jan-Feb;15(1):6-12 [18217863.001]
  • [Cites] Int J STD AIDS. 2012 Nov;23(11):833-4 [23155108.001]
  • [Cites] Cult Health Sex. 2012;14(6):677-90 [22591069.001]
  • [Cites] J Travel Med. 2003 Jul-Aug;10(4):214-8 [12946299.001]
  • [Cites] Soc Sci Med. 2012 Dec;75(12):2055-9 [23072818.001]
  • [Cites] J Travel Med. 2009 Sep-Oct;16(5):332-7 [19796104.001]
  • [Cites] Trop Med Int Health. 2010 Dec;15(12):1458-63 [20958895.001]
  • [Cites] Travel Med Infect Dis. 2006 May-Jul;4(3-4):184-95 [16887740.001]
  • [Cites] J Travel Med. 2008 Jul-Aug;15(4):237-42 [18666923.001]
  • [Cites] Travel Med Infect Dis. 2008 Sep;6(5):315-20 [18760256.001]
  • [Cites] Occup Med (Lond). 2011 Jan;61(1):6-18 [21183578.001]
  • [Cites] Sex Transm Dis. 2002 Sep;29(9):510-3 [12218841.001]
  • [Cites] Cult Health Sex. 2006 Mar-Apr;8(2):115-31 [16641061.001]
  • [Cites] Int J Environ Res Public Health. 2014 Sep 26;11(10 ):10051-61 [25264681.001]
  • [Cites] PLoS Med. 2009 Jul 21;6(7):e1000097 [19621072.001]
  • [Cites] Sex Health. 2009 Mar;6(1):35-9 [19254489.001]
  • (PMID = 27999275.001).
  • [ISSN] 1660-4601
  • [Journal-full-title] International journal of environmental research and public health
  • [ISO-abbreviation] Int J Environ Res Public Health
  • [Language] eng
  • [Publication-type] Review; Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; HIV / HIV acquisition overseas / expatriates / high- to low- and middle-income countries / population mobility / sexual health / travelers
  •  go-up   go-down


15. Wu ZQ, Zhang Y, Zhao N, Yu Z, Pan H, Chan TC, Zhang ZR, Liu SL: Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses. Int J Environ Res Public Health; 2017 Mar 04;14(3)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses.
  • In conclusion, old age, comorbidities, delayed confirmation, along with poultry exposure are the major risks contributing to fatal outcomes in human HPAI and LPAI infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Infect Dis. 2014 Sep 15;59(6):787-94 [24928293.001]
  • [Cites] Clin Infect Dis. 2015 Aug 15;61(4):563-71 [25940354.001]
  • [Cites] BMJ. 2013 Jun 24;346:f3693 [23798720.001]
  • [Cites] Sci Rep. 2015 Dec 22;5:18610 [26691585.001]
  • [Cites] BMC Infect Dis. 2014 Feb 21;14:98 [24559386.001]
  • [Cites] J Infect Dis. 2014 Jan 15;209(2):265-9 [23935201.001]
  • [Cites] Lancet. 2013 Jul 13;382(9887):129-37 [23803488.001]
  • [Cites] Annu Rev Med. 2015;66:361-71 [25386931.001]
  • [Cites] Lancet. 2006 Jan 7;367(9504):84 [16399159.001]
  • [Cites] Virol J. 2015 Sep 28;12:151 [26411256.001]
  • [Cites] Avian Dis. 2007 Mar;51(1 Suppl):167-73 [17494549.001]
  • [Cites] N Engl J Med. 2013 May 16;368(20):1888-97 [23577628.001]
  • [Cites] Emerg Microbes Infect. 2013 Jul;2(7):e41 [26038475.001]
  • [Cites] BMJ. 2013 Aug 06;347:f4752 [23920350.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62 [20798667.001]
  • [Cites] Infect Dis Clin North Am. 2005 Sep;19(3):569-84 [16102649.001]
  • [Cites] J Virol. 2007 Nov;81(21):11612-9 [17728231.001]
  • [Cites] Rev Med Virol. 2013 Jan;23(1):3-14 [22411229.001]
  • [Cites] N Engl J Med. 2014 Feb 6;370(6):520-32 [23614499.001]
  • [Cites] N Engl J Med. 2015 Jul 30;373(5):487-9 [26222578.001]
  • [Cites] Int J Infect Dis. 2014 Dec;29:254-8 [25462187.001]
  • [Cites] Euro Surveill. 2014 Jun 26;19(25):null [24993555.001]
  • [Cites] Pediatr Infect Dis J. 2015 Jan;34(1):104-7 [25068289.001]
  • [Cites] Clin Infect Dis. 2014 Sep 15;59(6):e76-83 [24867786.001]
  • [Cites] MBio. 2011 Jan 25;2(1):e00309-10 [21264063.001]
  • [Cites] Emerg Infect Dis. 2016 Jun;22(6):964-72 [27191934.001]
  • [Cites] N Engl J Med. 2016 Feb 11;374(6):596-8 [26863372.001]
  • [Cites] Biosci Trends. 2015 Feb;9(1):73-8 [25787912.001]
  • [Cites] J Infect Dis. 2010 Oct 15;202(8):1154-60 [20831384.001]
  • [Cites] Emerg Infect Dis. 2015 Jul;21(7):1261-2 [26079430.001]
  • [Cites] N Engl J Med. 2008 Jan 17;358(3):261-73 [18199865.001]
  • [Cites] Lancet. 2013 Jul 13;382(9887):138-45 [23803487.001]
  • [Cites] Emerg Infect Dis. 2014 Dec;20(12):2076-9 [25425075.001]
  • [Cites] Emerg Infect Dis. 2002 Feb;8(2):154-9 [11897066.001]
  • [Cites] Emerg Infect Dis. 2016 Jan;22(1):49-55 [26692185.001]
  • [Cites] J Infect. 2013 Dec;67(6):595-605 [23958687.001]
  • [Cites] J Wildl Dis. 2013 Oct;49(4):965-77 [24502724.001]
  • [Cites] Int J Infect Dis. 2016 Aug;49:9-17 [27235087.001]
  • [Cites] BMJ. 2015 Nov 19;351:h5765 [26586515.001]
  • [Cites] Lancet. 2013 Jun 1;381(9881):1916-25 [23623390.001]
  • [Cites] Int J Environ Res Public Health. 2015 Jan 15;12(1):816-28 [25599373.001]
  • [Cites] BMC Infect Dis. 2014 Dec 31;14:698 [25551435.001]
  • [Cites] Emerg Infect Dis. 2015 Nov;21(11):2088-90 [26488869.001]
  • [Cites] Emerg Infect Dis. 2015 Nov;21(11):2029-35 [26488195.001]
  • [Cites] Clin Infect Dis. 2012 Nov;55(9):1198-204 [22843781.001]
  • (PMID = 28273867.001).
  • [ISSN] 1660-4601
  • [Journal-full-title] International journal of environmental research and public health
  • [ISO-abbreviation] Int J Environ Res Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; endemic infection / horizontal transmission / influenza virus / seasonal incidence
  •  go-up   go-down


16. Wegener JT, Kraal T, Stevens MF, Hollmann MW, Kerkhoffs GMMJ, Haverkamp D: Low-dose dexamethasone during arthroplasty: What do we know about the risks? EFORT Open Rev; 2016 Aug;1(8):303-309
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, conflicting views of orthopaedic surgeons and anaesthesiologists regarding the use of dexamethasone raise questions about risks of impaired wound healing and surgical site infections (SSI).The aim of this systematic review is to determine the level of evidence for the safety of a peri-operative single low dose of dexamethasone in hip and knee arthroplasty.We systematically reviewed literature in PubMed, EMBASE and Cochrane databases and cited references in articles found in the initial search from 1980 to 2013 based on predefined inclusion criteria.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Anaesth. 2008 Oct;101(4):535-41 [18653493.001]
  • [Cites] Eur J Anaesthesiol. 2010 Apr;27(4):324-30 [19734790.001]
  • [Cites] Clin Ther. 2005 Jun;27(6):740-5 [16117980.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004125 [16856030.001]
  • [Cites] Eur J Anaesthesiol. 2009 Apr;26(4):318-21 [19401661.001]
  • [Cites] J Bone Joint Surg Am. 2009 Jul;91(7):1621-9 [19571084.001]
  • [Cites] Eur J Anaesthesiol. 2010 Feb;27(2):192-5 [19915480.001]
  • [Cites] Anesthesiology. 2011 Sep;115(3):575-88 [21799397.001]
  • [Cites] Anaesth Intensive Care. 2010 Jul;38(4):661-6 [20715728.001]
  • [Cites] J Clin Pharm Ther. 2010 Dec;35(6):679-84 [21054459.001]
  • [Cites] Acta Orthop Suppl. 2012 Oct;83(346):1-39 [23205862.001]
  • [Cites] Acta Anaesthesiol Scand. 2004 Nov;48(10):1223-31 [15504180.001]
  • [Cites] Clin Orthop Relat Res. 2008 Nov;466(11):2617-27 [18704616.001]
  • [Cites] Ann Pharmacother. 2006 May;40(5):856-72 [16670360.001]
  • [Cites] Br J Dermatol. 2002 Nov;147(5):859-68 [12410694.001]
  • [Cites] Anesth Analg. 2000 Jan;90(1):186-94 [10625002.001]
  • [Cites] Anesth Analg. 2003 Nov;97(5):1377-80 [14570655.001]
  • [Cites] J Arthroplasty. 2013 Mar;28(3):385-9 [23142444.001]
  • [Cites] Clin Orthop Relat Res. 2009 Jun;467(6):1463-7 [19224304.001]
  • [Cites] J Am Coll Surg. 2002 Nov;195(5):694-712 [12437261.001]
  • [Cites] Am J Orthop (Belle Mead NJ). 2004 Feb;33(2):85-92; discussion 92 [15005598.001]
  • [Cites] Anesth Analg. 2008 Apr;106(4):1253-7, table of contents [18349202.001]
  • [Cites] J Invest Dermatol. 1997 Mar;108(3):285-9 [9036926.001]
  • [Cites] Reg Anesth Pain Med. 2011 Jan-Feb;36(1):36-40 [21455087.001]
  • [Cites] Ann Surg. 1973 Feb;177(2):222-7 [4572787.001]
  • [Cites] Br J Anaesth. 2011 Feb;106(2):230-8 [21131371.001]
  • [Cites] Acta Anaesthesiol Scand. 2009 Sep;53(8):1073-83 [19572933.001]
  • [Cites] Br J Anaesth. 2013 Jan;110(1):66-73 [22986420.001]
  • [Cites] Pain Pract. 2010 May-Jun;10(3):245-8 [20230453.001]
  • [Cites] J Arthroplasty. 2013 Sep;28(8 Suppl):11-7 [23937923.001]
  • [Cites] N Engl J Med. 2004 Jun 10;350(24):2441-51 [15190136.001]
  • [Cites] J Obstet Gynaecol Res. 2011 Dec;37(12):1807-12 [21794004.001]
  • [Cites] Anaesth Intensive Care. 2010 Jul;38(4):654-60 [20715727.001]
  • [Cites] J Int Med Res. 2006 Nov-Dec;34(6):603-11 [17294992.001]
  • [Cites] PLoS Med. 2009 Jul 21;6(7):e1000097 [19621072.001]
  • (PMID = 28461961.001).
  • [Journal-full-title] EFORT open reviews
  • [ISO-abbreviation] EFORT Open Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; PONV / SSI / arthroplasty / hip / knee / post-operative nausea and vomiting / surgical site infections
  •  go-up   go-down


17. Nadaf MI, Lima L, Stranieri I, Takano OA, Carneiro-Sampaio M, Palmeira P: Passive acquisition of anti-Staphylococcus aureus antibodies by newborns via transplacental transfer and breastfeeding, regardless of maternal colonization. Clinics (Sao Paulo); 2016 Dec 01;71(12):687-694

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The high titers of anti-Sa IgG2 found in the cord serum indicate a greater reactivity with non-protein antigens, which may further contribute to the susceptibility to staphylococcal infections at birth.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Otolaryngol Allied Sci. 2003 Aug;28(4):335-40 [12871248.001]
  • [Cites] Autoimmun Rev. 2013 Apr;12(6):661-5 [23201924.001]
  • [Cites] Vaccine. 2012 Jul 20;30(34):5099-109 [22691432.001]
  • [Cites] Neonatology. 2009;96(1):61-8 [19252410.001]
  • [Cites] J Clin Invest. 2010 Sep;120(9):3220-33 [20739753.001]
  • [Cites] Front Immunol. 2013 Aug 06;4:222 [23964273.001]
  • [Cites] Pediatr Infect Dis J. 2012 Apr;31(4):360-3 [22189535.001]
  • [Cites] J Infect Dis. 1994 Sep;170(3):592-9 [8077716.001]
  • [Cites] Proteomics. 2011 Aug;11(15):3221-31 [21710570.001]
  • [Cites] J Infect Dev Ctries. 2011 Dec 13;5(12):828-33 [22169780.001]
  • [Cites] J Exp Med. 1988 Jul 1;168(1):127-42 [3260935.001]
  • [Cites] FEMS Immunol Med Microbiol. 2008 Oct;54(1):137-43 [18665847.001]
  • [Cites] Mol Immunol. 2011 Aug;48(14):1656-65 [21757235.001]
  • [Cites] Pediatr Allergy Immunol. 2009 Sep;20(6):528-35 [19220771.001]
  • [Cites] J Comp Pathol. 2007 Jul;137 Suppl 1:S16-9 [17553516.001]
  • [Cites] Arch Dis Child. 2013 Feb;98(2):146-54 [23142784.001]
  • [Cites] J Immunol Methods. 1987 Dec 4;105(1):111-7 [3316403.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):115-27 [18688664.001]
  • [Cites] J Pediatr Orthop. 2013 Jun;33(4):464-7 [23653039.001]
  • [Cites] Vaccine. 2009 Dec 10;28(1):256-60 [19799842.001]
  • [Cites] Pediatrics. 2012 May;129(5):e1252-9 [22473373.001]
  • [Cites] J Mol Biol. 2013 May 27;425(10):1641-54 [23416200.001]
  • [Cites] Immunotherapy. 2011 Sep;3(9):1063-73 [21913829.001]
  • [Cites] Nat Rev Immunol. 2007 Sep;7(9):715-25 [17703228.001]
  • [Cites] Scand J Immunol. 2010 Jul;72(1):66-73 [20591078.001]
  • [Cites] J Infect Dis. 2009 Mar 1;199(5):625-32 [19199541.001]
  • [Cites] Nat Immunol. 2010 Sep;11(9):785-97 [20720586.001]
  • [Cites] J Diarrhoeal Dis Res. 1996 Jun;14(2):90-4 [8870401.001]
  • [Cites] Clin Exp Immunol. 1999 Dec;118(3):402-7 [10594558.001]
  • [Cites] Clin Dev Immunol. 2012;2012:985646 [22235228.001]
  • [Cites] Clin Dev Immunol. 2013;2013:826303 [23935651.001]
  • [Cites] Clin Diagn Lab Immunol. 2005 Mar;12(3):387-98 [15753252.001]
  • [Cites] Semin Immunopathol. 2012 Mar;34(2):237-59 [22080185.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2010 May;29(5):509-18 [20186449.001]
  • [Cites] Am J Hum Biol. 2013 May-Jun;25(3):399-403 [23559469.001]
  • [Cites] Clin Infect Dis. 2013 Jun;56(11):1554-61 [23446627.001]
  • (PMID = 28076511.001).
  • [ISSN] 1980-5322
  • [Journal-full-title] Clinics (Sao Paulo, Brazil)
  • [ISO-abbreviation] Clinics (Sao Paulo)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


18. Carestia A, Frechtel G, Cerrone G, Linari MA, Gonzalez CD, Casais P, Schattner M: NETosis before and after Hyperglycemic Control in Type 2 Diabetes Mellitus Patients. PLoS One; 2016;11(12):e0168647
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION AND OBJECTIVE: Diabetes is characterized by chronic inflammation, endothelial dysfunction, increased risk of infections and early cardiovascular disease.
  • While TNFα stimulation of control neutrophils resulted in DNA release, patient neutrophils were not responsive.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2012 Jul;122(7):2661-71 [22684106.001]
  • [Cites] Life Sci. 2000 Jun 8;67(3):291-300 [10983873.001]
  • [Cites] J Cell Biol. 2007 Jan 15;176(2):231-41 [17210947.001]
  • [Cites] Diabetes Care. 2014 Jan;37 Suppl 1:S14-80 [24357209.001]
  • [Cites] Diabetologia. 2012 Feb;55(2):273-8 [22124608.001]
  • [Cites] J Exp Med. 2012 Apr 9;209(4):819-35 [22451716.001]
  • [Cites] Therapie. 2006 Sep-Oct;61(5):371-8 [17243265.001]
  • [Cites] J Clin Invest. 2005 May;115(5):1111-9 [15864338.001]
  • [Cites] Diabetes. 2016 Apr;65(4):1061-71 [26740598.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Nov;319(2):972-9 [16936242.001]
  • [Cites] Diabet Med. 1995 Oct;12(10):916-20 [8846684.001]
  • [Cites] Ann Rheum Dis. 2015 Jul;74(7):1417-24 [24570026.001]
  • [Cites] Acta Diabetol. 2015 Jun;52(3):497-503 [25387570.001]
  • [Cites] Science. 2015 Jul 17;349(6245):316-20 [26185250.001]
  • [Cites] Annu Rev Immunol. 2012;30:459-89 [22224774.001]
  • [Cites] Science. 2004 Mar 5;303(5663):1532-5 [15001782.001]
  • [Cites] Nat Med. 2007 Apr;13(4):463-9 [17384648.001]
  • [Cites] Clin Exp Immunol. 2016 Jun;184(3):318-22 [26939803.001]
  • [Cites] Pathobiology. 2016;83(5):243-51 [27189166.001]
  • [Cites] J Leukoc Biol. 2016 Jan;99(1):153-62 [26320263.001]
  • [Cites] PLoS One. 2016 Feb 05;11(2):e0148142 [26849138.001]
  • [Cites] J Thromb Haemost. 2014 Dec;12(12):2074-88 [25163512.001]
  • [Cites] PLoS One. 2014 Aug 22;9(8):e105698 [25148570.001]
  • [Cites] J Pharmacol Exp Ther. 2013 Jun;345(3):430-7 [23536315.001]
  • [Cites] Diabetes Metab Res Rev. 2007 Jan;23(1):3-13 [16960917.001]
  • [Cites] Nat Med. 2015 Jul;21(7):815-9 [26076037.001]
  • [Cites] FEBS Lett. 2013 Jul 11;587(14):2241-6 [23735697.001]
  • [Cites] Thromb Haemost. 2013 Nov;110(5):1035-45 [23965842.001]
  • [Cites] Arthritis Rheumatol. 2015 Dec;67(12):3190-200 [26245802.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5 [20798043.001]
  • [Cites] J Immunol. 2012 Sep 15;189(6):2689-95 [22956760.001]
  • [Cites] Thromb Haemost. 2014 Oct;112(4):678-91 [25209670.001]
  • (PMID = 28005949.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Toth K, Spencer JF, Ying B, Tollefson AE, Wold WSM: HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model. Viruses; 2017 Jun 13;9(6)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenovirus infections of immunocompromised patients can cause a severe multi-organ disease that often results in the patients' death.
  • Presently, there are no drugs specifically approved to treat adenovirus infections, and clinicians resort to the off-label use of antivirals that are approved to treat other DNA virus infections, most frequently cidofovir (CDV).
  • CDV, however, has considerable nephrotoxicity, thus it is recommended only for the most severe cases of adenovirus infections.
  • Further, we show for the first time that VGCV, and to a lesser extent CDV, can be used to treat respiratory adenovirus infections in the hamster model.
  • These results extend the utility of the hamster model, and demonstrate the efficacy of two drugs available for clinicians to treat adenovirus infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 2011 Mar 30;412(1):19-27 [21251688.001]
  • [Cites] J Virol. 2017 Apr 28;91(10 ): [28250128.001]
  • [Cites] Blood. 2010 Dec 16;116(25):5476-85 [20837781.001]
  • [Cites] J Gen Virol. 2009 Jan;90(Pt 1):1-20 [19088268.001]
  • [Cites] Expert Opin Pharmacother. 2015;16(14):2095-9 [26330121.001]
  • [Cites] Transpl Infect Dis. 2016 Oct;18(5):791-794 [27482652.001]
  • [Cites] Biol Blood Marrow Transplant. 2012 May;18(5):731-8 [21963623.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 May 20;105(20):7293-7 [18490659.001]
  • [Cites] Clin Microbiol Rev. 2008 Oct;21(4):704-15 [18854488.001]
  • [Cites] Methods Mol Med. 2007;130:223-35 [17401177.001]
  • [Cites] Semin Respir Crit Care Med. 2016 Aug;37(4):586-602 [27486739.001]
  • [Cites] Viruses. 2015 Mar 23;7(3):1409-28 [25807051.001]
  • [Cites] Adv Cancer Res. 2012;115:69-92 [23021242.001]
  • [Cites] Clin Infect Dis. 2006 Aug 1;43(3):331-9 [16804849.001]
  • [Cites] Cancer Gene Ther. 2009 Aug;16(8):625-37 [19197322.001]
  • [Cites] Cancer Gene Ther. 2009 Aug;16(8):644-54 [19197324.001]
  • [Cites] Antiviral Res. 2006 Sep;71(2-3):172-80 [16698093.001]
  • [Cites] Clin Microbiol Rev. 2014 Jul;27(3):441-62 [24982316.001]
  • [Cites] Antimicrob Agents Chemother. 2014 Dec;58(12):7171-81 [25224011.001]
  • [Cites] Am J Kidney Dis. 2005 May;45(5):804-17 [15861345.001]
  • [Cites] J Gene Med. 2010 May;12(5):435-45 [20440754.001]
  • [Cites] Orv Hetil. 2012 Dec 2;153(48):1896-904 [23183005.001]
  • [Cites] Biol Blood Marrow Transplant. 2017 Mar;23 (3):512-521 [28063938.001]
  • [Cites] Rev Med Virol. 2008 Nov-Dec;18(6):357-74 [18655013.001]
  • [Cites] Antiviral Res. 2014 Dec;112:38-46 [25453340.001]
  • [Cites] Clin Pharmacokinet. 2009;48(3):143-57 [19385708.001]
  • [Cites] J Clin Virol. 2016 Oct;83:1-4 [27513204.001]
  • [Cites] Cancer Res. 2006 Feb 1;66(3):1270-6 [16452178.001]
  • [Cites] Expert Rev Anti Infect Ther. 2013 Oct;11(10):1017-28 [24073835.001]
  • [Cites] Bone Marrow Transplant. 2000 Sep;26(5):511-6 [11019840.001]
  • [Cites] Virology. 2009 Nov 25;394(2):311-20 [19765790.001]
  • (PMID = 28608847.001).
  • [ISSN] 1999-4915
  • [Journal-full-title] Viruses
  • [ISO-abbreviation] Viruses
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; adenovirus / animal model / antiviral / hamster
  •  go-up   go-down


20. de Wolf ACMT, van Aalst S, Ludwig IS, Bodinham CL, Lewis DJ, van der Zee R, van Eden W, Broere F: Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS One; 2017;12(6):e0179942

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, these cells may also interfere with resolution of infections or with immune reactions following vaccination.
  • Taken together, we showed that vaccination with vaccines with an already established safe profile have only minimal impact on frequencies and characteristics of Treg over time.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Virol. 2013 Nov;158(11):2267-72 [23728719.001]
  • [Cites] PLoS One. 2016 Mar 17;11(3):e0151717 [26986976.001]
  • [Cites] BMC Immunol. 2012 Apr 11;13:17 [22489829.001]
  • [Cites] Curr Opin Immunol. 2014 Apr;27:1-7 [24413387.001]
  • [Cites] Nat Rev Immunol. 2014 May;14(5):343-9 [24722479.001]
  • [Cites] Dig Dis Sci. 2014 Jul;59(7):1475-83 [24442238.001]
  • [Cites] Ann N Y Acad Sci. 2016 Feb 25;:null [26918796.001]
  • [Cites] Clin Exp Immunol. 2007 Apr;148(1):90-100 [17309541.001]
  • [Cites] Hum Immunol. 2012 Apr;73(4):335-41 [22342871.001]
  • [Cites] J Immunol. 2013 Mar 1;190(5):2150-8 [23338234.001]
  • [Cites] Pediatr Res. 2015 Nov;78(5):483-91 [26267154.001]
  • [Cites] Virol J. 2011 May 10;8:215 [21569236.001]
  • [Cites] Vaccine. 2016 Apr 12;34(17 ):2027-34 [26768126.001]
  • [Cites] Am J Transplant. 2010 Nov;10(11):2410-20 [20977632.001]
  • [Cites] Immunol Lett. 2009 Feb 21;122(2):108-11 [19100777.001]
  • [Cites] Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1046-51 [22169715.001]
  • [Cites] Front Microbiol. 2014 Sep 11;5:477 [25309517.001]
  • [Cites] J Autoimmun. 2013 Dec;47:1-16 [24238833.001]
  • [Cites] PLoS One. 2009 Dec 23;4(12):e8393 [20037642.001]
  • [Cites] Expert Opin Biol Ther. 2010 Nov;10(11):1563-72 [20932226.001]
  • [Cites] Clin Immunol. 2010 Feb;134(2):113-20 [19846344.001]
  • [Cites] Immunity. 2009 Jun 19;30(6):899-911 [19464196.001]
  • [Cites] Microb Biotechnol. 2012 Mar;5(2):260-9 [21951341.001]
  • [Cites] J Immunol Res. 2015;2015:909406 [26380327.001]
  • [Cites] PLoS One. 2016 Jun 23;11(6):e0157066 [27336786.001]
  • [Cites] Vaccine. 2012 Aug 17;30(38):5595-602 [22781305.001]
  • [Cites] Front Immunol. 2015 Sep 14;6:471 [26441976.001]
  • [Cites] Cell Transplant. 2011;20(11-12):1747-58 [21457615.001]
  • [Cites] Hemodial Int. 2016 Apr;20(2):242-52 [26104830.001]
  • [Cites] Hepatology. 2012 Sep;56(3):873-83 [22487943.001]
  • [Cites] J Leukoc Biol. 2001 Dec;70(6):849-60 [11739546.001]
  • [Cites] Nat Rev Immunol. 2010 Jul;10(7):490-500 [20559327.001]
  • [Cites] Nat Rev Immunol. 2014 Mar;14(3):154-65 [24481337.001]
  • [Cites] Viral Immunol. 2015 Dec;28(10 ):580-9 [26501792.001]
  • [Cites] Virusdisease. 2014 Jan;25(1):18-25 [24426307.001]
  • [Cites] Nature. 1999 Oct 14;401(6754):708-12 [10537110.001]
  • [Cites] J Clin Invest. 2005 Jul;115(7):1953-62 [16007258.001]
  • [Cites] Immunology. 2012 May;136(1):1-10 [22211994.001]
  • [Cites] Immunol Rev. 2006 Aug;212:8-27 [16903903.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1225-32 [17449799.001]
  • [Cites] J Exp Med. 2007 Jun 11;204(6):1257-65 [17502665.001]
  • [Cites] Immunology. 2009 Apr;126(4):466-74 [19278420.001]
  • [Cites] J Virol. 2012 Mar;86(5):2817-25 [22205730.001]
  • [Cites] J Exp Med. 2001 Sep 17;194(6):847-53 [11560999.001]
  • (PMID = 28658271.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Al-Azri MH, Al-Belushi R, Al-Mamari M, Davidson R, Mathew AC: Knowledge and Health Beliefs Regarding Sickle Cell Disease Among Omanis in a Primary Healthcare Setting: Cross-sectional study. Sultan Qaboos Univ Med J; 2016 Nov;16(4):e437-e444

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Few participants were aware that SCD can be very painful (20.2%) and can cause strokes, infections and organ damage (20.0%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20 [12934793.001]
  • [Cites] Ann Hum Biol. 2000 May-Jun;27(3):321-6 [10834296.001]
  • [Cites] J Pediatr Psychol. 2013 Sep;38(8):809-28 [23843630.001]
  • [Cites] Health Educ Q. 1988 Summer;15(2):175-83 [3378902.001]
  • [Cites] J Pediatr Hematol Oncol. 2007 Nov;29(11):752-60 [17984693.001]
  • [Cites] J Natl Med Assoc. 2009 Nov;101(11):1163-72 [19998646.001]
  • [Cites] Arch Intern Med. 2005 Dec 12-26;165(22):2618-24 [16344419.001]
  • [Cites] Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83 [22099361.001]
  • [Cites] Niger Postgrad Med J. 2000 Sep;7(3):120-3 [11257917.001]
  • [Cites] J Natl Med Assoc. 2015 Feb;107(1):4-10 [27282522.001]
  • [Cites] J Genet Couns. 2011 Dec;20(6):572-92 [21748660.001]
  • [Cites] Sultan Qaboos Univ Med J. 2011 Nov;11(4):462-9 [22087394.001]
  • [Cites] Ann Saudi Med. 2010 Jul-Aug;30(4):284-8 [20622345.001]
  • [Cites] Blood. 2010 Jun 3;115(22):4331-6 [20233970.001]
  • [Cites] Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001431 [19588325.001]
  • [Cites] Genet Med. 2007 May;9(5):303-10 [17505208.001]
  • [Cites] J Natl Med Assoc. 2005 Jan;97(1):62-7 [15719873.001]
  • [Cites] J Natl Med Assoc. 2005 Mar;97(3):405-8 [15779507.001]
  • [Cites] J Community Genet. 2012 Jul;3(3):185-92 [22109912.001]
  • [Cites] Trends Parasitol. 2011 Jul;27(7):315-20 [21429801.001]
  • [Cites] Bull World Health Organ. 2008 Jun;86(6):480-7 [18568278.001]
  • [Cites] Reprod Health. 2009 Oct 08;6:17 [19811666.001]
  • [Cites] East Mediterr Health J. 2001 Nov;7(6):1004-11 [15332742.001]
  • [Cites] BMC Public Health. 2014 Apr 17;14:380 [24742222.001]
  • [Cites] ANS Adv Nurs Sci. 1984 Apr;6(3):73-85 [6426380.001]
  • [Cites] J Natl Med Assoc. 2006 May;98(5):704-10 [16749645.001]
  • [Cites] Oman Med J. 2012 Jul;27(4):291-6 [23071880.001]
  • [Cites] Pediatr Blood Cancer. 2012 Aug;59(2):386-90 [22535620.001]
  • [Cites] BMJ. 2006 Oct 21;333(7573):831-4 [17053236.001]
  • (PMID = 28003889.001).
  • [ISSN] 2075-0528
  • [Journal-full-title] Sultan Qaboos University medical journal
  • [ISO-abbreviation] Sultan Qaboos Univ Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Oman
  • [Keywords] NOTNLM ; Awareness / Genetic Screening / Oman / Primary Health Care / Sickle Cell Disease
  •  go-up   go-down


22. Beccari MV, Meaney CJ: Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review. Core Evid; 2017;12:11-24

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Electrolyte abnormalities occurred with patiromer and SPS, whereas urinary tract infections, edema, and corrected QT-interval prolongations were reported with ZS9.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Med Res Opin. 2016;32(1):155-64 [26456884.001]
  • [Cites] Am J Med. 2000 Sep;109(4):307-14 [10996582.001]
  • [Cites] J Am Soc Nephrol. 1998 Oct;9(10):1924-30 [9773794.001]
  • [Cites] N Engl J Med. 1961 Jan 19;264:115-9 [13747532.001]
  • [Cites] Clin J Am Soc Nephrol. 2010 Oct;5(10):1723-6 [20798253.001]
  • [Cites] Burns. 2002 Mar;28(2):189-90 [11900946.001]
  • [Cites] N Engl J Med. 2015 Apr 16;372(16):1577-8 [25875277.001]
  • [Cites] J Am Soc Nephrol. 2010 May;21(5):733-5 [20167700.001]
  • [Cites] Kidney Int. 2015 Aug;88(2):404-11 [25651363.001]
  • [Cites] Circ Heart Fail. 2010 Mar;3(2):253-60 [20103777.001]
  • [Cites] N Engl J Med. 2015 Jan 15;372(3):222-31 [25415807.001]
  • [Cites] Eur J Heart Fail. 2015 Oct;17(10):1050-6 [26011677.001]
  • [Cites] Eur Heart J. 2011 Apr;32(7):820-8 [21208974.001]
  • [Cites] Kidney Int. 2015 Dec;88(6):1427-1433 [26376130.001]
  • [Cites] J Am Soc Nephrol. 1998 Aug;9(8):1535-43 [9697678.001]
  • [Cites] Am J Kidney Dis. 1992 Aug;20(2):159-61 [1496969.001]
  • [Cites] Am J Cardiol. 2012 May 15;109(10):1510-3 [22342847.001]
  • [Cites] Eur J Heart Fail. 2015 Oct;17(10):1057-65 [26459796.001]
  • [Cites] Am J Med. 2013 Mar;126(3):264.e9-24 [23321430.001]
  • [Cites] PLoS One. 2014 Dec 22;9(12):e114686 [25531770.001]
  • [Cites] Gastroenterology. 1995 Mar;108(3):752-60 [7875477.001]
  • [Cites] JAMA. 2014 Dec 3;312(21):2223-33 [25402495.001]
  • [Cites] Circulation. 2013 Oct 15;128(16):e240-327 [23741058.001]
  • [Cites] Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1050-60 [24721891.001]
  • [Cites] Drug Saf. 2014 Sep;37(9):677-92 [25047526.001]
  • [Cites] Exp Clin Cardiol. 2010 Winter;15(4):e96-9 [21264075.001]
  • [Cites] N Engl J Med. 2004 Aug 5;351(6):585-92 [15295051.001]
  • [Cites] J Intensive Care Med. 2005 Sep-Oct;20(5):272-90 [16145218.001]
  • [Cites] N Engl J Med. 2015 Jan 15;372(3):211-21 [25415805.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2014 Oct-Dec;26(4):455-8 [25672163.001]
  • [Cites] Clin J Am Soc Nephrol. 2015 Dec 7;10 (12 ):2136-42 [26576619.001]
  • [Cites] JAMA. 2015 Jul 14;314(2):151-61 [26172895.001]
  • (PMID = 28356904.001).
  • [ISSN] 1555-1741
  • [Journal-full-title] Core evidence
  • [ISO-abbreviation] Core Evid
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Keywords] NOTNLM ; evidence-based review / hyperkalemia / patiromer / sodium polystyrene sulfonate / sodium zirconium cyclosilicate
  •  go-up   go-down


23. Kim GS, Lee KS, Park CK, Kang SK, Kim DW, Oh SG, Oh BS, Jung Y, Kim S, Yun JS, Song SY, Na KJ, Jeong IS, Ahn BH: Nosocomial Infection in Adult Patients Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation. J Korean Med Sci; 2017 Apr;32(4):593-598

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Data on the frequency of nosocomial infections during extracorporeal membrane oxygenation (ECMO) in adult populations remain scarce.
  • We investigated the risk factors for nosocomial infections in adult patients undergoing venoarterial ECMO (VA-ECMO) support.
  • Mean patient age was 60.6 ± 14.3 years and 21 (34.4%) patients were female.
  • There were 18 nosocomial infections in 14 (23.0%) patients.
  • These included respiratory tract infections in 9 cases and bloodstream infections in a further 9.
  • Therefore, to avoid the development of nosocomial infections, strategies to shorten the length of ECMO support should be applied whenever possible.
  • [MeSH-minor] Adult. Aged. Creatinine / blood. Female. Gram-Negative Bacteria / isolation & purification. Humans. Incidence. Male. Middle Aged. Multivariate Analysis. Odds Ratio. Proportional Hazards Models. Respiratory Tract Infections / diagnosis. Respiratory Tract Infections / therapy. Risk Factors. Shock, Cardiogenic / etiology. Time Factors. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 The Korean Academy of Medical Sciences.
  • [Cites] ASAIO J. 2005 Sep-Oct;51(5):487-9 [16322701.001]
  • [Cites] Clin Infect Dis. 2012 Dec;55(12):1633-41 [22990851.001]
  • [Cites] Semin Respir Crit Care Med. 2011 Apr;32(2):115-38 [21506049.001]
  • [Cites] Pediatr Crit Care Med. 2006 Nov;7(6):546-50 [17006389.001]
  • [Cites] JAMA. 1995 Aug 23-30;274(8):639-44 [7637145.001]
  • [Cites] J Am Soc Nephrol. 2008 Mar;19(3):547-58 [18235097.001]
  • [Cites] Infect Control Hosp Epidemiol. 2013 Jan;34(1):24-30 [23221189.001]
  • [Cites] J Hosp Infect. 2014 Jul;87(3):152-8 [24856114.001]
  • [Cites] ASAIO J. 2013 May-Jun;59(3):202-10 [23644605.001]
  • [Cites] Am J Infect Control. 1988 Jun;16(3):128-40 [2841893.001]
  • [Cites] Clin Nephrol. 2011 Sep;76(3):165-73 [21888852.001]
  • [Cites] J Trauma Acute Care Surg. 2013 Apr;74(4):1005-13 [23511138.001]
  • [Cites] J Pediatr Surg. 1995 Jun;30(6):809-12 [7666312.001]
  • [Cites] N Engl J Med. 1972 Mar 23;286(12 ):629-34 [5060491.001]
  • [Cites] Artif Organs. 2013 Dec;37(12):1080-1 [24329546.001]
  • [Cites] Pediatr Crit Care Med. 2011 May;12(3):277-81 [20495508.001]
  • [Cites] Contrib Nephrol. 2011;174:56-64 [21921609.001]
  • [Cites] Clin Infect Dis. 1999 Apr;28(4):828-33 [10825046.001]
  • [Cites] Lancet. 2009 Oct 17;374(9698):1351-63 [19762075.001]
  • [Cites] ASAIO J. 2016 Jan-Feb;62(1):80-6 [26579980.001]
  • [Cites] Clin Infect Dis. 2009 Mar 1;48(5):503-35 [19191635.001]
  • (PMID = 28244284.001).
  • [ISSN] 1598-6357
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] AYI8EX34EU / Creatinine
  • [Keywords] NOTNLM ; Extracorporeal Membrane Oxygenation Support / Infection
  •  go-up   go-down


24. Ngobeni R, Samie A: PREVALENCE OF <i>TOXOPLASMA GONDII</i> IGG AND IGM AND ASSOCIATED RISK FACTORS AMONG HIV-POSITIVE AND HIV-NEGATIVE PATIENTS IN VHEMBE DISTRICT OF SOUTH AFRICA. Afr J Infect Dis; 2017;11(2):1-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: The present study has shown a high prevalence of <i>T. gondii</i> (IgG) among patients attending different HIV clinics in the Vhembe district with no current infections among pregnant women.
  • In addition to the sero-positive status of the patient to HIV, other significant risk factors for toxoplasmosis included high viral load, non-adherence to ARV therapy and age (>25 years).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Korean J Parasitol. 2014 Dec;52(6):581-93 [25548409.001]
  • [Cites] Rev Soc Bras Med Trop. 2015 May-Jun;48(3):338-42 [26108015.001]
  • [Cites] Korean J Parasitol. 2016 Feb;54(1):93-6 [26951986.001]
  • [Cites] Pathog Glob Health. 2016 Mar;110(2):62-7 [27092763.001]
  • [Cites] Asian Pac J Trop Med. 2011 Apr;4(4):271-4 [21771468.001]
  • [Cites] Am J Trop Med Hyg. 2008 Mar;78(3):504-8 [18337350.001]
  • [Cites] Int J STD AIDS. 2007 Aug;18(8):555-8 [17686219.001]
  • [Cites] Am J Trop Med Hyg. 2016 Jul 6;95(1):168-74 [27139453.001]
  • [Cites] Pathog Glob Health. 2015 ;109 (8):377-82 [26924348.001]
  • [Cites] BMC Infect Dis. 2016 Apr 16;16:157 [27083153.001]
  • [Cites] J Parasitol. 2012 Aug;98(4):871-2 [22360636.001]
  • [Cites] Adv Food Nutr Res. 2010;60:1-19 [20691951.001]
  • [Cites] East Afr J Public Health. 2008 Dec;5(3):211-4 [19374326.001]
  • [Cites] Pediatr Infect Dis J. 2014 Jan;33(1):5-10 [24064557.001]
  • [Cites] East Mediterr Health J. 2009 Sep-Oct;15(5):1278-84 [20214142.001]
  • [Cites] BMC Infect Dis. 2012 Dec 05;12:337 [23216887.001]
  • [Cites] Parasitol Res. 2016 Apr;115(4):1627-34 [26762861.001]
  • [Cites] Protist. 2006 Jun;157(2):173-83 [16621694.001]
  • [Cites] Acta Trop. 2016 Jun;158:160-9 [26952970.001]
  • [Cites] Parasitol Int. 2016 Oct;65(5 Pt A):363-6 [27155133.001]
  • (PMID = 28670634.001).
  • [ISSN] 2006-0165
  • [Journal-full-title] African journal of infectious diseases
  • [ISO-abbreviation] Afr J Infect Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  • [Keywords] NOTNLM ; ELISA / HIV / Opportunistic infections / Sero-prevalence / Toxoplasma gondii
  •  go-up   go-down


25. Hamid PH, Prastowo J, Widyasari A, Taubert A, Hermosilla C: Knockdown resistance (kdr) of the voltage-gated sodium channel gene of Aedes aegypti population in Denpasar, Bali, Indonesia. Parasit Vectors; 2017 Jun 05;10(1):283

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Aedes aegypti is the main vector of several arthropod-borne viral infections in the tropics profoundly affecting humans, such as dengue fever (DF), West Nile (WN), chikungunya and more recently Zika.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3332 [25569164.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2438 [24069492.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Nov 14;7(11):e2503 [24244765.001]
  • [Cites] Insect Biochem Mol Biol. 2013 Apr;43(4):407-16 [23123179.001]
  • [Cites] Parasit Vectors. 2014 Jan 15;7:25 [24428880.001]
  • [Cites] Parasit Vectors. 2015 Mar 25;8:181 [25888775.001]
  • [Cites] Insect Mol Biol. 2007 Dec;16(6):785-98 [18093007.001]
  • [Cites] J Agromedicine. 2004;9(2):329-45 [19785227.001]
  • [Cites] Med Vet Entomol. 2003 Mar;17(1):87-94 [12680930.001]
  • [Cites] Am J Trop Med Hyg. 2015 Jan;92(1):201-9 [25371186.001]
  • [Cites] Parasit Vectors. 2015 Jun 12;8:325 [26068925.001]
  • [Cites] Nat Rev Dis Primers. 2016 Aug 18;2:16055 [27534439.001]
  • [Cites] Parasit Vectors. 2011 Jan 12;4:5 [21226942.001]
  • [Cites] Trop Med Int Health. 2011 Apr;16(4):501-9 [21342372.001]
  • [Cites] Pest Manag Sci. 2015 Jun;71(6):863-9 [24935645.001]
  • [Cites] PLoS Negl Trop Dis. 2009 Oct 13;3(10):e531 [19829709.001]
  • [Cites] Insect Biochem Mol Biol. 2004 Jul;34(7):653-65 [15242706.001]
  • [Cites] Heredity (Edinb). 2015 Sep;115(3):243-52 [25899013.001]
  • [Cites] Evolution. 2002 Dec;56(12):2435-44 [12583584.001]
  • [Cites] Am J Trop Med Hyg. 2010 Aug;83(2):277-84 [20682868.001]
  • [Cites] PLoS Negl Trop Dis. 2009 Oct 06;3(10):e527 [19806205.001]
  • [Cites] PLoS One. 2016 Mar 03;11(3):e0150577 [26939002.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3085 [25166902.001]
  • [Cites] Parasit Vectors. 2016 Jul 26;9(1):417 [27460671.001]
  • [Cites] Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):994-9 [23277539.001]
  • [Cites] Parasit Vectors. 2013 Aug 30;6(1):253 [24059267.001]
  • [Cites] Insects. 2015 Jul 23;6(3):658-85 [26463408.001]
  • [Cites] Evol Med Public Health. 2013 Jan;2013(1):197-207 [24481199.001]
  • [Cites] Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11785-90 [23821746.001]
  • [Cites] Southeast Asian J Trop Med Public Health. 2012 Nov;43(6):1380-6 [23413701.001]
  • [Cites] PLoS Negl Trop Dis. 2013;7(1):e1913 [23326609.001]
  • (PMID = 28583207.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Aedes aegypti / Denpasar / Indonesia / Kdr / Resistance
  •  go-up   go-down


26. Courjon J, Demonchy E, Degand N, Risso K, Ruimy R, Roger PM: Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study. Ann Clin Microbiol Antimicrob; 2017 May 19;16(1):40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eleven patients had polymicrobial infections.
  • The leading bacterial species involved were Escherichia coli 25/115 (22%), group D Streptococci 12/115 (10%), viridans Streptococci 12/115 (10%) and Staphylococcus aureus 11/115 (9%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virulence. 2016 Apr 2;7(3):248-51 [26890622.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1973-80 [24907852.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90 [11401878.001]
  • [Cites] J Infect. 2014 Feb;68(2):149-55 [24429297.001]
  • [Cites] Clin Microbiol Infect. 2003 Aug;9(8):793-802 [14616699.001]
  • [Cites] Clin Microbiol Rev. 2014 Oct;27(4):870-926 [25278577.001]
  • [Cites] J Infect. 2017 Feb;74(2):131-141 [27838521.001]
  • [Cites] Infection. 2011 Dec;39(6):549-54 [21898120.001]
  • [Cites] Crit Care. 2015 Aug 27;19:302 [26307060.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):453-7 [17541655.001]
  • [Cites] Chest. 2003 May;123(5):1615-24 [12740282.001]
  • [Cites] Clin Microbiol Infect. 2011 Oct;17(10):1581-6 [21073629.001]
  • [Cites] Clin Infect Dis. 2002 Jul 15;35(2):156-61 [12087521.001]
  • [Cites] Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53 [18154538.001]
  • [Cites] Clin Infect Dis. 1992 Feb;14(2):436-43 [1445517.001]
  • [Cites] Crit Care. 2016 Nov 6;20(1):360 [27816060.001]
  • [Cites] Med Mal Infect. 2008 Sep;38(9):457-64 [18707833.001]
  • [Cites] Crit Care. 2015 Feb 16;19:63 [25888181.001]
  • [Cites] Clin Infect Dis. 1997 Apr;24(4):584-602 [9145732.001]
  • (PMID = 28526094.001).
  • [ISSN] 1476-0711
  • [Journal-full-title] Annals of clinical microbiology and antimicrobials
  • [ISO-abbreviation] Ann. Clin. Microbiol. Antimicrob.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Antimicrobial resistance / Bacteremia / Bacteremia of unknown origin / Empirical antibiotic treatment / Primary bacteremia / Severe sepsis
  •  go-up   go-down


27. Truong DT, Bui MT, Memon P, Cavanagh HD: Microbial Keratitis at an Urban Public Hospital: A 10-Year Update. J Clin Exp Ophthalmol; 2015 Dec;6(6)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the past ten years, epidemiology has shifted towards greater contact lens wear with more Pseudomonal infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Refract Surg. 1997 Jul-Aug;13(4):388-91 [9268940.001]
  • [Cites] Cornea. 1998 May;17(3):282-7 [9603384.001]
  • [Cites] Am J Ophthalmol. 2002 Apr;133(4):463-6 [11931779.001]
  • [Cites] Ophthalmology. 2015 May;122(5):918-24 [25600200.001]
  • [Cites] Lancet. 1991 Sep 14;338(8768):650-3 [1679472.001]
  • [Cites] Cornea. 2005 Mar;24(2):201-5 [15725889.001]
  • [Cites] Arch Ophthalmol. 1997 Apr;115(4):462-5 [9109753.001]
  • [Cites] Cornea. 2010 Oct;29(10):1131-5 [20595899.001]
  • [Cites] Cornea. 2008 Jan;27(1):22-7 [18245962.001]
  • [Cites] Br J Ophthalmol. 1987 Feb;71(2):96-101 [3103672.001]
  • [Cites] Eye (Lond). 2011 Apr;25(4):489-93 [21252952.001]
  • [Cites] Ophthalmology. 1997 Nov;104(11):1902-9 [9373124.001]
  • [Cites] Int Ophthalmol Clin. 1973 Winter;13(4):1-29 [4784000.001]
  • [Cites] Eye Contact Lens. 2010 Jul;36(4):195-200 [20626115.001]
  • [Cites] Ophthalmology. 1996 Mar;103(3):479-84 [8600426.001]
  • [Cites] Ophthalmology. 2000 Aug;107(8):1497-502 [10919897.001]
  • [Cites] Indian J Ophthalmol. 2009 Jul-Aug;57(4):273-9 [19574694.001]
  • [Cites] Arch Ophthalmol. 2003 Sep;121(9):1229-33 [12963604.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1996 Dec;234(12):731-8 [8986444.001]
  • [Cites] Ophthalmology. 2012 Sep;119(9):1785-90 [22627118.001]
  • [Cites] Clin Exp Ophthalmol. 2011 Jul;39(5):393-7 [21176039.001]
  • [Cites] J Ocul Pharmacol Ther. 2013 Apr;29(3):339-44 [23289847.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Aug 21;64(32):865-70 [26292204.001]
  • [Cites] Eye Contact Lens. 2007 Jan;33(1):45-9 [17224678.001]
  • (PMID = 28540138.001).
  • [Journal-full-title] Journal of clinical & experimental ophthalmology
  • [ISO-abbreviation] J Clin Exp Ophthalmol
  • [Language] eng
  • [Grant] United States / NEI NIH HHS / EY / P30 EY020799
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Antibiotic resistance / Corneal ulcer / Keratitis / Microbial keratitis
  •  go-up   go-down


28. Norris P, Ralph N, Moloney C: Does metabolic syndrome predict surgical complications? A protocol for a systematic review and meta-analysis. Syst Rev; 2017 Jun 17;6(1):115

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Surgical patients with MetS are at significantly higher risk of a range of adverse outcomes including death, morbid cardiovascular events, coma, stroke, renal failure, myocardial infarction, and surgical site infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circulation. 2007 Sep 11;116(11 Suppl):I213-9 [17846306.001]
  • [Cites] BMJ. 2016 Oct 12;355:i4919 [27733354.001]
  • [Cites] Diabet Med. 1998 Jul;15(7):539-53 [9686693.001]
  • [Cites] Syst Rev. 2015 Jan 01;4:1 [25554246.001]
  • [Cites] Circulation. 2002 Dec 17;106(25):3143-421 [12485966.001]
  • [Cites] J Am Coll Cardiol. 2007 Aug 28;50(9):843-51 [17719470.001]
  • [Cites] J Arthroplasty. 2014 Sep;29(9):1842-5 [24851795.001]
  • [Cites] Am J Kidney Dis. 2006 Jul;48(1):134-42 [16797396.001]
  • [Cites] J Card Surg. 2014 Jan;29(1):26-34 [24283711.001]
  • [Cites] Curr Hypertens Rep. 2011 Apr;13(2):149-57 [20957457.001]
  • [Cites] J Arthroplasty. 2013 Jun;28(6):904-7 [23522489.001]
  • [Cites] Surgery. 2016 Oct;160(4):1111-7 [27498302.001]
  • [Cites] Arq Bras Cardiol. 2007 Apr;88(4):413-7 [17546270.001]
  • [Cites] JAMA. 2000 Apr 19;283(15):2008-12 [10789670.001]
  • [Cites] Circ J. 2008 Sep;72(9):1481-6 [18724026.001]
  • [Cites] Anesthesiology. 2010 Oct;113(4):859-72 [20808207.001]
  • [Cites] Circulation. 2009 Oct 20;120(16):1640-5 [19805654.001]
  • [Cites] Obes Surg. 2004 Sep;14(8):1042-50 [15487110.001]
  • [Cites] Spine (Phila Pa 1976). 2012 May 15;37(11):989-95 [22024892.001]
  • [Cites] Kidney Int Suppl. 2010 Dec;(119):S42-6 [21116317.001]
  • [Cites] Ann Surg Oncol. 2017 May;24(5):1443-1450 [27896516.001]
  • [Cites] J Arthroplasty. 2012 Apr;27(4):514-9 [21890314.001]
  • [Cites] J Int Med Res. 2010 Jan-Feb;38(1):202-7 [20233530.001]
  • [Cites] Foot Ankle Int. 2014 May;35(5):463-70 [24583475.001]
  • [Cites] Int J Cancer. 2016 Dec 15;139(12 ):2705-2713 [27560834.001]
  • [Cites] Diabetes Care. 2005 Nov;28(11):2745-9 [16249550.001]
  • [Cites] Ann Surg. 2004 Aug;240(2):205-13 [15273542.001]
  • [Cites] Coron Artery Dis. 2006 Feb;17 (1):41-4 [16374140.001]
  • [Cites] BMJ. 1997 Sep 13;315(7109):629-34 [9310563.001]
  • [Cites] Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8 [1334988.001]
  • [Cites] J Arthroplasty. 2016 Jun;31(6):1322-5 [26989028.001]
  • [Cites] J Arthroplasty. 2017 Feb;32(2):362-366 [27651122.001]
  • [Cites] Res Cardiovasc Med. 2014 Aug;3(3):e20270 [25478548.001]
  • [Cites] J Arthroplasty. 2012 Dec;27(10):1743-1749.e1 [22677144.001]
  • [Cites] Am J Med. 2006 Oct;119(10):812-9 [17000207.001]
  • [Cites] J Rheumatol. 2010 Sep;37(9):1917-22 [20634242.001]
  • [Cites] Am J Crit Care. 2009 Sep;18(5):468-73 [19723867.001]
  • [Cites] Obes Rev. 2015 Jan;16(1):1-12 [25407540.001]
  • (PMID = 28623943.001).
  • [ISSN] 2046-4053
  • [Journal-full-title] Systematic reviews
  • [ISO-abbreviation] Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Adverse events / Complications / Metabolic syndrome / Prevalence / Risk / Safety / Surgery
  •  go-up   go-down


29. Logoluso N, Drago L, Gallazzi E, George DA, Morelli I, Romanò CL: Calcium-Based, Antibiotic-Loaded Bone Substitute as an Implant Coating: A Pilot Clinical Study. J Bone Jt Infect; 2016;1:59-64

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • <b>Background:</b> Implant-related infections remain a major complication after orthopaedic surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Arthroplasty. 2014 Feb;29(2):272-6 [23890832.001]
  • [Cites] BMC Musculoskelet Disord. 2015 May 13;16:115 [25968241.001]
  • [Cites] Science. 1987 Sep 25;237(4822):1588-95 [3629258.001]
  • [Cites] Clin Orthop Relat Res. 2004 Oct;(427):86-93 [15552142.001]
  • [Cites] Acta Orthop Scand. 2001 Dec;72(6):557-71 [11817870.001]
  • [Cites] Orthop Clin North Am. 2005 Jan;36(1):89-95, vii [15542127.001]
  • [Cites] Clin Orthop Relat Res. 2005 Aug;(437):91-6 [16056032.001]
  • [Cites] J Mater Sci Mater Med. 2014 Oct;25(10):2445-61 [24865980.001]
  • [Cites] J Mater Sci Mater Med. 2010 Mar;21(3):1031-5 [19842017.001]
  • [Cites] J Orthop Surg Res. 2013 Jul 31;8:25 [23899023.001]
  • [Cites] Orthopedics. 2004 Jan;27(1 Suppl):s103-7 [14763538.001]
  • [Cites] Med Prog Technol. 1988-1989;14(3-4):205-24 [2978593.001]
  • [Cites] Drugs. 2000 Jun;59(6):1223-32 [10882159.001]
  • [Cites] Bone Joint J. 2013 May;95-B(5):583-97 [23632666.001]
  • [Cites] Clin Orthop Relat Res. 2013 Dec;471(12):4065-75 [24155178.001]
  • [Cites] J Orthop Surg Res. 2015 Oct 01;10:157 [26429342.001]
  • [Cites] J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):281-6 [19904822.001]
  • [Cites] Eur Orthop Traumatol. 2011 May;1(6):207-217 [21837262.001]
  • [Cites] Bone. 2015 Dec;81:112-21 [26163110.001]
  • [Cites] Semin Arthroplasty. 1994 Oct;5(4):160-70 [10155159.001]
  • [Cites] Injury. 2011 Sep;42 Suppl 2:S82-6 [21762911.001]
  • [Cites] Acta Orthop. 2010 Dec;81(6):660-6 [21110700.001]
  • [Cites] Injury. 2015 Aug;46(8):1447-56 [26007616.001]
  • [Cites] Int J Biomater. 2012;2012:538061 [22899933.001]
  • [Cites] Clin Infect Dis. 2003 May 1;36(9):1157-61 [12715311.001]
  • (PMID = 28529855.001).
  • [Journal-full-title] Journal of bone and joint infection
  • [ISO-abbreviation] J Bone Jt Infect
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Keywords] NOTNLM ; Calcium sulphate / Coating / Hydroxyapatite. / Peri-prosthetic infection
  •  go-up   go-down


30. Harris BJ, Holzmayer V, Qureshi H, Khan MA, Khan SA, Salamat N, Jafri S, Brennan CA: Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors. PLoS One; 2017;12(6):e0178988

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While regional differences were observed, the most prevalent HBV strains are subgenotypes of D with subgenotype D1/subtype ayw2 accounting for the majority of infections; 90.2% at AFIT and 52.5% at HBB.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Virol. 2013 Jul;57(3):201-8 [22789139.001]
  • [Cites] J Med Virol. 2011 Jan;83(1):95-100 [21108344.001]
  • [Cites] Hepat Mon. 2011 Jan;11(1):14-8 [22087110.001]
  • [Cites] J Clin Virol. 2013 Sep;58(1):59-66 [23871163.001]
  • [Cites] J Med Virol. 2006;78 Suppl 1:S59-65 [16622880.001]
  • [Cites] Infect Genet Evol. 2010 Dec;10(8):1242-6 [20727423.001]
  • [Cites] J Med Virol. 2006 Jan;78(1):24-36 [16299725.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1997-2001 [8700874.001]
  • [Cites] J Virol. 1999 Jan;73(1):152-60 [9847317.001]
  • [Cites] J Pak Med Assoc. 2002 Sep;52(9):398-402 [12532573.001]
  • [Cites] Hepatol Res. 2010 Jan;40(1):14-30 [20156297.001]
  • [Cites] BMC Infect Dis. 2006 Jun 23;6:101 [16792819.001]
  • [Cites] BMC Infect Dis. 2007 Oct 08;7:115 [17922910.001]
  • [Cites] J Med Virol. 2008 Apr;80(4):598-602 [18297712.001]
  • [Cites] Int J Infect Dis. 2009 Jan;13(1):9-19 [18835208.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2011 Oct 14;60(40):1385-90 [21993343.001]
  • [Cites] Transfusion. 2015 Jul;55(7):1803-11 [25648663.001]
  • [Cites] J Transl Med. 2012 Jan 31;10:20 [22293125.001]
  • [Cites] BMC Infect Dis. 2007 Jun 27;7:64 [17597512.001]
  • [Cites] Virol J. 2011 Mar 06;8:102 [21375760.001]
  • [Cites] Virol J. 2011 Jun 06;8:275 [21645287.001]
  • [Cites] J Gen Virol. 2010 Jan;91(Pt 1):68-73 [19759242.001]
  • [Cites] J Med Virol. 2006;78 Suppl 1:S36-42 [16622876.001]
  • [Cites] J Pak Med Assoc. 2010 Dec;60(12):1045-58 [21381562.001]
  • [Cites] Virol J. 2011 May 13;8:225 [21569532.001]
  • [Cites] Intervirology. 2007;50(1):45-51 [17164557.001]
  • [Cites] BMC Gastroenterol. 2005 Aug 08;5:26 [16086833.001]
  • [Cites] East Mediterr Health J. 2010;16 Suppl:S15-23 [21495584.001]
  • (PMID = 28582431.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Adnan M, Patel M, Hadi S: Functional and health promoting inherent attributes of &lt;i&gt;Enterococcus hirae&lt;/i&gt; F2 as a novel probiotic isolated from the digestive tract of the freshwater fish &lt;i&gt;Catla catla&lt;/i&gt;. PeerJ; 2017;5:e3085

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Probiotic microorganisms are gaining global importance because of their use in the preparation of a nutraceutical or in the treatment of infections.
  • DISCUSSION: The isolation of <i>Enterococcus hirae</i> with probiotic potential from the gut of fish is a new approach and done for the first time.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Nutr. 2013 Mar;97(3):524-30 [23364011.001]
  • [Cites] Probiotics Antimicrob Proteins. 2011 Dec;3(3-4):175-85 [26781678.001]
  • [Cites] Appl Environ Microbiol. 1987 Jun;53(6):1382-4 [16347367.001]
  • [Cites] Int J Food Microbiol. 2009 Sep 30;135(1):28-33 [19666197.001]
  • [Cites] J Biosci Bioeng. 2005 Dec;100(6):583-92 [16473765.001]
  • [Cites] J Appl Microbiol. 2007 May;102(5):1178-86 [17448153.001]
  • [Cites] Appl Environ Microbiol. 1989 Feb;55(2):279-83 [2719474.001]
  • [Cites] Appl Environ Microbiol. 2000 Sep;66(9):3698-704 [10966379.001]
  • [Cites] Bull Exp Biol Med. 2008 Feb;145(2):232-4 [19023977.001]
  • [Cites] Int J Food Microbiol. 1997 Apr 29;36(1):1-29 [9168311.001]
  • [Cites] Can J Infect Dis Med Microbiol. 2006 Sep;17(5):291-5 [18382642.001]
  • [Cites] FEMS Microbiol Rev. 2002 Jun;26(2):163-71 [12069881.001]
  • [Cites] Cancer Biol Ther. 2006 Oct;5(10):1265-9 [16969130.001]
  • [Cites] Meat Sci. 2000 Jul;55(3):297-300 [22061286.001]
  • [Cites] Anaerobe. 2012 Feb;18(1):103-9 [22261519.001]
  • [Cites] Pediatrics. 2005 Jan;115(1):5-9 [15629974.001]
  • [Cites] J Bacteriol. 1991 Jan;173(2):697-703 [1987160.001]
  • [Cites] FEMS Microbiol Lett. 1998 May 15;162(2):295-301 [9627964.001]
  • [Cites] Appl Environ Microbiol. 2001 Apr;67(4):1628-35 [11282615.001]
  • [Cites] Int J Food Microbiol. 2004 Mar 15;91(3):253-60 [14984773.001]
  • [Cites] World J Microbiol Biotechnol. 2014 Jul;30(7):2111-8 [24609495.001]
  • [Cites] Nutrition. 2008 Oct;24(10):933-40 [18562172.001]
  • [Cites] Med Microbiol Immunol. 2001 Apr;189(3):147-52 [11388612.001]
  • [Cites] Int J Food Microbiol. 2003 Dec 1;88(2-3):235-40 [14596995.001]
  • [Cites] J Food Prot. 2003 Jun;66(6):931-6 [12800991.001]
  • [Cites] Appl Environ Microbiol. 2003 Aug;69(8):4743-52 [12902267.001]
  • [Cites] J Appl Microbiol. 2003;94(6):981-7 [12752805.001]
  • [Cites] Cell. 2009 Sep 4;138(5):976-89 [19737523.001]
  • [Cites] J Appl Microbiol. 1999 Jan;86(1):22-8 [10030010.001]
  • [Cites] Science. 2001 Feb 2;291(5505):881-4 [11157169.001]
  • [Cites] Microbes Infect. 2000 Jul;2(8):907-13 [10962274.001]
  • [Cites] Clin Infect Dis. 2002 Nov 15;35(10):1155-60 [12410474.001]
  • [Cites] J Appl Microbiol. 1998 Jul;85(1):42-50 [9721655.001]
  • [Cites] Food Microbiol. 2010 Oct;27(7):955-61 [20688238.001]
  • (PMID = 28316889.001).
  • [Journal-full-title] PeerJ
  • [ISO-abbreviation] PeerJ
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Acid tolerance / Catla catla / Enterococcus hirae / Gastrointestinal conditions / Probiotic
  •  go-up   go-down


32. Renk H, Stoll L, Neunhoeffer F, Hölzl F, Kumpf M, Hofbeck M, Hartl D: Suspicion of respiratory tract infection with multidrug-resistant Enterobacteriaceae: epidemiology and risk factors from a Paediatric Intensive Care Unit. BMC Infect Dis; 2017 Feb 21;17(1):163
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Multidrug-resistant (MDR) infections are a serious concern for children admitted to the Paediatric Intensive Care Unit (PICU).
  • [MeSH-major] Cross Infection / diagnosis. Drug Resistance, Multiple, Bacterial. Enterobacteriaceae / isolation & purification. Enterobacteriaceae Infections / diagnosis. Intensive Care Units, Pediatric. Respiratory Tract Infections / diagnosis. Trachea / microbiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Shock. 2008 Oct;30 Suppl 1:23-9 [18704013.001]
  • [Cites] Indian Pediatr. 2007 Jul;44(7):511-8 [17939179.001]
  • [Cites] Infection. 2007 Oct;35(5):339-45 [17721736.001]
  • [Cites] J Microbiol Immunol Infect. 2009 Apr;42(2):160-5 [19597649.001]
  • [Cites] J Hosp Infect. 2006 Oct;64(2):115-23 [16859810.001]
  • [Cites] Pediatrics. 1999 Apr;103(4 Pt 1):719-23 [10103292.001]
  • [Cites] Infection. 2010 Feb;38(1):33-40 [20108162.001]
  • [Cites] J Clin Invest. 2010 Dec;120(12):4332-41 [21099116.001]
  • [Cites] Respir Care. 2005 Jun;50(6):725-39; discussion 739-41 [15913465.001]
  • [Cites] J Chemother. 2015 Oct;27(5):283-9 [24981117.001]
  • [Cites] Clin Infect Dis. 2011 Jun;52(11):1324-31 [21540205.001]
  • [Cites] Int J Antimicrob Agents. 2015 Nov;46(5):518-25 [26358970.001]
  • [Cites] Pediatr Infect Dis J. 2011 Jan;30(1):11-8 [20686433.001]
  • [Cites] Clin Microbiol Rev. 2012 Jul;25(3):450-70 [22763634.001]
  • [Cites] Crit Care. 2010;14(3):R113 [20546564.001]
  • [Cites] Pediatrics. 2009 Apr;123(4):1108-15 [19336369.001]
  • [Cites] Acta Med Port. 2011 Dec;24 Suppl 2:197-206 [22849904.001]
  • [Cites] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Oct;55(10):1311-54 [23011096.001]
  • [Cites] Pediatr Crit Care Med. 2010 Mar;11(2):246-52 [19794325.001]
  • [Cites] Clin Infect Dis. 2014 May;58(10):1439-48 [24501388.001]
  • [Cites] BMC Infect Dis. 2006 Feb 14;6:24 [16478537.001]
  • [Cites] Clin Infect Dis. 2014 Oct;59(7):944-52 [24973312.001]
  • [Cites] Pediatr Cardiol. 2014 Dec;35(8):1448-55 [24996642.001]
  • [Cites] Pediatrics. 2002 Sep;110(3):481-5 [12205248.001]
  • [Cites] Lancet Infect Dis. 2002 Oct;2(10):628-35 [12383613.001]
  • [Cites] J Hosp Infect. 2010 Sep;76(1):66-9 [20621392.001]
  • [Cites] J Pediatric Infect Dis Soc. 2014 Dec;3(4):312-9 [26625451.001]
  • [Cites] Clin Infect Dis. 2015 May 1;60(9):1389-97 [25595742.001]
  • [Cites] J Pediatr (Rio J). 2005 Jan-Feb;81(1):29-33 [15742083.001]
  • [Cites] Clin Microbiol Infect. 2012 Mar;18(3):268-81 [21793988.001]
  • [Cites] Pediatr Crit Care Med. 2014 May;15(4):299-305 [24614608.001]
  • [Cites] Trends Microbiol. 2006 Sep;14(9):413-20 [16876996.001]
  • [Cites] Infect Control Hosp Epidemiol. 2007 Mar;28(3):299-306 [17326020.001]
  • [Cites] Pediatrics. 2008 Oct;122(4):770-4 [18829800.001]
  • [Cites] Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9 [16355321.001]
  • [Cites] J Hosp Infect. 2015 Aug;90(4):310-5 [25933918.001]
  • [Cites] J Pediatric Infect Dis Soc. 2014 Dec;3(4):320-8 [26625452.001]
  • (PMID = 28222699.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Observational Study
  • [Publication-country] England
  •  go-up   go-down


33. Bouziat R, Hinterleitner R, Brown JJ, Stencel-Baerenwald JE, Ikizler M, Mayassi T, Meisel M, Kim SM, Discepolo V, Pruijssers AJ, Ernest JD, Iskarpatyoti JA, Costes LM, Lawrence I, Palanski BA, Varma M, Zurenski MA, Khomandiak S, McAllister N, Aravamudhan P, Boehme KW, Hu F, Samsom JN, Reinecker HC, Kupfer SS, Guandalini S, Semrad CE, Abadie V, Khosla C, Barreiro LB, Xavier RJ, Ng A, Dermody TS, Jabri B: Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science; 2017 Apr 07;356(6333):44-50

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Viral infections have been proposed to elicit pathological processes leading to the initiation of T helper 1 (T<sub>H</sub>1) immunity against dietary gluten and celiac disease (CeD).
  • Reovirus is an avirulent pathogen that elicits protective immunity, but we discovered that it can nonetheless disrupt intestinal immune homeostasis at inductive and effector sites of oral tolerance by suppressing peripheral regulatory T cell (pT<sub>reg</sub>) conversion and promoting T<sub>H</sub>1 immunity to dietary antigen.
  • Initiation of T<sub>H</sub>1 immunity to dietary antigen was dependent on interferon regulatory factor 1 and dissociated from suppression of pT<sub>reg</sub> conversion, which was mediated by type-1 interferon.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017, American Association for the Advancement of Science.
  • [Cites] N Engl J Med. 2003 Jun 19;348(25):2517-24 [12815137.001]
  • [Cites] Nat Rev Immunol. 2015 Dec;15(12 ):771-83 [26567920.001]
  • [Cites] Cell. 2014 Mar 27;157(1):142-50 [24679532.001]
  • [Cites] Nat Rev Immunol. 2014 Jan;14(1):36-49 [24362405.001]
  • [Cites] Am J Gastroenterol. 2014 Jun;109(6):913-21 [24777149.001]
  • [Cites] J Infect Dis. 2005 Apr 15;191(8):1221-4 [15776366.001]
  • [Cites] J Leukoc Biol. 2006 Dec;80(6):1500-11 [16966383.001]
  • [Cites] J Virol. 2012 Feb;86(4):2302-11 [22156521.001]
  • [Cites] Immunity. 2016 Apr 19;44(4):860-74 [27067057.001]
  • [Cites] Am J Gastroenterol. 2007 Sep;102(9):2026-35 [17573785.001]
  • [Cites] J Exp Med. 2007 Jun 11;204(6):1349-58 [17502662.001]
  • [Cites] Bioinformatics. 2010 Sep 15;26(18):i531-9 [20823318.001]
  • [Cites] Nat Immunol. 2016 May;17(5):545-55 [27019226.001]
  • [Cites] Gastroenterology. 2007 Oct;133(4):1175-87 [17919493.001]
  • [Cites] Mucosal Immunol. 2012 May;5(3):232-9 [22318493.001]
  • [Cites] J Immunol. 2008 Aug 1;181(3):1673-82 [18641303.001]
  • [Cites] J Exp Med. 1997 Jan 20;185(2):231-8 [9016872.001]
  • [Cites] Gastroenterology. 2016 Oct;151(4):670-83 [27373514.001]
  • [Cites] Mucosal Immunol. 2017 May;10 (3):635-649 [27579860.001]
  • [Cites] Gastroenterology. 1998 Sep;115(3):551-63 [9721152.001]
  • [Cites] Cell. 2010 Jun 25;141(7):1135-45 [20602997.001]
  • [Cites] J Pediatr. 2012 Nov;161(5):908-14 [22704250.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1757-64 [17620361.001]
  • [Cites] Pediatr Res. 2003 Sep;54(3):312-8 [12788988.001]
  • [Cites] J Virol. 1989 Mar;63(3):1188-93 [2915380.001]
  • [Cites] Nat Rev Immunol. 2013 Apr;13(4):294-302 [23493116.001]
  • [Cites] Annu Rev Immunol. 2011;29:493-525 [21219178.001]
  • [Cites] Annu Rev Immunol. 2015;33:417-43 [25861977.001]
  • [Cites] Am J Gastroenterol. 2016 Jun;111(6):879-90 [27045926.001]
  • [Cites] Curr Opin Virol. 2012 Aug;2(4):419-25 [22677178.001]
  • [Cites] Nature. 2011 Mar 10;471(7337):220-4 [21307853.001]
  • [Cites] Nat Immunol. 2016 May;17(5):474-6 [27092796.001]
  • [Cites] Immunity. 1997 Jun;6(6):673-9 [9208840.001]
  • [Cites] Eur J Immunol. 2015 Jan;45(1):119-29 [25312824.001]
  • [Cites] J Immunol. 2003 Jan 15;170(2):997-1001 [12517966.001]
  • [Cites] J Exp Med. 2006 Mar 20;203(3):497-500 [16533891.001]
  • [Cites] Bioinformatics. 2002 Apr;18(4):536-45 [12016051.001]
  • [Cites] Am J Gastroenterol. 2006 Oct;101(10):2333-40 [17032199.001]
  • [Cites] Science. 2002 Sep 27;297(5590):2275-9 [12351792.001]
  • [Cites] Immunity. 2009 May;30(5):626-35 [19464985.001]
  • [Cites] Immunogenetics. 2010 Oct;62(10):641-51 [20661732.001]
  • [Cites] Gastroenterology. 2015 Sep;149(3):681-91.e10 [26001928.001]
  • [Cites] J Exp Med. 2004 Jul 19;200(2):235-45 [15263030.001]
  • [Cites] Annu Rev Immunol. 2008;26:535-84 [18303999.001]
  • [Cites] Autoimmun Rev. 2009 Feb;8(4):316-9 [18973831.001]
  • (PMID = 28386004.001).
  • [ISSN] 1095-9203
  • [Journal-full-title] Science (New York, N.Y.)
  • [ISO-abbreviation] Science
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK067180; United States / NIDDK NIH HHS / DK / P30 DK042086; United States / NIDDK NIH HHS / DK / P30 DK043351; United States / NCI NIH HHS / CA / P30 CA014599; United States / NIDDK NIH HHS / DK / R01 DK068181; United States / NIDDK NIH HHS / DK / F31 DK108562; United States / NIAID NIH HHS / AI / R01 AI113333; United States / NIAID NIH HHS / AI / R01 AI038296; United States / NCI NIH HHS / CA / P30 CA068485; United States / NIDDK NIH HHS / DK / R01 DK100619; United States / NIDDK NIH HHS / DK / R01 DK063158; United States / NIDDK NIH HHS / DK / R01 DK098435; United States / NIDDK NIH HHS / DK / U24 DK059637
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Elgizouli M, Logan C, Grychtol R, Rothenbacher D, Nieters A, Heinzmann A: Reduced PRF1 enhancer methylation in children with a history of severe RSV bronchiolitis in infancy: an association study. BMC Pediatr; 2017 Mar 03;17(1):65

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epidemiological data suggest an association between severe viral respiratory infections in infancy and increased incidence of childhood wheeze and asthma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 1999 Nov 1;190(9):1297-308 [10544201.001]
  • [Cites] Immunity. 2014 Nov 20;41(5):853-65 [25517617.001]
  • [Cites] Pediatr Infect Dis J. 2007 Dec;26(12):1094-8 [18043444.001]
  • [Cites] Nature. 2010 Sep 16;467(7313):338-42 [20720541.001]
  • [Cites] Eur J Pediatr. 2007 Dec;166(12):1267-72 [17308898.001]
  • [Cites] J Pediatr. 2003 Nov;143(5 Suppl):S118-26 [14615710.001]
  • [Cites] Immunol Cell Biol. 2015 Mar;93(3):226-32 [25666097.001]
  • [Cites] J Leukoc Biol. 2010 Feb;87(2):237-43 [19915166.001]
  • [Cites] Thorax. 2010 Dec;65(12):1045-52 [20581410.001]
  • [Cites] Lancet. 1987 Oct 3;2(8562):769-71 [2888988.001]
  • [Cites] Annu Rev Nutr. 2007;27:363-88 [17465856.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Jan;161(1):182-6 [10619818.001]
  • [Cites] Am J Respir Crit Care Med. 2015 Jan 1;191(1):34-44 [25369458.001]
  • [Cites] Viral Immunol. 2006 Summer;19(2):147-55 [16817757.001]
  • [Cites] Genome Res. 2012 Apr;22(4):623-32 [22300631.001]
  • [Cites] Lancet. 2013 Apr 20;381(9875):1380-90 [23369797.001]
  • [Cites] J Immunol. 2003 May 15;170(10):5124-32 [12734359.001]
  • [Cites] Medicine (Baltimore). 2015 Jan;94(1):e332 [25569648.001]
  • [Cites] J Allergy Clin Immunol. 2013 Jul;132(1):227-9 [23419541.001]
  • [Cites] Nat Protoc. 2007;2(9):2265-75 [17853883.001]
  • [Cites] PLoS One. 2012;7(9):e44213 [22970180.001]
  • [Cites] Am J Epidemiol. 1991 Jun 1;133(11):1135-51 [2035517.001]
  • [Cites] Acta Paediatr. 2000 Jun;89(6):654-60 [10914957.001]
  • [Cites] N Engl J Med. 2009 Feb 5;360(6):588-98 [19196675.001]
  • [Cites] PLoS One. 2012;7(11):e48796 [23226205.001]
  • [Cites] Int Immunol. 2005 Nov;17(11):1419-28 [16186162.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Sep 15;168(6):633-9 [12773328.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Jan 15;171(2):137-41 [15516534.001]
  • [Cites] Environ Mol Mutagen. 2014 Apr;55(3):231-43 [24323745.001]
  • [Cites] Hum Mol Genet. 2015 Apr 15;24(8):2201-17 [25552657.001]
  • [Cites] Lancet. 2010 May 1;375(9725):1545-55 [20399493.001]
  • [Cites] Pediatrics. 2005 Jan;115(1):e7-14 [15629968.001]
  • [Cites] N Engl J Med. 2013 May 9;368(19):1791-9 [23656644.001]
  • [Cites] Nat Struct Mol Biol. 2013 Mar;20(3):282-9 [23463313.001]
  • (PMID = 28253869.001).
  • [ISSN] 1471-2431
  • [Journal-full-title] BMC pediatrics
  • [ISO-abbreviation] BMC Pediatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; DNA methylation / Infant bronchiolitis / PRF1 / Perforin / Respiratory syncytial virus
  •  go-up   go-down


35. Cho SY, Yang SB, Shin HS, Lee SH, Koh JS, Kwon S, Jung WS, Moon SK, Park JM, Ko CN, Park SU: Anti-inflammatory and immune regulatory effects of acupuncture after craniotomy: study protocol for a parallel-group randomized controlled trial. Trials; 2017 Jan 10;18(1):10
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Certain patients still develop infections severe enough to require a repeat operation despite antibiotic prophylaxis.
  • The primary outcome measure will be the C-reactive protein levels, while the secondary outcomes will be the serum erythrocyte sedimentation rate and the tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels measured at four different time points: within 48 h prior to the craniotomy and on days 2, 4, and 7 after surgery.

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mediators Inflamm. 2003 Apr;12(2):59-69 [12775355.001]
  • [Cites] Exp Ther Med. 2013 Sep;6(3):699-702 [24137250.001]
  • [Cites] Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):418-22 [26649089.001]
  • [Cites] J Integr Med. 2014 Sep;12(5):417-24 [25292341.001]
  • [Cites] Evid Based Complement Alternat Med. 2013;2013:591796 [23476696.001]
  • [Cites] J Exp Med. 1996 Oct 1;184(4):1397-411 [8879212.001]
  • [Cites] Neurosurgery. 2007 Apr;60(4):621-5; discussion 625 [17415198.001]
  • [Cites] Asian Pac J Trop Med. 2014 Jun;7(6):492-5 [25066401.001]
  • [Cites] N Engl J Med. 2010 Jan 14;362(2):146-54 [20071704.001]
  • [Cites] Acupunct Med. 2014 Aug;32(4):340-5 [24820260.001]
  • [Cites] Arthritis Rheum. 2008 Sep 15;59(9):1249-56 [18759255.001]
  • [Cites] Evid Based Complement Alternat Med. 2015;2015:340126 [26612993.001]
  • [Cites] Clin Biochem. 2016 Feb;49(3):219-24 [26522777.001]
  • [Cites] Annu Rev Immunol. 2009;27:519-50 [19302047.001]
  • [Cites] Med J Islam Repub Iran. 2013 Feb;27(1):1-6 [23483125.001]
  • [Cites] Neurosurg Focus. 2008;24(6):E10 [18518740.001]
  • [Cites] Biochim Biophys Acta. 2011 May;1813(5):878-88 [21296109.001]
  • [Cites] J Periodontol. 2015 Jun;86(6):801-11 [25741581.001]
  • [Cites] Aust Prescr. 2015 Jun;38(3):93-4 [26648629.001]
  • [Cites] Br J Surg. 2002 Nov;89(11):1450-6 [12390391.001]
  • [Cites] Acupunct Med. 2015 Apr;33(2):115-20 [25520280.001]
  • [Cites] Int J Clin Exp Med. 2015 Feb 15;8(2):2662-7 [25932216.001]
  • [Cites] Zhen Ci Yan Jiu. 2013 Feb;38(1):1-6 [23650792.001]
  • [Cites] Afr J Tradit Complement Altern Med. 2014 Jan 28;11(2):469-74 [25435635.001]
  • [Cites] Scand J Clin Lab Invest. 2015 Oct;75(6):500-7 [26114621.001]
  • (PMID = 28069040.001).
  • [ISSN] 1745-6215
  • [Journal-full-title] Trials
  • [ISO-abbreviation] Trials
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT02761096
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Acupuncture / Craniotomy / Electroacupuncture / Immune function / Inflammation / Neurosurgery
  •  go-up   go-down


36. Kenters N, Huijskens EGW, de Wit SCJ, Sanders IGJM, van Rosmalen J, Kuijper EJ, Voss A: Effectiveness of various cleaning and disinfectant products on &lt;i&gt;Clostridium difficile&lt;/i&gt; spores of PCR ribotypes 010, 014 and 027. Antimicrob Resist Infect Control; 2017;6:54

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In healthcare facilities, <i>Clostridium difficile</i> infections spread by transmission of bacterial spores.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hosp Infect. 2008 Sep;70(1):15-20 [18602185.001]
  • [Cites] J Hosp Infect. 2015 Jun;90(2):91-101 [25913648.001]
  • [Cites] Infect Control Hosp Epidemiol. 2009 Jun;30(6):570-3 [19432509.001]
  • [Cites] J Hosp Infect. 1999 Oct;43(2):85-100 [10549308.001]
  • [Cites] Am J Infect Control. 2015 Jul 1;43(7):724-8 [25997876.001]
  • [Cites] Clin Infect Dis. 2013 Oct;57(8):1094-102 [23881150.001]
  • [Cites] Am J Infect Control. 2010 May;38(4):289-92 [20123151.001]
  • [Cites] Antimicrob Resist Infect Control. 2012 May 30;1(1):20 [22958425.001]
  • [Cites] Nat Genet. 2013 Jan;45(1):109-13 [23222960.001]
  • [Cites] Clin Infect Dis. 1993 Jun;16 Suppl 4:S228-33 [8324124.001]
  • [Cites] J Hosp Infect. 2008 Nov;70(3):265-71 [18801594.001]
  • [Cites] N Engl J Med. 2013 Sep 26;369(13):1195-205 [24066741.001]
  • [Cites] Int J Food Microbiol. 2001 Dec 30;71(2-3):131-8 [11789930.001]
  • [Cites] Jt Comm J Qual Patient Saf. 2013 Jul;39(7):298-305 [23888639.001]
  • [Cites] J AOAC Int. 2011 Mar-Apr;94(2):618-26 [21563698.001]
  • [Cites] J Hosp Infect. 2015 Jan;89(1):2-15 [25477061.001]
  • [Cites] J Infect. 2013 Feb;66(2):115-28 [23103666.001]
  • [Cites] Clin Microbiol Rev. 1999 Jan;12(1):147-79 [9880479.001]
  • [Cites] J Hosp Infect. 2010 Apr;74(4):309-18 [20153547.001]
  • [Cites] Clin Microbiol Infect. 2008 May;14 Suppl 5:2-20 [18412710.001]
  • [Cites] Nat Rev Dis Primers. 2016 Apr 07;2:16020 [27158839.001]
  • (PMID = 28588767.001).
  • [ISSN] 2047-2994
  • [Journal-full-title] Antimicrobial resistance and infection control
  • [ISO-abbreviation] Antimicrob Resist Infect Control
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; ATP / C. difficile / CFU / Cleaning/disinfecting sprays / Cleaning/disinfecting wipes
  •  go-up   go-down


37. Nyoyoko NP, Umoh AV: The prevalence and determinants of HIV seroconversion among booked ante natal clients in the University of Uyo teaching hospital, Uyo Akwa Ibom State, Nigeria. Pan Afr Med J; 2016;25:247
MedlinePlus Health Information. consumer health - Infections and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Determinants of seroconversion at multivariate level were age bracket of 25-29 years (OR: 3.20; 95%CI: 2.39-4.29) clients' partners who had sexually transmitted infections, as evidenced by penile discharge (OR: 0.09; 95%CI: 0.01-0.45); Clients in polygamous setting (OR: 3.98; CI: 1.64-9.65); those taking alcohol (OR: 0.12; CI: 0.20-0.80) and those with partners taking recreational drugs (OR: 0.05, 95%CI: 0.002-0.995).
  • [MeSH-major] HIV Infections / diagnosis. Infectious Disease Transmission, Vertical / prevention & control. Pregnancy Complications, Infectious / diagnosis. Seroconversion
  • [MeSH-minor] Adult. Counseling / methods. Cross-Sectional Studies. Female. Hospitals, Teaching. Humans. Mass Screening / methods. Nigeria / epidemiology. Pregnancy. Prenatal Care / methods. Prevalence. Time Factors

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AIDS Behav. 2011 Feb;15(2):479-86 [20981479.001]
  • [Cites] Obstet Gynecol. 2003 Oct;102(4):782-90 [14551009.001]
  • [Cites] N Engl J Med. 1999 Aug 5;341(6):394-402 [10432324.001]
  • [Cites] J Infect Dis. 2009 Sep 1;200(5):682-6 [19627245.001]
  • [Cites] Curr HIV/AIDS Rep. 2005 Jun;2(2):55-60 [16091249.001]
  • [Cites] Afr J Reprod Health. 2006 Apr;10(1):76-80 [16999197.001]
  • [Cites] BMC Infect Dis. 2008 Dec 31;8:174 [19117527.001]
  • [Cites] West Indian Med J. 2010 Jul;59(4):424-8 [21355519.001]
  • [Cites] Soc Sci Med. 2006 Jan;62(1):217-27 [16054281.001]
  • [Cites] Int J Epidemiol. 2000 Oct;29(5):911-5 [11034977.001]
  • [Cites] Cochrane Database Syst Rev. 2002;(1):CD003255 [11869658.001]
  • [Cites] Cent Afr J Med. 2001 May;47(5):115-8 [11921668.001]
  • [Cites] PLoS One. 2009 Jul 31;4(7):e6470 [19649242.001]
  • [Cites] Lancet. 1992 Sep 5;340(8819):585-8 [1355163.001]
  • [Cites] AIDS. 2009 Jun 19;23(10):1255-9 [19455017.001]
  • [Cites] MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4 [16988643.001]
  • [Cites] AIDS Res Ther. 2006 Oct 17;3:27 [17044932.001]
  • (PMID = 28293363.001).
  • [ISSN] 1937-8688
  • [Journal-full-title] The Pan African medical journal
  • [ISO-abbreviation] Pan Afr Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Uganda
  • [Keywords] NOTNLM ; HCT / HIV / Nigeria / PMTCT / Uyo / ante natal care / determinants / prevalence / seroconversion / window period
  •  go-up   go-down


38. Turhan O, Ozhak-Baysan B, Zaragoza O, Er H, Sarıtas ZE, Ongut G, Ogunc D, Colak D, Cuenca-Estrella M: Evaluation of MALDI-TOF-MS for the Identification of Yeast Isolates Causing Bloodstream Infection. Clin Lab; 2017 04 01;63(4):699-703

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Infections due to Candida species are major causes of morbidity and mortality in humans, causing a diverse spectrum of clinical disease ranging from superficial and mucosal infections to invasive disease.
  • The aim of this study was to assess the performance of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) system for the correct and rapid identification of yeast isolates causing bloodstream infection.
  • METHODS: Between January 2014 and January 2015, a total of 117 yeast like organisms isolated from blood culture samples of 117 episodes from 102 patients who had blood stream infections were included in the study.
  • RESULTS: One hundred and seventeen yeast isolates including 115 Candida spp and two non-Candida yeasts were analysed.
  • The Biotyper correctly identified 115 (98.3%) isolates to the genus level and 102 (87.2%) isolates to the species level using the manufacturer's recommended cutoff scores.
  • Early identification with MALDI-TOF MS would save time for determination of antifungal susceptibility and proper treatment strategy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28397475.001).
  • [ISSN] 1433-6510
  • [Journal-full-title] Clinical laboratory
  • [ISO-abbreviation] Clin. Lab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


39. Kirk SK, Levy JK, Crawford PC: Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs. J Vet Intern Med; 2017 Jul;31(4):1108-1112

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Traditional management of B. gibsoni with polymerase chain reaction (PCR)-screening, treatment with commercially available azithromycin and atovaquone, and PCR testing after 60 and 90 days is costly and impractical for large numbers of dogs at a time.
  • HYPOTHESIS/OBJECTIVES: To assess the efficacy of an alternative protocol in which commercial atovaquone was replaced by compounded medication and PCR monitoring was initiated at 30 days after the end of treatment to decrease the total management time.
  • PCR testing was repeated at 30 and 60 days after end of treatment if dogs with positive PCR tests at either time were tested at 90 days.
  • This more economical protocol can remove barriers to mass screening and management of B. gibsoni infections in dogfighting cases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
  • [Cites] Drugs. 2002;62(10):1481-502 [12093316.001]
  • [Cites] Antimicrob Agents Chemother. 1998 Jun;42(6):1315-8 [9624466.001]
  • [Cites] J Am Vet Med Assoc. 2002 Feb 1;220(3):325-9 [11829262.001]
  • [Cites] J Vet Med Sci. 2016 Mar;78(3):489-91 [26549436.001]
  • [Cites] J Vet Med Sci. 2004 Aug;66(8):893-7 [15353837.001]
  • [Cites] J Am Anim Hosp Assoc. 1999 Mar-Apr;35(2):125-8 [10102180.001]
  • [Cites] J Am Vet Med Assoc. 2003 Apr 1;222(7):959-63, 952 [12685786.001]
  • [Cites] J Am Vet Med Assoc. 2009 Sep 1;235(5):535-9 [19719443.001]
  • [Cites] Exp Parasitol. 2007 Oct;117(2):115-23 [17543304.001]
  • [Cites] J Vet Intern Med. 2009 May-Jun;23(3):493-8 [19645835.001]
  • [Cites] Vet J. 2016 May;211:64-9 [27056107.001]
  • [Cites] J Am Vet Med Assoc. 2005 Sep 15;227(6):942-7 [16190594.001]
  • [Cites] Parasit Vectors. 2016 Jun 11;9(1):336 [27289223.001]
  • [Cites] Vet Parasitol. 2012 May 25;186(3-4):159-64 [22222008.001]
  • [Cites] J Am Anim Hosp Assoc. 2003 Nov-Dec;39(6):551-7 [14736721.001]
  • [Cites] J Am Anim Hosp Assoc. 2011 Sep-Oct;47(5):1-42 [21998907.001]
  • [Cites] Vet Clin Pathol. 2001;30(4):180-188 [12024299.001]
  • [Cites] Animals (Basel). 2016 Nov 15;6(11): [27854270.001]
  • [Cites] Vet Parasitol. 2011 Sep 27;181(2-4):160-5 [21524856.001]
  • [Cites] J Vet Intern Med. 2004 Jul-Aug;18(4):494-8 [15320586.001]
  • [Cites] Aust Vet J. 2007 Nov;85(11):459-63 [17970851.001]
  • (PMID = 28625019.001).
  • [ISSN] 1939-1676
  • [Journal-full-title] Journal of veterinary internal medicine
  • [ISO-abbreviation] J. Vet. Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Anemia / Animal shelter / Babesiosis / Dog fighting / Pit bull
  •  go-up   go-down


40. Jaishankar D, Shukla D: Genital Herpes: Insights into Sexually Transmitted Infectious Disease. Microb Cell; 2016 Jun 27;3(9):438-450

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Etiology, transmission and protection: Herpes simplex virus-2 (HSV-2) is a leading cause of sexually transmitted infections with recurring manifestations throughout the lifetime of infected hosts.
  • Pathology/Symptomatology: Primary and recurrent infections result in lesions and inflammation around the genital area and the latter accounts for majority of genital herpes instances.
  • Immunocompromised patients including neonates are susceptible to additional systemic infections including debilitating consequences of nervous system inflammation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Pathog. 2013;9(12):e1003806 [24367260.001]
  • [Cites] Am J Med. 1984 Dec;77(6):1055-60 [6507459.001]
  • [Cites] JAMA. 2006 Aug 23;296(8):964-73 [16926356.001]
  • [Cites] J Infect Dis. 2002 Apr 15;185(8):1019-24 [11930310.001]
  • [Cites] J Virol. 2004 Feb;78(3):1139-49 [14722269.001]
  • [Cites] Mol Biol Cell. 2002 Aug;13(8):2795-809 [12181347.001]
  • [Cites] J Virol. 2005 Jun;79(12):7609-16 [15919913.001]
  • [Cites] J Virol. 2003 May;77(9):5324-32 [12692234.001]
  • [Cites] Nat Commun. 2015 Apr 27;6:6985 [25912399.001]
  • [Cites] J Gen Virol. 2010 Dec;91(Pt 12):3002-9 [20810749.001]
  • [Cites] Trends Biotechnol. 2003 Dec;21(12):556-62 [14624865.001]
  • [Cites] Sex Transm Dis. 2003 Oct;30(10):797-800 [14520181.001]
  • [Cites] J Cell Biol. 1997 Mar 10;136(5):1007-21 [9060466.001]
  • [Cites] J Virol. 1979 Dec;32(3):779-89 [229267.001]
  • [Cites] Cell. 1999 Oct 1;99(1):13-22 [10520990.001]
  • [Cites] Nat Med. 2009 Aug;15(8):886-92 [19648930.001]
  • [Cites] Ann Intern Med. 2005 Nov 15;143(10):707-13 [16287791.001]
  • [Cites] J Pept Sci. 2013 Mar;19(3):148-58 [23389903.001]
  • [Cites] J Neuroimmunol. 1995 Aug;61(1):7-16 [7560014.001]
  • [Cites] J Infect Dis. 2000 Apr;181(4):1454-7 [10762576.001]
  • [Cites] J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):631-42 [18043318.001]
  • [Cites] J Virol. 1996 Sep;70(9):6076-82 [8709231.001]
  • [Cites] J Clin Virol. 1999 May;12(3):243-52 [10382821.001]
  • [Cites] Virol Sin. 2012 Dec;27(6):333-8 [23180288.001]
  • [Cites] J Virol. 1996 Jan;70(1):264-71 [8523535.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8 [9023344.001]
  • [Cites] Herpes. 2004 Apr;11 Suppl 1:2A-23A [15115626.001]
  • [Cites] J Ocul Pharmacol Ther. 2010 Dec;26(6):541-7 [21029018.001]
  • [Cites] J Virol. 2010 Oct;84(20):10773-83 [20686018.001]
  • [Cites] Pediatrics. 2005 Apr;115(4):845-51 [15805354.001]
  • [Cites] J Virol. 1995 Mar;69(3):1389-99 [7853471.001]
  • [Cites] J Virol. 2015 Feb;89(3):1932-8 [25428865.001]
  • [Cites] Sex Transm Infect. 2004 Oct;80(5):406-10 [15459412.001]
  • [Cites] J Exp Med. 2007 Mar 19;204(3):595-603 [17325200.001]
  • [Cites] Viruses. 2015 Mar 04;7(3):915-38 [25746217.001]
  • [Cites] J Infect Dis. 1997 Nov;176(5):1129-34 [9359709.001]
  • [Cites] Vaccine. 2011 Nov 3;29(47):8530-41 [21767588.001]
  • [Cites] J Virol. 1992 Apr;66(4):2240-50 [1312629.001]
  • [Cites] Lancet. 2007 Dec 22;370(9605):2127-37 [18156035.001]
  • [Cites] J Gen Virol. 1993 Dec;74 ( Pt 12):2813-7 [8277292.001]
  • [Cites] J Virol. 1987 Jul;61(7):2311-5 [3035230.001]
  • [Cites] Sci Rep. 2015 Aug 07;5:12985 [26248741.001]
  • [Cites] J Virol. 2014 Sep 1;88(17):10026-38 [24942591.001]
  • [Cites] MBio. 2014 Jan 14;5(1):e00958-13 [24425731.001]
  • [Cites] PLoS One. 2014 Apr 02;9(4):e93444 [24695322.001]
  • [Cites] J Virol. 2008 Apr;82(7):3530-7 [18160436.001]
  • [Cites] J Infect Dis. 2011 Mar 1;203(5):602-9 [21220779.001]
  • [Cites] J Virol. 1998 Nov;72(11):8933-42 [9765438.001]
  • [Cites] BMJ. 2002 Jun 8;324(7350):1366-7 [12052804.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Jan 1;391(1):176-81 [19909728.001]
  • [Cites] Ann Intern Med. 1983 Jun;98(6):958-72 [6344712.001]
  • [Cites] J Clin Invest. 2001 Aug;108(4):503-10 [11518721.001]
  • [Cites] J Neurovirol. 1997 Jun;3(3):206-11 [9200068.001]
  • [Cites] J Cell Biol. 2006 Sep 25;174(7):1009-21 [17000878.001]
  • [Cites] Sci Transl Med. 2012 Jun 13;4(138):138ra79 [22700955.001]
  • [Cites] J Virol. 1996 Sep;70(9):6067-70 [8709230.001]
  • [Cites] J Virol. 2013 Jul;87(14):8029-37 [23678175.001]
  • [Cites] J Virol. 2014 Jun;88(12):6599-610 [24672046.001]
  • [Cites] J Antimicrob Chemother. 2005 Apr;55(4):420-3 [15743896.001]
  • [Cites] Antivir Ther. 2014;19(1):15-29 [23813409.001]
  • [Cites] Herpes. 2004 Apr;11 Suppl 1:24A-35A [15115627.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):866-71 [20080767.001]
  • [Cites] J Virol. 1987 Jul;61(7):2208-16 [3035221.001]
  • [Cites] Virology. 2000 Dec 5;278(1):207-16 [11112495.001]
  • [Cites] J Virol. 2014 Aug;88(15):8421-32 [24829358.001]
  • [Cites] J Gen Virol. 1987 Jun;68 ( Pt 6):1761-5 [3035069.001]
  • [Cites] Cell Host Microbe. 2007 Mar 15;1(1):23-35 [18005679.001]
  • [Cites] Annu Rev Microbiol. 2013;67:355-74 [24024635.001]
  • [Cites] J Virol. 1993 Apr;67(4):2285-97 [8383241.001]
  • [Cites] J Leukoc Biol. 2001 May;69(5):691-7 [11358975.001]
  • [Cites] Autophagy. 2006 Jan-Mar;2(1):24-9 [16874088.001]
  • [Cites] J Virol. 2009 Feb;83(4):1952-61 [19073735.001]
  • [Cites] J Gen Virol. 2007 Apr;88(Pt 4):1075-9 [17374750.001]
  • [Cites] Science. 2000 Feb 25;287(5457):1500-3 [10688801.001]
  • [Cites] Nat Rev Microbiol. 2008 Mar;6(3):211-21 [18264117.001]
  • [Cites] J Gen Virol. 1994 Jun;75 ( Pt 6):1211-22 [8207388.001]
  • [Cites] J Virol. 2012 Jun;86(12):6434-43 [22491462.001]
  • [Cites] Sex Transm Dis. 2003 Oct;30(10):801-2 [14520182.001]
  • [Cites] Cell. 2008 Mar 21;132(6):935-44 [18358807.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2013 Feb 05;54(2):1070-9 [23341013.001]
  • [Cites] J Virol. 1989 Feb;63(2):943-7 [2536115.001]
  • [Cites] J Exp Med. 2000 May 1;191(9):1459-66 [10790421.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1229-33 [9990006.001]
  • [Cites] Sex Transm Infect. 2006 Jun;82(3):189-90 [16731663.001]
  • [Cites] Appl Microbiol Biotechnol. 2007 Feb;74(2):263-72 [17131147.001]
  • [Cites] Clin Infect Dis. 2006 May 15;42(10):1431-8 [16619156.001]
  • [Cites] Virol Sin. 2014 Jun;29(3):139-47 [24938714.001]
  • [Cites] Nature. 1984 Jun 14-20;309(5969):633-5 [6328323.001]
  • [Cites] J Virol. 2007 Jan;81(2):800-12 [17079321.001]
  • [Cites] Sex Transm Dis. 2004 May;31(5):322-4 [15107637.001]
  • [Cites] J Virol. 2001 Sep;75(18):8803-17 [11507225.001]
  • [Cites] N Engl J Med. 1986 Mar 13;314(11):686-91 [3005858.001]
  • [Cites] AIDS. 2001 Aug;15 Suppl 4:S97-108 [11686471.001]
  • [Cites] J Virol. 2006 Mar;80(5):2358-68 [16474142.001]
  • [Cites] FEBS J. 2009 Dec;276(24):7228-36 [19878306.001]
  • [Cites] J Infect Dis. 2006 Sep 15;194 Suppl 1:S11-8 [16921466.001]
  • [Cites] J Virol. 2009 Dec;83(24):13042-5 [19812165.001]
  • [Cites] J Virol. 2010 Oct;84(19):9889-96 [20631136.001]
  • [Cites] N Engl J Med. 2015 Aug 6;373(6):530-9 [26244306.001]
  • [Cites] Sex Transm Infect. 2000 Jun;76(3):179-82 [10961194.001]
  • [Cites] J Med Virol. 1993;Suppl 1:33-8 [8245890.001]
  • [Cites] J Virol. 2004 Nov;78(22):12508-18 [15507638.001]
  • [Cites] MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137 [26042815.001]
  • [Cites] Microbiol Immunol. 2014 Feb;58(2):103-11 [24329555.001]
  • [Cites] J Neurovirol. 2003 Jun;9(3):285-90 [12775412.001]
  • [Cites] N Engl J Med. 2002 Nov 21;347(21):1652-61 [12444179.001]
  • [Cites] J Virol. 1987 Mar;61(3):714-21 [3027398.001]
  • [Cites] J Immunol. 1996 Oct 15;157(8):3542-9 [8871654.001]
  • [Cites] PLoS Pathog. 2010 Jul 08;6(7):e1000991 [20628567.001]
  • [Cites] J Virol. 2010 Apr;84(8):4013-25 [20147400.001]
  • [Cites] J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45 [15021308.001]
  • [Cites] J Virol. 2004 Sep;78(18):10178-86 [15331750.001]
  • [Cites] FEBS Lett. 2007 May 22;581(11):2150-5 [17320081.001]
  • [Cites] Curr Eye Res. 2008 May;33(5):455-67 [18568883.001]
  • [Cites] J Virol. 1988 Apr;62(4):1347-54 [2831396.001]
  • [Cites] Sex Transm Dis. 2004 Jun;31(6):331-6 [15167640.001]
  • [Cites] N Y State J Med. 1983 Apr;83(5):714-6 [6575277.001]
  • [Cites] J Immunol. 2001 Mar 15;166(6):4049-58 [11238653.001]
  • [Cites] J Virol. 2003 Feb;77(4):2686-95 [12552008.001]
  • [Cites] J Virol. 1991 Mar;65(3):1090-8 [1847438.001]
  • [Cites] J Virol. 2001 Nov;75(22):11178-84 [11602757.001]
  • [Cites] Virology. 2000 Sep 15;275(1):1-8 [11017782.001]
  • [Cites] Antiviral Res. 2012 Dec;96(3):363-75 [23047013.001]
  • [Cites] J Virol. 1998 Feb;72(2):1177-85 [9445016.001]
  • [Cites] Med Microbiol Immunol. 2003 Aug;192(3):177-81 [12761673.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3901-10 [26157134.001]
  • [Cites] PLoS One. 2014 Jun 05;9(6):e99425 [24901434.001]
  • [Cites] J Virol. 1998 Sep;72(9):7476-83 [9696844.001]
  • [Cites] Virol J. 2014 May 12;11:83 [24885431.001]
  • [Cites] J Virol. 2015 Aug;89(16):8497-509 [26041292.001]
  • [Cites] J Clin Microbiol. 1987 Feb;25(2):323-6 [3029166.001]
  • [Cites] FASEB J. 2013 Jul;27(7):2584-99 [23507869.001]
  • [Cites] Nature. 2010 Oct 14;467(7317):859-62 [20944748.001]
  • [Cites] Vaccine. 2011 Nov 3;29(47):8520-9 [21945262.001]
  • [Cites] J Virol. 2002 Apr;76(7):3471-81 [11884571.001]
  • [Cites] J Virol. 1995 Sep;69(9):5401-13 [7636985.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16055-9 [16247011.001]
  • (PMID = 28357380.001).
  • [Journal-full-title] Microbial cell (Graz, Austria)
  • [ISO-abbreviation] Microb Cell
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Austria
  • [Keywords] NOTNLM ; antivirals / herpes simplex virus / viral glycoproteins / viral latency / virus entry
  •  go-up   go-down


41. Suarez G, Romero-Gallo J, Sierra JC, Piazuelo MB, Krishna US, Gomez MA, Wilson KT, Peek RM Jr: Genetic Manipulation of &lt;i&gt;Helicobacter pylori&lt;/i&gt; Virulence Function by Host Carcinogenic Phenotypes. Cancer Res; 2017 May 01;77(9):2401-2412

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Serial infections of Mongolian gerbils with <i>H. pylori</i> strain 7.13 identified an oscillating pattern of <i>cag</i>T4SS function.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] ©2017 American Association for Cancer Research.
  • [Cites] Cancer Res. 2015 Apr 15;75(8):1749-59 [25732381.001]
  • [Cites] J Gastroenterol Hepatol. 2004 Oct;19(10):1192-8 [15377299.001]
  • [Cites] Clin Microbiol Infect. 2010 Apr;16(4):369-78 [19456839.001]
  • [Cites] J Infect Dis. 2016 Aug 15;214(4):644-8 [27190191.001]
  • [Cites] World J Gastroenterol. 2014 Sep 28;20(36):12753-66 [25278676.001]
  • [Cites] Vaccine. 1997 Oct;15(15):1598-605 [9364689.001]
  • [Cites] Nat Immunol. 2004 Nov;5(11):1166-74 [15489856.001]
  • [Cites] Oncogene. 2016 Dec 1;35(48):6262-6269 [27157617.001]
  • [Cites] J Biol Chem. 2009 Mar 13;284(11):6790-800 [19147492.001]
  • [Cites] J Exp Med. 2000 Dec 4;192(11):1601-10 [11104802.001]
  • [Cites] Gastroenterology. 2000 Jan;118(1):48-59 [10611153.001]
  • [Cites] Gastroenterology. 1998 Sep;115(3):642-8 [9721161.001]
  • [Cites] PLoS Pathog. 2011 May;7(5):e1002050 [21589900.001]
  • [Cites] PLoS Pathog. 2013 Feb;9(2):e1003189 [23468628.001]
  • [Cites] Infect Immun. 2010 Nov;78(11):4660-6 [20805339.001]
  • [Cites] Cancer Res. 1998 Oct 1;58(19):4255-9 [9766647.001]
  • [Cites] J Natl Cancer Inst. 1976 Nov;57(5):1027-35 [1003539.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51 [16027366.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1455-60 [24474772.001]
  • [Cites] J Clin Invest. 2001 Mar;107(5):611-20 [11238562.001]
  • [Cites] J Leukoc Biol. 2014 Aug;96(2):201-12 [24868089.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):997-1002 [17215377.001]
  • [Cites] FEMS Microbiol Lett. 2001 Sep 11;203(1):109-14 [11557148.001]
  • [Cites] Cell Microbiol. 2002 May;4(5):285-96 [12064285.001]
  • [Cites] Gastroenterology. 2016 Dec;151(6):1164-1175.e3 [27569724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14625-30 [11724955.001]
  • [Cites] J Infect Dis. 2004 May 15;189(10):1914-20 [15122529.001]
  • [Cites] Infect Immun. 1995 Apr;63(4):1183-7 [7890370.001]
  • (PMID = 28209611.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA028842; United States / NCI NIH HHS / CA / R01 CA077955; United States / NCI NIH HHS / CA / R01 CA190612; United States / NIDDK NIH HHS / DK / P30 DK058404; United States / NCI NIH HHS / CA / P01 CA116087; United States / BLRD VA / BX / I01 BX001453; United States / NIDDK NIH HHS / DK / R01 DK058587
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Dull B, Conant L, Myckatyn T, Tenenbaum M, Cyr A, Margenthaler JA: Nipple-sparing mastectomies: Clinical outcomes from a single academic institution. Mol Clin Oncol; 2017 May;6(5):737-742

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Charts were reviewed for demographic data and patient characteristics.
  • The mean patient age was 44.4 years (range, 20-77).
  • A total of 34 (17.2%) complications occurred, including infections, hematomas and nipple necrosis, with 9 requiring removal of the NAC and 13 requiring removal of the tissue expander or implant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plast Reconstr Surg. 1977 Apr;59(4):535-7 [847031.001]
  • [Cites] Ann Surg Oncol. 2015 Oct;22(10):3241-9 [26242363.001]
  • [Cites] Ann Surg Oncol. 2016 Aug;23(8):2665-72 [27038458.001]
  • [Cites] Plast Reconstr Surg. 2013 Nov;132(5):1043-54 [23924650.001]
  • [Cites] Eur J Surg Oncol. 2006 Nov;32(9):937-40 [16829015.001]
  • [Cites] Ann Plast Surg. 2005 Sep;55(3):240-4 [16106159.001]
  • [Cites] Cancer. 1985 May 15;55(10):2459-63 [2985236.001]
  • [Cites] Ann Surg Oncol. 2012 Apr;19(4):1174-80 [22006374.001]
  • [Cites] Plast Reconstr Surg. 2013 May;131(5):969-84 [23629079.001]
  • [Cites] Ann Surg Oncol. 2011 Oct;18(11):3123-8 [21861222.001]
  • [Cites] Eur J Surg Oncol. 2008 Feb;34(2):143-8 [17709228.001]
  • [Cites] Ann Plast Surg. 2016 Jun;76(6):629-34 [25003437.001]
  • [Cites] J Plast Surg Hand Surg. 2012 Oct;46(5):344-8 [22931106.001]
  • [Cites] Breast. 2016 Feb;25:75-81 [26612083.001]
  • [Cites] J Am Coll Surg. 2016 Jun;222(6):1149-55 [27118712.001]
  • [Cites] Aesthetic Plast Surg. 1989 Winter;13(1):15-21 [2728994.001]
  • [Cites] Ann Surg Oncol. 2016 Jan;23 (1):257-64 [26193963.001]
  • [Cites] N Engl J Med. 1985 Mar 14;312(11):665-73 [3883167.001]
  • [Cites] Ann Surg. 2009 Mar;249(3):461-8 [19247035.001]
  • [Cites] Cancer. 1980 Jul 1;46(1):1-13 [6992972.001]
  • [Cites] Scand J Surg. 2010;99(3):115-8 [21044925.001]
  • [Cites] N Engl J Med. 1999 Jan 14;340(2):77-84 [9887158.001]
  • [Cites] Plast Reconstr Surg. 2013 Sep;132(3):330e-8e [23985644.001]
  • [Cites] JAMA Surg. 2014 Oct;149(10):1015-21 [25141939.001]
  • [Cites] Plast Reconstr Surg. 1991 Jun;87(6):1048-53 [1852020.001]
  • [Cites] Ann Oncol. 2012 Aug;23(8):2053-8 [22231025.001]
  • [Cites] Arch Surg. 2008 Jan;143(1):38-45; discussion 45 [18209151.001]
  • [Cites] Plast Reconstr Surg Transplant Bull. 1962 Dec;30:676-82 [13959443.001]
  • [Cites] Plast Reconstr Surg. 2014 Mar;133(3):496-506 [24572843.001]
  • [Cites] Ann Surg Oncol. 2011 Jun;18(6):1665-70 [21174155.001]
  • [Cites] Pathol Res Pract. 1980;166(4):515-35 [6253967.001]
  • [Cites] Ann Surg. 2009 Jan;249(1):26-32 [19106672.001]
  • [Cites] J Surg Oncol. 2011 Mar 15;103(4):313-6 [21337564.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):177-81 [19926200.001]
  • [Cites] Cancer. 1977 Jun;39(6 Suppl):2827-39 [326381.001]
  • [Cites] Ann Surg Oncol. 2008 Feb;15(2):438-42 [18004629.001]
  • [Cites] J Reconstr Microsurg. 2015 Jul;31(6):434-41 [25910179.001]
  • (PMID = 28515925.001).
  • [ISSN] 2049-9450
  • [Journal-full-title] Molecular and clinical oncology
  • [ISO-abbreviation] Mol Clin Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; breast cancer / nipple-sparing mastectomy / reconstruction
  •  go-up   go-down


43. Soleymanian T, Kokabeh Z, Ramaghi R, Mahjoub A, Argani H: Clinical outcomes and quality of life in hemodialysis diabetic patients versus non-diabetics. J Nephropathol; 2017 Mar;6(2):81-89
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Transplantation rate was 4 and 9 per 100 patient years in diabetics and non-diabetics, respectively.
  • Death rate was two folds higher in diabetics (24 versus 12 per 100 patient years).
  • Cardiovascular diseases ( ± infections/other causes) comprised 80.5% of death in diabetics and 54.5% in non-diabetics.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabet Med. 2009 Sep;26(9):921-7 [19719714.001]
  • [Cites] Nephrol Dial Transplant. 1997 Dec;12(12):2501-9 [9430842.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 2010 Mar;118(3):205-8 [19226477.001]
  • [Cites] BMC Nephrol. 2012 Aug 03;13:78 [22863310.001]
  • [Cites] Kidney Int. 2004 Apr;65(4):1408-15 [15086482.001]
  • [Cites] Nephrol Dial Transplant. 2003 Oct;18(10):1993-8 [13679472.001]
  • [Cites] Nephrol Dial Transplant. 1999 Jan;14(1):129-36 [10052492.001]
  • [Cites] Kidney Int. 1999 Feb;55(2):648-58 [9987089.001]
  • [Cites] Adv Ren Replace Ther. 2001 Jan;8(1):42-56 [11172326.001]
  • [Cites] Diabetes Care. 2010 Aug;33(8):1811-6 [20484126.001]
  • [Cites] J Am Soc Nephrol. 2015 Jan;26(1):183-91 [25063436.001]
  • [Cites] J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S25-9 [14684667.001]
  • [Cites] Nephrol Dial Transplant. 2003 Jun;18(6):1159-66 [12748350.001]
  • [Cites] Transplantation. 1986 May;41(5):598-602 [3518165.001]
  • [Cites] Kidney Int. 1992 Oct;42(4):991-6 [1453592.001]
  • [Cites] J Am Soc Nephrol. 2010 Feb;21(2):223-30 [20075063.001]
  • [Cites] J Ren Nutr. 2009 Mar;19(2):127-35 [19218039.001]
  • [Cites] Kidney Int Suppl. 1992 Oct;38:S4-15 [1405380.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1361-6 [21030940.001]
  • [Cites] Kidney Int. 2006 Jul;70(1):187-91 [16688116.001]
  • [Cites] Med Care. 1992 Jun;30(6):473-83 [1593914.001]
  • [Cites] N Engl J Med. 1993 Sep 30;329(14):1001-6 [8366899.001]
  • [Cites] Diabetes Care. 2001 Sep;24(9):1689-90 [11522723.001]
  • [Cites] J Ren Nutr. 2010 Jul;20(4):243-54 [20199875.001]
  • [Cites] Semin Dial. 2005 Sep-Oct;18(5):365-9 [16191172.001]
  • [Cites] Kidney Int. 2005 Apr;67(4):1489-99 [15780102.001]
  • [Cites] Kidney Int. 2002 Aug;62(2):593-601 [12110023.001]
  • [Cites] J Am Soc Nephrol. 1993 Mar;3(9):1631-7 [8507820.001]
  • [Cites] J Vasc Access. 2015 Jul-Aug;16(4):259-64 [25656252.001]
  • [Cites] Kidney Int. 1993 Jul;44(1):115-9 [8355451.001]
  • [Cites] Am J Kidney Dis. 1998 Dec;32(6 Suppl 4):S118-25 [9892378.001]
  • [Cites] Am J Kidney Dis. 2010 Jan;55(1 Suppl 1):S1-420, A6-7 [20082919.001]
  • [Cites] Nephrol Dial Transplant. 2004 Sep;19(9):2347-53 [15252167.001]
  • [Cites] J Am Soc Nephrol. 2008 Feb;19(2):405-12 [18199805.001]
  • [Cites] Clin Nephrol. 1993 Mar;39(3):172-4 [8462206.001]
  • (PMID = 28491858.001).
  • [ISSN] 2251-8363
  • [Journal-full-title] Journal of nephropathology
  • [ISO-abbreviation] J Nephropathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Cardiovascular disease / Diabetes mellitus / Hemodialysis / Patient outcomes / Quality of life
  •  go-up   go-down


44. Bustamante-Rengifo JA, Matta AJ, Pazos AJ, Bravo LE: Effect of treatment failure on the CagA EPIYA motif in &lt;i&gt;Helicobacter pylori&lt;/i&gt; strains from Colombian subjects. World J Gastroenterol; 2017 Mar 21;23(11):1980-1989

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: Unsuccessful treatment limits colonization by low-virulence strains resulting in partial and selective eradication in mixed infections, and acts on the <i>cagA</i>-positive strains inducing genetic rearrangements in <i>cagA</i> variable region that produces a loss or gain of EPIYA repetitions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Gastroenterol. 2002 Nov;97(11):2839-42 [12425557.001]
  • [Cites] Clin Microbiol Infect. 2010 Apr;16(4):369-78 [19456839.001]
  • [Cites] Intern Med. 2008;47(12):1077-83 [18552463.001]
  • [Cites] Am J Gastroenterol. 2006 Jul;101(7):1467-75 [16863547.001]
  • [Cites] World J Gastroenterol. 2015 Oct 7;21(37):10563-72 [26457016.001]
  • [Cites] J Clin Microbiol. 2005 Feb;43(2):791-5 [15695681.001]
  • [Cites] Nucleic Acids Res. 1992 Oct 11;20(19):5137-42 [1408828.001]
  • [Cites] Gut. 2012 May;61(5):646-64 [22491499.001]
  • [Cites] World J Gastroenterol. 2013 Sep 28;19(36):6044-54 [24106405.001]
  • [Cites] Cancer Causes Control. 2013 Feb;24(2):249-56 [23224271.001]
  • [Cites] Gut. 2005 Nov;54(11):1536-40 [15985559.001]
  • [Cites] Acta Gastroenterol Latinoam. 2009 Dec;39(4):282-90 [20178259.001]
  • [Cites] Gut. 2000 Mar;46(3):321-6 [10673291.001]
  • [Cites] Gut. 2011 Sep;60(9):1189-95 [21357593.001]
  • [Cites] J Clin Microbiol. 1998 May;36(5):1271-6 [9574690.001]
  • [Cites] Gastroenterology. 1998 Nov;115(5):1272-7 [9797384.001]
  • [Cites] Gastroenterol Hepatol. 2011 Feb;34(2):89-99 [21371619.001]
  • [Cites] J Biol Chem. 2006 Oct 27;281(43):32344-52 [16954210.001]
  • [Cites] J Gastroenterol Hepatol. 2007 Dec;22(12):2251-55 [18031390.001]
  • [Cites] Acta Gastroenterol Latinoam. 2007 Dec;37(4):238-45 [18254262.001]
  • [Cites] Am J Surg Pathol. 1996 Oct;20(10):1161-81 [8827022.001]
  • [Cites] Helicobacter. 2008 Apr;13(2):135-45 [18321303.001]
  • [Cites] Cancer Lett. 2009 Sep 8;282(1):1-8 [19111390.001]
  • [Cites] PLoS Pathog. 2009 Oct;5(10):e1000544 [19855816.001]
  • [Cites] World J Gastroenterol. 2010 Aug 21;16(31):3936-43 [20712055.001]
  • [Cites] Int J Epidemiol. 2002 Feb;31(1):128-39 [11914309.001]
  • [Cites] J Clin Invest. 2009 Sep;119(9):2475-87 [19729845.001]
  • [Cites] Helicobacter. 2005 Jun;10(3):157-71 [15904473.001]
  • [Cites] Helicobacter. 2012 Apr;17(2):107-15 [22404440.001]
  • [Cites] J Clin Invest. 2013 Jan;123(1):479-92 [23257361.001]
  • [Cites] Cell Microbiol. 2006 Jan;8(1):97-106 [16367869.001]
  • [Cites] Science. 2002 Jan 25;295(5555):683-6 [11743164.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Feb;17(3):421-8 [12562456.001]
  • [Cites] J Med Microbiol. 2005 Jun;54(Pt 6):567-74 [15888466.001]
  • [Cites] Int J Infect Dis. 2010 Sep;14 Suppl 3:e85-92 [20304694.001]
  • [Cites] Nat Rev Microbiol. 2007 Jun;5(6):441-52 [17505524.001]
  • [Cites] Nat Rev Cancer. 2010 Jun;10(6):403-14 [20495574.001]
  • [Cites] Nat Rev Microbiol. 2004 Sep;2(9):747-65 [15372085.001]
  • [Cites] Scand J Gastroenterol. 2006 Mar;41(3):280-7 [16497614.001]
  • [Cites] Res Microbiol. 2001 Jan-Feb;152(1):11-6 [11281320.001]
  • [Cites] J Clin Microbiol. 2001 May;39(5):1833-9 [11325999.001]
  • [Cites] Nat Rev Cancer. 2002 Jan;2(1):28-37 [11902583.001]
  • [Cites] Am J Gastroenterol. 2000 Feb;95(2):564-6 [10685783.001]
  • [Cites] Gut. 1995 Jun;36(6):845-7 [7615271.001]
  • [Cites] J Biol Chem. 2005 Jun 17;280(24):23130-7 [15831497.001]
  • [Cites] J Clin Microbiol. 2007 Feb;45(2):488-95 [17151214.001]
  • (PMID = 28373764.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; 3’ cagA variable region / EPIYA motifs / Helicobacter pylori / RAPD-PCR / Treatment failure
  •  go-up   go-down


45. Salaheen S, Peng M, Joo J, Teramoto H, Biswas D: Eradication and Sensitization of Methicillin Resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; to Methicillin with Bioactive Extracts of Berry Pomace. Front Microbiol; 2017;8:253

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In summary, novel and sustainable prophylactic therapy can be developed with BPE in combination with currently available antibiotics, especially methicillin, against skin and soft tissue infections with MRSA.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Microbiol Infect. 2008 Jan;14(1):29-34 [17986212.001]
  • [Cites] J Agric Food Chem. 2008 Feb 13;56(3):681-8 [18211029.001]
  • [Cites] Curr Microbiol. 2015 May;70(5):698-703 [25586078.001]
  • [Cites] Postgrad Med. 2001 Feb;109(2 Suppl):43-50 [19667557.001]
  • [Cites] Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3B [18432654.001]
  • [Cites] J Food Prot. 2014 May;77(5):758-64 [24780330.001]
  • [Cites] Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2442-7 [17131705.001]
  • [Cites] J Agric Food Chem. 2011 May 25;59(10):5312-7 [21469731.001]
  • [Cites] Int J Food Microbiol. 2016 Nov 21;237:128-135 [27565525.001]
  • [Cites] J Food Sci. 2015 Mar;80(3):M635-41 [25627431.001]
  • [Cites] JAMA. 2007 Oct 17;298(15):1803-4 [17940239.001]
  • [Cites] BMC Complement Altern Med. 2012 Aug 16;12:125 [22894560.001]
  • [Cites] J Appl Microbiol. 2005;98 (4):991-1000 [15752346.001]
  • [Cites] PLoS One. 2013 Jul 05;8(7):e69508 [23861974.001]
  • [Cites] J Pharm Biomed Anal. 2002 Jun 15;28(6):1205-13 [12049985.001]
  • [Cites] Pediatr Int. 2011 Jun;53(3):363-7 [20723106.001]
  • [Cites] Antimicrob Agents Chemother. 1994 Nov;38(11):2590-8 [7872753.001]
  • [Cites] Int J Antimicrob Agents. 2004 May;23 (5):462-7 [15120724.001]
  • [Cites] Genet Mol Res. 2003 Mar 31;2(1):63-76 [12917803.001]
  • [Cites] J Appl Microbiol. 2013 Aug;115(2):346-57 [23510516.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1327-32 [18216255.001]
  • [Cites] Phytochemistry. 2004 Feb;65(3):331-5 [14751304.001]
  • [Cites] Int J Food Microbiol. 2008 Jul 31;125(3):252-8 [18524407.001]
  • [Cites] Perspect Medicin Chem. 2014 Aug 28;6:25-64 [25232278.001]
  • [Cites] Br J Clin Pharmacol. 2015 Feb;79(2):173-81 [24803175.001]
  • [Cites] Foodborne Pathog Dis. 2004 Winter;1(4):241-6 [15992286.001]
  • [Cites] Can J Infect Dis. 2000 Jul;11(4):202-11 [18159291.001]
  • [Cites] Nat Immunol. 2007 Oct;8(10):1114-22 [17721536.001]
  • [Cites] Appl Environ Microbiol. 2009 Jan;75(1):265-7 [18978079.001]
  • [Cites] PLoS One. 2013;8(4):e60463 [23565251.001]
  • [Cites] Euro Surveill. 2008 Feb 28;13(9):null [18445406.001]
  • [Cites] Science. 2008 Feb 15;319(5865):910-1 [18276877.001]
  • [Cites] Biochem Pharmacol. 2007 Dec 3;74(11):1619-27 [17869225.001]
  • [Cites] J Microbiol. 2016 Jan;54(1):1-8 [26727895.001]
  • [Cites] Lett Appl Microbiol. 2000 Dec;31(6):438-42 [11123552.001]
  • [Cites] Ann Clin Microbiol Antimicrob. 2011 Jun 09;10:25 [21658242.001]
  • [Cites] Microb Drug Resist. 1999 Fall;5(3):163-75 [10566865.001]
  • [Cites] Int J Med Microbiol. 2006 Apr;296(2-3):149-61 [16503194.001]
  • [Cites] J Dairy Sci. 2016 May;99(5):3667-74 [26947297.001]
  • (PMID = 28270804.001).
  • [Journal-full-title] Frontiers in microbiology
  • [ISO-abbreviation] Front Microbiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Staphylococcus aureus / antibiotic resistance / antimicrobials / gene expression / phenolic compounds
  •  go-up   go-down


46. Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P: Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Joint Res; 2017 May;6(5):296-306

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Thermal stability is a key property in determining the suitability of an antibiotic agent for local application in the treatment of orthopaedic infections.
  • Antibacterial activity over time was determined by the Kirby-Bauer disk diffusion assay.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Moriarty et al.
  • [Cites] Clin Orthop Relat Res. 2004 Oct;(427):79-85 [15552141.001]
  • [Cites] Pediatrics. 2007 Dec;120(6):1255-9 [18055674.001]
  • [Cites] Drug Dev Ind Pharm. 2009 Apr;35(4):471-9 [19048426.001]
  • [Cites] Pharmazie. 2011 Aug;66(8):631-2 [21901990.001]
  • [Cites] J Biomech. 1980;13(4):347-52 [7400163.001]
  • [Cites] Clin Chem Lab Med. 2016 Feb;54(2):265-74 [26351928.001]
  • [Cites] J Antimicrob Chemother. 2013 May;68(5):1179-82 [23302579.001]
  • [Cites] Drugs. 2000 Jun;59(6):1223-32 [10882159.001]
  • [Cites] J Antimicrob Chemother. 2008 Jun;61(6):1295-301 [18339637.001]
  • [Cites] Lancet Infect Dis. 2001 Oct;1(3):175-88 [11871494.001]
  • [Cites] J Orthop Res. 2006 Aug;24(8):1615-21 [16788986.001]
  • [Cites] Int Orthop. 1995;19(3):157-61 [7558491.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Aug;46(8):2327-32 [12121900.001]
  • [Cites] J Antimicrob Chemother. 2008 Feb;61(2):382-8 [18070831.001]
  • [Cites] J Antimicrob Chemother. 2008 Feb;61(2):235-7 [18065413.001]
  • [Cites] Clin Infect Dis. 2012 Dec;55(11):1474-80 [22918993.001]
  • [Cites] Cold Spring Harb Perspect Med. 2016 Jun 01;6(6):null [27252397.001]
  • [Cites] J Bone Joint Surg Am. 2007 Apr;89(4):871-82 [17403814.001]
  • [Cites] J Orthop Res. 2000 Sep;18(5):721-7 [11117292.001]
  • [Cites] Arch Orthop Trauma Surg. 2011 May;131(5):657-62 [20938669.001]
  • [Cites] Clin Pharmacokinet. 2009;48(2):89-124 [19271782.001]
  • [Cites] Clin Infect Dis. 2013 Jan;56(1):e1-e25 [23223583.001]
  • [Cites] Clin Pharmacokinet. 1995 Jul;29(1):36-45 [7586897.001]
  • [Cites] Acta Orthop. 2008 Oct;79(5):637-42 [18839370.001]
  • [Cites] J Orthop Res. 2011 Jul;29(7):1070-4 [21567453.001]
  • [Cites] Int J Antimicrob Agents. 2008 May;31(5):434-9 [18328674.001]
  • [Cites] Scand J Infect Dis. 2013 Mar;45(3):161-75 [23270477.001]
  • [Cites] J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):467-75 [19145626.001]
  • [Cites] J Antimicrob Chemother. 2010 May;65(5):1073-5 [20176578.001]
  • [Cites] J Antimicrob Chemother. 2004 Apr;53(4):675-7 [15014060.001]
  • [Cites] Int J Biomater. 2012;2012:538061 [22899933.001]
  • [Cites] Clin Microbiol Infect. 2014 Apr;20(4):O255-66 [24131428.001]
  • [Cites] Clin Pharmacokinet. 2005;44(11):1097-115 [16231964.001]
  • [Cites] J Antimicrob Chemother. 2003 Jul;52(1):18-23 [12775671.001]
  • (PMID = 28515059.001).
  • [Journal-full-title] Bone & joint research
  • [ISO-abbreviation] Bone Joint Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Bone cement / Local antibiotics / Thermal stability
  •  go-up   go-down


47. Groff SM, Fallatah W, Yang S, Murphy J, Crutchfield C, Marzinke M, Kurtzberg J, Lee CKK, Burd I, Farzin A: Effect of Maternal Obesity on Maternal-Fetal Transfer of Preoperative Cefazolin at Cesarean Section. J Pediatr Pharmacol Ther; 2017 May-Jun;22(3):227-232
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We sought to evaluate 1) cefazolin plasma concentrations among obese and non-obese patients after administration of a 2-g cefazolin dose for prevention of surgical wound infections, and 2) whether cefazolin concentration in fetal circulation may be protective against pathogens that cause early onset neonatal sepsis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Obstet Gynecol. 2015 May;125(5):1205-10 [25932849.001]
  • [Cites] Clin Perinatol. 2010 Jun;37(2):375-92 [20569813.001]
  • [Cites] Cochrane Database Syst Rev. 2014 Oct 28;(10):CD007482 [25350672.001]
  • [Cites] Am J Obstet Gynecol. 2009 Feb;200(2):170.e1-7 [19006783.001]
  • [Cites] Cardiovasc Res Cent Bull. 1962-1963 Winter;1:39-44 [14011956.001]
  • [Cites] Mayo Clin Proc. 1999 Feb;74(2):187-95 [10069359.001]
  • [Cites] Surg Infect (Larchmt). 2002;3 Suppl 1:S9-21 [12573036.001]
  • [Cites] Obstet Gynecol. 2011 Apr;117(4):877-82 [21422859.001]
  • [Cites] J Antimicrob Chemother. 2002 Sep;50(3):429-32 [12205071.001]
  • [Cites] Obstet Gynecol Surv. 2005 Jul;60(7):462-73 [15995563.001]
  • [Cites] Clin Pharmacokinet. 1997 Nov;33(5):328-43 [9391746.001]
  • [Cites] Antimicrob Agents Chemother. 2014 Jun;58(6):3504-13 [24733461.001]
  • [Cites] Am J Obstet Gynecol. 2015 Oct;213(4):541.e1-7 [26103528.001]
  • [Cites] J Clin Invest. 2005 Oct;115(10):2592-7 [16200191.001]
  • [Cites] Obstet Gynecol Clin North Am. 2009 Jun;36(2):285-300, viii [19501314.001]
  • [Cites] J Biomed Biotechnol. 2011;2011:783528 [21785566.001]
  • [Cites] Eur J Clin Pharmacol. 2011 Oct;67(10):985-92 [21499760.001]
  • [Cites] Int J Gynaecol Obstet. 2014 Mar;124(3):244-7 [24380609.001]
  • [Cites] Pediatr Infect Dis J. 2011 Nov;30(11):937-41 [21654548.001]
  • [Cites] Obstet Gynecol. 2001 Dec;98(6):1075-9 [11755556.001]
  • [Cites] Surg Infect (Larchmt). 2013 Oct;14(5):455-9 [23859672.001]
  • [Cites] Am J Obstet Gynecol. 1990 Sep;163(3):938-43 [2119561.001]
  • [Cites] Biomed Res Int. 2014;2014:897216 [24672799.001]
  • [Cites] Obstet Gynecol. 2011 Jun;117(6):1472-83 [21606770.001]
  • [Cites] Pediatr Clin North Am. 2013 Apr;60(2):367-89 [23481106.001]
  • [Cites] Am J Obstet Gynecol. 2015 Sep;213(3):415.e1-8 [26003059.001]
  • [Cites] J Clin Pharm Ther. 2007 Dec;32(6):595-602 [18021337.001]
  • [Cites] J Nutr Health Aging. 2007 Mar-Apr;11(2):111-8 [17435953.001]
  • (PMID = 28638306.001).
  • [ISSN] 1551-6776
  • [Journal-full-title] The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
  • [ISO-abbreviation] J Pediatr Pharmacol Ther
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / K08 HD073315
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; antibiotic prophylaxis / cefazolin / obesity / pregnancy / surgical wound infection
  •  go-up   go-down


48. Montenegro DC, Bitencourth K, de Oliveira SV, Borsoi AP, Cardoso KM, Sousa MSB, Giordano-Dias C, Amorim M, Serra-Freire NM, Gazêta GS, Brazil RP: Spotted Fever: Epidemiology and Vector-&lt;i&gt;Rickettsia-&lt;/i&gt;Host Relationship in Rio de Janeiro State. Front Microbiol; 2017;8:505

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The epidemiologic dynamics of SF in RJ State are very heterogeneous in time and space, with outbreaks, high mortality rates and periods of epidemiological silence (no SF cases reported).
  • This study found confirmed human infections for only the <i>R. rickettsii</i> carrier <i>Amblyomma sculptum</i>, which reinforces the importance of this species as a vector of the pathogen in Brazil.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Emerg Infect Dis. 2014 Mar;20(3):498-500 [24565262.001]
  • [Cites] Clin Microbiol Rev. 2013 Oct;26(4):657-702 [24092850.001]
  • [Cites] Ecohealth. 2011 Sep;8(3):320-31 [22173291.001]
  • [Cites] Mem Inst Oswaldo Cruz. 1961 Jul;59:115-29 [13861962.001]
  • [Cites] Braz J Infect Dis. 2008 Apr;12(2):149-51 [18641853.001]
  • [Cites] Clin Microbiol Infect. 2009 Dec;15 Suppl 2:267-8 [19298400.001]
  • [Cites] J Bacteriol. 1991 Mar;173(5):1576-89 [1671856.001]
  • [Cites] Rev Soc Bras Med Trop. 2015 Jan-Feb;48(1):11-7 [25860458.001]
  • [Cites] Mem Inst Oswaldo Cruz. 2011 Dec;106(8):926-30 [22241112.001]
  • [Cites] Curr Infect Dis Rep. 2009 Jan;11(1):40-50 [19094824.001]
  • [Cites] Ann N Y Acad Sci. 2003 Jun;990:12-24 [12860595.001]
  • [Cites] Clin Microbiol Rev. 1997 Oct;10(4):694-719 [9336669.001]
  • [Cites] Epidemiol Infect. 2015 Aug;143(11):2446-50 [25483025.001]
  • [Cites] Biomedica. 2013 Sep;33 Suppl 1:38-51 [24652248.001]
  • [Cites] Ann N Y Acad Sci. 2009 May;1166:156-66 [19538276.001]
  • [Cites] Rev Bras Epidemiol. 2015 Apr-Jun;18(2):299-312 [26083504.001]
  • [Cites] J Clin Microbiol. 2004 Jan;42(1):90-8 [14715737.001]
  • [Cites] Ticks Tick Borne Dis. 2010 Jun;1(2):75-99 [21771514.001]
  • [Cites] Ticks Tick Borne Dis. 2012 Dec;3(5-6):332-7 [23182271.001]
  • [Cites] Clin Microbiol Infect. 2009 Dec;15 Suppl 2:269-70 [19281455.001]
  • [Cites] Rev Panam Salud Publica. 2010 Jun;27(6):461-6 [20721447.001]
  • [Cites] Nucleic Acids Res. 1997 Nov 15;25(22):4692-3 [9358185.001]
  • [Cites] Front Cell Infect Microbiol. 2013 Aug 08;3:29 [23964348.001]
  • [Cites] Front Public Health. 2015 Apr 21;3:55 [25954738.001]
  • [Cites] Rev Soc Bras Med Trop. 2002 Sep-Oct;35(5):523-5 [12621675.001]
  • [Cites] Front Cell Infect Microbiol. 2013 Jul 12;3:27 [23875178.001]
  • (PMID = 28424664.001).
  • [Journal-full-title] Frontiers in microbiology
  • [ISO-abbreviation] Front Microbiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; eco-epidemiology / public health / rickettsioses / tick-borne diseases / zoonosis
  •  go-up   go-down


49. Wilburn L, Yodmeeklin A, Kochjan P, Saikruang W, Kumthip K, Khamrin P, Maneekarn N: Molecular detection and characterization of picobirnaviruses in piglets with diarrhea in Thailand. Arch Virol; 2017 Apr;162(4):1061-1066
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PBV infects a wide range of hosts and causes opportunistic infections, but its role in diarrheal disease remains unclear.
  • PBV was detected in 86 of 265 (32.5%) diarrheic piglets and in 26 of 115 (22.6%) non-diarrheic piglets.
  • [MeSH-major] Diarrhea / veterinary. Picobirnavirus / genetics. RNA Virus Infections / veterinary. Swine Diseases / virology

  • MedlinePlus Health Information. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28032197.001).
  • [ISSN] 1432-8798
  • [Journal-full-title] Archives of virology
  • [ISO-abbreviation] Arch. Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  • [Keywords] NOTNLM ; Diarrhea / Picobirnavirus / Thailand
  •  go-up   go-down


50. Flokas ME, Karanika S, Alevizakos M, Mylonakis E: Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis. PLoS One; 2017;12(1):e0171216

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis.
  • BACKGROUND: Pediatric bloodstream infections (BSIs) with Extended-Spectrum Beta-Lactamase- producing Enterobacteriaceae (ESBL-PE) are associated with worse clinical outcomes.
  • We aimed to estimate the prevalence of and the mortality associated with ESBL-PE in this patient population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rev Argent Microbiol. 2008 Apr-Jun;40(2):111-5 [18705494.001]
  • [Cites] PLoS One. 2016 Feb 11;11(2):e0143729 [26867226.001]
  • [Cites] Indian Pediatr. 2004 Jan;41(1):97-9 [14767101.001]
  • [Cites] Med Princ Pract. 2005 Nov-Dec;14(6):417-21 [16220016.001]
  • [Cites] J Clin Diagn Res. 2013 Dec;7(12):2732-5 [24551625.001]
  • [Cites] J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i1-9 [18684701.001]
  • [Cites] Infect Control Hosp Epidemiol. 2004 Sep;25(9):781-3 [15484805.001]
  • [Cites] Diagn Microbiol Infect Dis. 2004 Sep;50(1):59-69 [15380279.001]
  • [Cites] Biomed Res Int. 2013;2013:756209 [24175299.001]
  • [Cites] Arch Public Health. 2014 Nov 10;72(1):39 [25810908.001]
  • [Cites] Clin Microbiol Rev. 2005 Oct;18(4):657-86 [16223952.001]
  • [Cites] Control Clin Trials. 1986 Sep;7(3):177-88 [3802833.001]
  • [Cites] Intern Med J. 2006 Dec;36(12):765-72 [17096739.001]
  • [Cites] J Clin Diagn Res. 2014 Jun;8(6):DC24-7 [25120982.001]
  • [Cites] Indian J Med Microbiol. 2008 Oct-Dec;26(4):356-60 [18974490.001]
  • [Cites] Med Sci Monit. 2007 Jun;13(6):CR251-7 [17534230.001]
  • [Cites] Infect Control Hosp Epidemiol. 2000 Apr;21(4):260-3 [10782588.001]
  • [Cites] Malays J Pathol. 2002 Dec;24(2):83-9 [12887165.001]
  • [Cites] Stat Med. 2002 Jun 15;21(11):1559-73 [12111920.001]
  • [Cites] BMC Med Res Methodol. 2008 Nov 27;8:79 [19036172.001]
  • [Cites] Am J Infect Control. 2008 Jun;36(5):309-32 [18538699.001]
  • [Cites] J Lab Physicians. 2015 Jan-Jun;7(1):32-7 [25949057.001]
  • [Cites] Antimicrob Agents Chemother. 2007 Jun;51(6):1987-94 [17387156.001]
  • [Cites] Am J Infect Control. 2009 Aug;37(6):435-41 [19155096.001]
  • [Cites] Indian J Med Res. 2013 Apr;137(4):791-9 [23703349.001]
  • [Cites] J Infect Dev Ctries. 2007 Dec 01;1(3):269-74 [19734604.001]
  • [Cites] BMC Infect Dis. 2015 Mar 25;15:152 [25885702.001]
  • [Cites] Clin Microbiol Infect. 2000 Sep;6(9):460-3 [11168179.001]
  • [Cites] BMC Infect Dis. 2014 Dec 20;14:3859 [25526763.001]
  • [Cites] Antimicrob Agents Chemother. 2002 May;46(5):1481-91 [11959586.001]
  • [Cites] J Clin Microbiol. 2005 Feb;43(2):745-9 [15695674.001]
  • [Cites] Clin Perinatol. 2010 Jun;37(2):307-37 [20569810.001]
  • [Cites] Ceylon Med J. 2013 Jun;58(2):56-61 [23817934.001]
  • [Cites] ISRN Pediatr. 2012;2012:508512 [22919509.001]
  • [Cites] J Clin Neonatol. 2012 Apr;1(2):72-5 [24027694.001]
  • [Cites] Am J Infect Control. 2007 Nov;35(9):613-8 [17980241.001]
  • [Cites] BMC Pediatr. 2010 Jun 04;10:39 [20525358.001]
  • [Cites] Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F72-8 [26369370.001]
  • [Cites] Am J Gastroenterol. 2015 Mar;110(3):381-90; quiz 391 [25732416.001]
  • [Cites] J Med Microbiol. 2003 May;52(Pt 5):421-5 [12721319.001]
  • [Cites] J Med Microbiol. 2011 Apr;60(Pt 4):500-7 [21183602.001]
  • [Cites] J Glob Infect Dis. 2015 Apr-Jun;7(2):75-7 [26069427.001]
  • [Cites] BMJ. 1997 Sep 13;315(7109):629-34 [9310563.001]
  • [Cites] BMC Res Notes. 2015 Apr 02;8:123 [25889421.001]
  • [Cites] Pediatrics. 2005 Apr;115(4):942-9 [15805368.001]
  • [Cites] J Coll Physicians Surg Pak. 2014 Jun;24(6):396-399 [24953929.001]
  • [Cites] BMC Pediatr. 2015 Apr 02;15:33 [25884449.001]
  • [Cites] Ann Trop Paediatr. 2007 Mar;27(1):45-54 [17469732.001]
  • [Cites] Int J Infect Dis. 2000;4(1):21-5 [10689210.001]
  • [Cites] J Pediatric Infect Dis Soc. 2014 Dec;3(4):320-8 [26625452.001]
  • [Cites] PLoS Med. 2009 Jul 21;6(7):e1000097 [19621072.001]
  • (PMID = 28141845.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


51. Sundén F, Butler D, Wullt B: Triggered Urine Interleukin-6 Correlates to Severity of Symptoms in Nonfebrile Lower Urinary Tract Infections. J Urol; 2017 Jul;198(1):107-115
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Triggered Urine Interleukin-6 Correlates to Severity of Symptoms in Nonfebrile Lower Urinary Tract Infections.
  • PURPOSE: Objective diagnosis of symptomatic urinary tract infections in patients prone to asymptomatic bacteriuria is compromised by local host responses that are already present and the positive urine culture.
  • However, in urinary tract infections with worse symptoms interleukin-6 and neutrophils demonstrated equal good/excellent outcomes.
  • Future studies should explore interleukin-6 as a biomarker of urinary tract infection severity and assess the treatment indication in nonfebrile urinary tract infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28161350.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Escherichia coli / bacteriuria / diagnosis / differential / interleukin-6 / urinary tract infections
  •  go-up   go-down


52. Wesolowska-Andersen A, Everman JL, Davidson R, Rios C, Herrin R, Eng C, Janssen WJ, Liu AH, Oh SS, Kumar R, Fingerlin TE, Rodriguez-Santana J, Burchard EG, Seibold MA: Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome. Genome Biol; 2017 Jan 19;18(1):12
MedlinePlus Health Information. consumer health - Asthma in Children.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome.
  • Little is known about the effects of respiratory viral infections in the absence of illness.
  • Using quantitative PCR (qPCR) for common respiratory viruses and for two genes known to be highly upregulated in viral infections (CCL8/CXCL11), we screened 92 asthmatic and 69 healthy children without illness for respiratory virus infections.
  • [MeSH-major] Asthma / genetics. Host-Pathogen Interactions / genetics. RNA Virus Infections / genetics. RNA Virus Infections / virology. RNA Viruses. Respiratory Tract Infections / genetics. Respiratory Tract Infections / virology. Transcriptome

  • MedlinePlus Health Information. consumer health - Asthma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Respir Crit Care Med. 2009 Sep 1;180(5):388-95 [19483109.001]
  • [Cites] J Virol. 1998 Feb;72(2):1280-6 [9445028.001]
  • [Cites] Bioinformatics. 2015 Jan 15;31(2):166-9 [25260700.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [16199517.001]
  • [Cites] BMC Bioinformatics. 2011 Aug 04;12:322 [21816037.001]
  • [Cites] PLoS One. 2015 Feb 23;10(2):e0118286 [25706956.001]
  • [Cites] Am J Respir Cell Mol Biol. 2016 Sep;55(3):323-36 [27144410.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38 [24843156.001]
  • [Cites] PLoS One. 2015 Nov 16;10(11):e0143164 [26569120.001]
  • [Cites] BMC Bioinformatics. 2009 May 27;10:161 [19473525.001]
  • [Cites] Am J Respir Crit Care Med. 2000 May;161(5):1501-7 [10806145.001]
  • [Cites] Bioinformatics. 2010 Jan 1;26(1):139-40 [19910308.001]
  • [Cites] Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8765-70 [27432971.001]
  • [Cites] PLoS One. 2015 Jun 30;10(6):e0131819 [26125632.001]
  • [Cites] J Med Virol. 2010 Jul;82(7):1282-90 [20513097.001]
  • [Cites] J Gen Virol. 2006 Jul;87(Pt 7):1805-21 [16760383.001]
  • [Cites] J Allergy Clin Immunol. 2015 Mar;135(3):663-9.e12 [25476729.001]
  • [Cites] J Pediatr. 2016 Apr;171:133-9.e1 [26787374.001]
  • [Cites] Hepatology. 2010 Aug;52(2):443-53 [20683944.001]
  • [Cites] J Clin Microbiol. 2016 Apr;54(4):1000-7 [26818672.001]
  • [Cites] J Allergy Clin Immunol. 2014 Mar;133(3):670-8.e12 [24495433.001]
  • [Cites] Genome Res. 2008 May;18(5):821-9 [18349386.001]
  • [Cites] Pediatrics. 1995 Apr;95(4):500-5 [7700748.001]
  • [Cites] J Gen Virol. 1976 Feb;30(2):263-7 [181536.001]
  • [Cites] Nat Protoc. 2008;3(6):1101-8 [18546601.001]
  • [Cites] Clin Microbiol Infect. 2016 May;22(5):458.e1-9 [26802214.001]
  • [Cites] Emerg Infect Dis. 2009 May;15(5):719-26 [19402957.001]
  • [Cites] J Allergy Clin Immunol. 2016 Oct;138(4):1042-1050 [27720018.001]
  • [Cites] Science. 1998 Dec 18;282(5397):2258-61 [9856949.001]
  • [Cites] Pediatr Infect Dis J. 2008 Dec;27(12):1103-7 [18978518.001]
  • [Cites] J Med Virol. 2016 Jan;88(1):45-50 [26100363.001]
  • [Cites] JCI Insight. 2016 Sep 8;1(14 ):e87871 [27699235.001]
  • [Cites] J Clin Virol. 2015 May;66:6-11 [25866327.001]
  • [Cites] Biotechnol Bioeng. 2014 Dec;111(12):2499-507 [24942535.001]
  • [Cites] World J Pediatr. 2016 May;12 (2):183-9 [26684315.001]
  • [Cites] J Allergy Clin Immunol. 2014 May;133(5):1301-7, 1307.e1-3 [24698319.001]
  • [Cites] Bioinformatics. 2013 Nov 1;29(21):2810-1 [23958726.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 2):S2-6 [11254543.001]
  • [Cites] BMC Bioinformatics. 2008 Dec 29;9:559 [19114008.001]
  • [Cites] Bioinformatics. 2010 Mar 15;26(6):841-2 [20110278.001]
  • [Cites] Bioinformatics. 2010 Apr 1;26(7):873-81 [20147302.001]
  • [Cites] J Clin Microbiol. 2015 Jul;53(7):2238-50 [25972420.001]
  • [Cites] Biol Cell. 2010 Jul 09;102(9):499-513 [20690903.001]
  • [Cites] Genome Res. 2015 Dec;25(12):1910-20 [26395152.001]
  • [Cites] J Allergy Clin Immunol. 2017 Feb;139(2):501-507 [27312820.001]
  • [Cites] Gene Ther. 2015 Oct;22(10):822-9 [26043872.001]
  • [Cites] Virol J. 2011 Jun 29;8:332 [21714915.001]
  • [Cites] Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20035-40 [23169653.001]
  • [Cites] Proc Natl Acad Sci U S A. 1978 Dec;75(12):5893-7 [282611.001]
  • [Cites] Methods Mol Biol. 2002;188:115-37 [11987537.001]
  • [Cites] Genome Med. 2014 Jan 17;6(1):1 [24433494.001]
  • [Cites] Phys Chem Chem Phys. 2015 Nov 14;17(42):27968-80 [26024367.001]
  • [Cites] J Allergy Clin Immunol. 2013 Oct;132(4):896-905.e1 [23684070.001]
  • [Cites] PLoS Pathog. 2013;9(5):e1003341 [23671415.001]
  • [Cites] Nat Rev Microbiol. 2012 Sep;10(9):618-30 [22890146.001]
  • [Cites] PLoS One. 2015 Oct 29;10(10):e0141484 [26513464.001]
  • [Cites] MBio. 2015 Sep 22;6(5):e01491-15 [26396248.001]
  • [Cites] Pediatr Infect Dis J. 2012 Dec;31(12):1221-6 [22739572.001]
  • [Cites] BMC Bioinformatics. 2009 Dec 15;10:421 [20003500.001]
  • [Cites] Bioorg Med Chem Lett. 2015 May 1;25(9):1876-9 [25857943.001]
  • [Cites] J Med Virol. 2016 Apr;88(4):578-87 [26331908.001]
  • [Cites] Nat Immunol. 2006 Mar;7(3):274-83 [16474395.001]
  • [Cites] Genome Biol. 2007;8(9):R183 [17784955.001]
  • [Cites] Am J Respir Crit Care Med. 2008 Oct 1;178(7):667-72 [18565953.001]
  • [Cites] Am J Pathol. 2012 Feb;180(2):599-607 [22189618.001]
  • [Cites] Genome Biol. 2014;15(12):550 [25516281.001]
  • (PMID = 28103897.001).
  • [ISSN] 1474-760X
  • [Journal-full-title] Genome biology
  • [ISO-abbreviation] Genome Biol.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL128439; United States / NIBIB NIH HHS / EB / T32 EB009383
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Airway epithelium / Asthma / Asymptomatic / Children / Host response / Host-virus interactions / Infection / RNA-seq / Transcriptome / Virus
  •  go-up   go-down


53. López Daneri AG, Arechavala A, Iovannitti CA, Mujica MT: [Disseminated histoplasmosis in patients with AIDS. Buenos Aires, 2009-2014]. Medicina (B Aires); 2016;76(6):332-337
HIV InSite. treatment guidelines - Histoplasmosis and HIV Infection .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Other opportunistic infections were observed in 70/171 (40.9%) prior to or concomitantly with histoplasmosis.
  • The severity of histoplasmosis determined the monotherapy with amphotericin B deoxycholate in 115 (67.3%), itraconazole in 42 (24.5%), and combined therapies in 14 (8.2%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27959839.001).
  • [ISSN] 0025-7680
  • [Journal-full-title] Medicina
  • [ISO-abbreviation] Medicina (B Aires)
  • [Language] spa
  • [Publication-type] Journal Article; English Abstract
  • [Publication-country] Argentina
  • [Keywords] NOTNLM ; AIDS / HIV / histoplasmosis
  •  go-up   go-down


54. Bilgic HB, Bakırcı S, Kose O, Unlu AH, Hacılarlıoglu S, Eren H, Weir W, Karagenc T: Prevalence of tick-borne haemoparasites in small ruminants in Turkey and diagnostic sensitivity of single-PCR and RLB. Parasit Vectors; 2017 Apr 27;10(1):211

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnostic sensitivity of these two approaches was then compared in terms of their ability to detect single species and mixed infections.
  • OT1, T. luwenshuni and T. uilenbergi in Turkey was revealed for the first time while the presence of Babesia motasi, B. crassa and T. separata in Turkish small ruminants was confirmed using molecular methods.
  • More than 80% of the mixed infections contained T. ovis and/or A. ovis.
  • The RLB approach was found to be capable of detecting mixed infections with species such as Theileria sp.
  • However, the latter approach was still capable of identifying a high proportion of individuals containing mixed-species infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Parassitologia. 1997 Jun;39(2):99-109 [9530692.001]
  • [Cites] Parasit Vectors. 2013 Sep 24;6(1):277 [24499621.001]
  • [Cites] Vet Parasitol. 2006 Sep 10;140(3-4):259-63 [16682122.001]
  • [Cites] Ann N Y Acad Sci. 2006 Oct;1081:498-504 [17135558.001]
  • [Cites] Transbound Emerg Dis. 2013 Nov;60 Suppl 2:113-8 [24589110.001]
  • [Cites] Parasitol Res. 2012 Jul;111(1):149-53 [22231266.001]
  • [Cites] Ticks Tick Borne Dis. 2011 Jun;2(2):94-8 [21771542.001]
  • [Cites] Vet Microbiol. 2015 Aug 5;178(3-4):246-51 [26051478.001]
  • [Cites] Parasitol Res. 2009 Jun;104(6):1417-23 [19205742.001]
  • [Cites] Transbound Emerg Dis. 2008 Aug;55(5-6):233-7 [18666967.001]
  • [Cites] Zoonoses Public Health. 2007;54(1):8-15 [17359441.001]
  • [Cites] Parasitol Res. 2008 Jul;103(2):319-23 [18421476.001]
  • [Cites] Fam Med. 2005 May;37(5):360-3 [15883903.001]
  • [Cites] Vet Parasitol. 2008 May 31;153(3-4):225-30 [18329810.001]
  • [Cites] Parasitol Res. 2009 Apr;104(5):1243-8 [19247690.001]
  • [Cites] J Clin Microbiol. 2006 Nov;44(11):4120-4 [17088370.001]
  • [Cites] Parasit Vectors. 2016 Apr 13;9:203 [27075661.001]
  • [Cites] Turkiye Parazitol Derg. 2007;31(4):268-71 [18224614.001]
  • [Cites] Vet Parasitol. 2013 Nov 15;198(1-2):72-7 [24029713.001]
  • [Cites] Vet Parasitol. 1995 Mar;57(1-3):19-41 [7597784.001]
  • [Cites] Ann N Y Acad Sci. 2000;916:271-5 [11193632.001]
  • [Cites] Trop Anim Health Prod. 2010 Oct;42(7):1327-31 [20405320.001]
  • [Cites] Trop Biomed. 2015 Jun;32(2):233-9 [26691251.001]
  • [Cites] Vector Borne Zoonotic Dis. 2015 Oct;15(10 ):580-90 [26394065.001]
  • [Cites] Parassitologia. 1997 Jun;39(2):153-6 [9530701.001]
  • [Cites] Int J Parasitol. 2004 Aug;34(9):1059-67 [15313132.001]
  • [Cites] Ticks Tick Borne Dis. 2012 Jun;3(3):147-53 [22534515.001]
  • [Cites] Vector Borne Zoonotic Dis. 2009 Oct;9(5):457-63 [18945185.001]
  • [Cites] Ann N Y Acad Sci. 1998 Jun 29;849:52-62 [9668449.001]
  • [Cites] Int J Parasitol Parasites Wildl. 2012 Nov 22;2:1-9 [24533310.001]
  • [Cites] Parasit Vectors. 2015 Dec 09;8:627 [26652614.001]
  • [Cites] Vet Microbiol. 2002 Oct 22;89(2-3):223-38 [12243899.001]
  • [Cites] Int J Parasitol. 2004 Apr;34(5):603-13 [15064125.001]
  • [Cites] Ticks Tick Borne Dis. 2013 Feb;4(1-2):148-51 [23238244.001]
  • [Cites] Biochem Med (Zagreb). 2012;22(3):276-82 [23092060.001]
  • [Cites] Vet Microbiol. 2007 Jan 31;119(2-4):375-81 [17052866.001]
  • [Cites] Vet Parasitol. 2014 Mar 1;200(3-4):276-83 [24424312.001]
  • [Cites] Vet Microbiol. 2011 Dec 15;153(3-4):293-8 [21684091.001]
  • [Cites] PCR Methods Appl. 1994 Feb;3(4):S65-75 [8173510.001]
  • [Cites] Int J Syst Evol Microbiol. 2001 Nov;51(Pt 6):2145-65 [11760958.001]
  • [Cites] J Wildl Dis. 1992 Jan;28(1):125-9 [1548791.001]
  • [Cites] Parasitol Res. 2016 May;115(5):2125-30 [26997339.001]
  • [Cites] Ticks Tick Borne Dis. 2013 Feb;4(1-2):72-7 [23246094.001]
  • [Cites] Vet Parasitol. 2008 Aug 1;155(1-2):1-9 [18472219.001]
  • [Cites] Biotechniques. 1997 Sep;23(3):504-11 [9298224.001]
  • [Cites] J Clin Microbiol. 1995 Mar;33(3):675-9 [7538510.001]
  • [Cites] Parasitol Res. 2004 Feb;92(3):189-96 [14652747.001]
  • [Cites] Parasitol Res. 2003 Nov;91(5):398-406 [14505044.001]
  • [Cites] Vet Parasitol. 2013 Jan 16;191(1-2):35-43 [22889552.001]
  • [Cites] Vet Rec. 1998 Nov 14;143(20):553-5 [9854317.001]
  • [Cites] Acta Vet Hung. 2008 Sep;56(3):281-92 [18828480.001]
  • [Cites] Rev Sci Tech. 1994 Dec;13(4):1201-26 [7711310.001]
  • [Cites] Vet Microbiol. 2007 Jun 21;122(3-4):316-22 [17336001.001]
  • [Cites] Parasitol Res. 2007 Sep;101 Suppl 2:S187-9 [17823826.001]
  • [Cites] Ann N Y Acad Sci. 2002 Oct;969:159-63 [12381583.001]
  • [Cites] Vet Res Commun. 2007 Aug;31 Suppl 1:79-84 [17682851.001]
  • [Cites] Trop Anim Health Prod. 1997 Nov;29(4 Suppl):8S-10S [9512737.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Aug 07;8(8):e3067 [25101999.001]
  • [Cites] Exp Appl Acarol. 2012 May;57(1):91-104 [22371208.001]
  • [Cites] Vet Parasitol. 2012 Jul 6;187(3-4):567-71 [22365338.001]
  • [Cites] Parassitologia. 1997 Jun;39(2):161-5 [9530703.001]
  • [Cites] Vet Parasitol. 2006 May 31;138(1-2):3-10 [16513280.001]
  • [Cites] Parasitol Res. 2007 Sep;101 Suppl 2:S191-5 [17823827.001]
  • [Cites] Vet Parasitol. 2011 Feb 10;175(3-4):331-42 [21106294.001]
  • [Cites] Parasit Vectors. 2015 Jan 15;8:26 [25589064.001]
  • [Cites] J Parasitol. 2013 Feb;99(1):77-81 [22924924.001]
  • [Cites] Turkiye Parazitol Derg. 2009;33(4):273-9 [20101576.001]
  • [Cites] Parasitol Res. 2007 Mar;100(4):797-802 [17096146.001]
  • [Cites] Vet Parasitol. 2006 Apr 30;137(3-4):231-41 [16481113.001]
  • (PMID = 28449722.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Goat / Prevalence / RLB / Sheep / Species-specific PCR / Tick-borne pathogens / Turkey
  •  go-up   go-down


55. Luang-Suarkia D, Ernst T, Alpers MP, Garruto R, Smith D, Imrie A: Serological evidence for transmission of multiple dengue virus serotypes in Papua New Guinea and West Papua prior to 1963. PLoS Negl Trop Dis; 2017 Apr;11(4):e0005488
MedlinePlus Health Information. consumer health - Dengue.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The majority of positive sera demonstrated evidence of multiple previous DENV infections and neutralizing activity against all four serotypes was detected, with anti-DENV-2 responses being most frequent and of greatest magnitude.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trop Geogr Med. 1975 Dec;27(4):405-8 [1216322.001]
  • [Cites] Bacteriol Rev. 1950 Sep;14(3):225-32 [14772197.001]
  • [Cites] Am J Trop Med Hyg. 1988 Jan;38(1):172-80 [3341519.001]
  • [Cites] Infect Genet Evol. 2009 Jul;9(4):523-40 [19460319.001]
  • [Cites] Emerg Infect Dis. 2007 Feb;13(2):282-6 [17479892.001]
  • [Cites] J Infect Dis. 2015 Feb 15;211(4):590-9 [25336728.001]
  • [Cites] Science. 1945 Jun 22;101(2634):640-2 [17844088.001]
  • [Cites] J Virol. 2007 Sep;81(18):10081-91 [17626101.001]
  • [Cites] Emerg Infect Dis. 2012 Apr;18(4):623-30 [22469290.001]
  • [Cites] BMC Infect Dis. 2014 Jul 26;14:412 [25064368.001]
  • [Cites] Aust N Z J Public Health. 2006 Jun;30(3):220-5 [16800197.001]
  • [Cites] Curr Top Microbiol Immunol. 2010;338:83-98 [19802580.001]
  • [Cites] Annu Rev Microbiol. 2008;62:71-92 [18429680.001]
  • [Cites] Am J Trop Med Hyg. 2011 Apr;84(4):630-6 [21460022.001]
  • [Cites] Am J Trop Med Hyg. 2011 Jul;85(1):132-7 [21734138.001]
  • [Cites] Nature. 2013 Apr 25;496(7446):504-7 [23563266.001]
  • [Cites] Am J Trop Med Hyg. 2003 May;68(5):529-35 [12812338.001]
  • [Cites] Arch Virol. 2013 Jul;158(7):1445-59 [23471635.001]
  • [Cites] J Virol. 2000 Apr;74(7):3227-34 [10708439.001]
  • [Cites] Am J Hyg. 1963 May;77:317-43 [14011049.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jan 30;9(1):e0003442 [25635775.001]
  • [Cites] Science. 1960 Apr 15;131(3407):1102-3 [14399343.001]
  • [Cites] Am J Trop Med Hyg. 1961 Jan;10:92-109 [13718931.001]
  • [Cites] Clin Microbiol Rev. 1998 Jul;11(3):480-96 [9665979.001]
  • [Cites] Am J Trop Med Hyg. 1952 Jan;1(1):30-50 [14903434.001]
  • [Cites] Am J Trop Med Hyg. 2002 Feb;66(2):208-12 [12135295.001]
  • [Cites] J Infect Dis. 2006 Oct 1;194(7):1023-4; author reply 1024-5 [16960794.001]
  • [Cites] PLoS Negl Trop Dis. 2009;3(4):e423 [19399166.001]
  • [Cites] Am J Trop Med Hyg. 1979 Jul;28(4):717-24 [464193.001]
  • [Cites] J Infect Dis. 1952 Jan-Feb;90(1):1-9 [14888958.001]
  • [Cites] Am J Epidemiol. 1984 Nov;120(5):653-69 [6496446.001]
  • [Cites] Clin Microbiol Rev. 1990 Oct;3(4):376-96 [2224837.001]
  • [Cites] Am J Trop Med Hyg. 2008 Jul;79(1):115-22 [18606774.001]
  • [Cites] Med J Aust. 2005 Jul 4;183(1):35-7 [15992338.001]
  • [Cites] Trends Microbiol. 2014 Mar;22(3):138-46 [24468533.001]
  • [Cites] Emerg Infect Dis. 2012 Nov;18(11):1850-7 [23092682.001]
  • [Cites] Virology. 1990 Feb;174(2):479-93 [2129562.001]
  • [Cites] Am J Trop Med Hyg. 1975 Jul;24(4):664-75 [1155702.001]
  • [Cites] Viral Immunol. 2007 Dec;20(4):672-5 [18158740.001]
  • [Cites] Am J Trop Med Hyg. 1997 Jul;57(1):49-55 [9242317.001]
  • (PMID = 28437465.001).
  • [ISSN] 1935-2735
  • [Journal-full-title] PLoS neglected tropical diseases
  • [ISO-abbreviation] PLoS Negl Trop Dis
  • [Language] eng
  • [Publication-type] Historical Article; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Neutralizing; 0 / Antibodies, Viral
  •  go-up   go-down


56. Uzodi AS, Lohse CM, Banerjee R: Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children. Infect Dis Ther; 2017 Jun;6(2):245-257

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children.
  • INTRODUCTION: The recent increase in multidrug-resistant (MDR) Escherichia coli infections is not well described in children.
  • We determined the risk factors and outcomes of extraintestinal E. coli infections in children in our region.
  • Children with MDR infections were more likely to have a complex infection (35% vs. 17%, P = 0.026), less likely to receive effective empiric antibiotics (47% vs. 74%, P < 0.001), had longer time to receipt of effective antibiotics (median 19.2 vs. 0.6 h, P < 0.001), and longer hospitalization (median 10 vs. 4 days, P = 0.029) than children with non-MDR infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Pediatr Adolesc Med. 2005 Oct;159(10):924-8 [16203936.001]
  • [Cites] J Urol. 2013 Jul;190(1):222-7 [23369720.001]
  • [Cites] Epidemiol Infect. 2012 Apr;140(4):633-42 [21733246.001]
  • [Cites] Pediatrics. 2011 May;127(5):817-26 [21518717.001]
  • [Cites] J Clin Epidemiol. 2007 Nov;60(11):1149-55 [17938057.001]
  • [Cites] Pediatr Infect Dis J. 2014 Jun;33(6):595-9 [24326416.001]
  • [Cites] Infect Control Hosp Epidemiol. 2013 Apr;34(4):361-9 [23466908.001]
  • [Cites] Mayo Clin Proc. 2012 Aug;87(8):753-9 [22795635.001]
  • [Cites] Australas Med J. 2012;5(7):344-8 [22905060.001]
  • [Cites] J Glob Infect Dis. 2012 Oct;4(4):193-8 [23326076.001]
  • [Cites] Epidemiol Infect. 2009 Jun;137(6):879-88 [19000341.001]
  • [Cites] Am J Infect Control. 2009 Aug;37(6):435-41 [19155096.001]
  • [Cites] Infect Control Hosp Epidemiol. 2013 Sep;34(9):947-53 [23917909.001]
  • [Cites] Pediatrics. 2014 Feb;133(2):e322-9 [24420803.001]
  • [Cites] Antimicrob Agents Chemother. 2002 May;46(5):1481-91 [11959586.001]
  • [Cites] Am J Infect Control. 2012 Nov;40(9):849-53 [22325481.001]
  • [Cites] Infection. 2012 Dec;40(6):685-7 [22971936.001]
  • [Cites] Clin Microbiol Infect. 2012 Mar;18(3):268-81 [21793988.001]
  • [Cites] Pediatrics. 2013 Dec;132(6):990-6 [24218461.001]
  • [Cites] Pediatr Nephrol. 2010 May;25(5):919-25 [20151161.001]
  • [Cites] Pediatrics. 2005 Apr;115(4):942-9 [15805368.001]
  • [Cites] Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14 [23221186.001]
  • [Cites] Indian J Med Res. 2009 Jun;129(6):695-700 [19692752.001]
  • [Cites] Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9 [16355321.001]
  • [Cites] Can J Infect Dis Med Microbiol. 2009 Fall;20(3):e43-8 [20808455.001]
  • [Cites] Ann Intern Med. 2002 Nov 19;137(10):791-7 [12435215.001]
  • [Cites] Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):355-6 [23473674.001]
  • (PMID = 28374267.001).
  • [ISSN] 2193-8229
  • [Journal-full-title] Infectious diseases and therapy
  • [ISO-abbreviation] Infect Dis Ther
  • [Language] eng
  • [Grant] United States / NIA NIH HHS / AG / R01 AG034676; United States / NCATS NIH HHS / TR / UL1 TR000135
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Keywords] NOTNLM ; Antimicrobial resistance / E. coli / Multidrug-resistant E. coli
  •  go-up   go-down


57. Liu HY, Liu CC, Shen TH, Wang YJ, Liu JY, Chen TJ, Chou LF, Hwang SJ: Pattern of Visits to Older Family Physicians in Taiwan. Int J Environ Res Public Health; 2017 May 08;14(5)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, the proportions of visits for upper respiratory tract infections, hypertension, diabetes mellitus, and dyslipidemia did not differ significantly among different age groups of physicians.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ. 2004 Feb 7;328(7435):329 [14764496.001]
  • [Cites] Ann Intern Med. 2005 Feb 15;142(4):260-73 [15710959.001]
  • [Cites] EPMA J. 2010 Dec;1(4):563-85 [23199110.001]
  • [Cites] BMC Health Serv Res. 2012 Dec 18;12:467 [23249631.001]
  • [Cites] J Contin Educ Health Prof. 2010 Summer;30(3):153-60 [20872769.001]
  • [Cites] Ear Nose Throat J. 2016 Apr-May;95(4-5):E35-48 [27140028.001]
  • [Cites] Health Aff (Millwood). 2012 Nov;31(11):2453-63 [23129676.001]
  • [Cites] Am J Obstet Gynecol. 2002 Oct;187(4):1008-12 [12388997.001]
  • [Cites] BMJ Open. 2016 Feb 19;6(2):e010592 [26895989.001]
  • [Cites] JAMA. 2006 Sep 6;296(9):1094-102 [16954489.001]
  • [Cites] J Am Coll Surg. 2008 Jul;207(1):69-78; discussion 78-9 [18589364.001]
  • [Cites] J Am Coll Surg. 2010 Sep;211(3):303-7 [20800185.001]
  • [Cites] Ann Fam Med. 2014 Sep-Oct;12(5):427-31 [25354406.001]
  • [Cites] Hum Resour Health. 2016 Nov 15;14 (1):67 [27846852.001]
  • [Cites] London J Prim Care (Abingdon). 2010 Dec;3(2):115-9 [25949636.001]
  • [Cites] Med Care. 2010 Feb;48(2):95-100 [20057331.001]
  • [Cites] Ann Fam Med. 2016 Jul;14 (4):344-9 [27401422.001]
  • [Cites] Med J Aust. 2008 Dec 1-15;189(11-12):622-4 [19061450.001]
  • [Cites] Int Psychogeriatr. 2007 Oct;19(5):974-84 [17506910.001]
  • [Cites] Fam Pract. 2003 Aug;20(4):474-7 [12876124.001]
  • [Cites] Acad Med. 2006 Oct;81(10):915-8 [16985357.001]
  • [Cites] PeerJ. 2015 Aug 06;3:e1145 [26290798.001]
  • [Cites] BMJ. 2009 Jan 12;338:b97 [19139141.001]
  • (PMID = 28481318.001).
  • [ISSN] 1660-4601
  • [Journal-full-title] International journal of environmental research and public health
  • [ISO-abbreviation] Int J Environ Res Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Taiwan / aged / ambulatory care / family physicians / national health programs
  •  go-up   go-down


58. Chatterjee CM: Desert Dermatoses (Thar Desert, India). Indian J Dermatol; 2017 Jan-Feb;62(1):52-58

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infections are the most common conditions seen among this population, and among them, fungal infections are the most common.
  • The high incidence of these infections would be accounted for by the poor hygienic conditions due to lack of bathing facilities due to scarcity of water and the consequent sweat retention and overgrowth of cutaneous infective organisms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Dermatol. 2010 Apr;49(4):406-9 [20465695.001]
  • [Cites] Med J Armed Forces India. 2001 Jul;57(3):269-70 [27365617.001]
  • [Cites] J Trop Med Hyg. 1987 Apr;90(2):51-9 [3550122.001]
  • [Cites] Indian J Dermatol. 2015 Jan-Feb;60(1):21-7 [25657392.001]
  • [Cites] Vet Rec. 1984 Jul 7;115(1):15-6 [6431688.001]
  • [Cites] Indian J Dermatol Venereol Leprol. 2002 Jul-Aug;68(4):206-7 [17656937.001]
  • [Cites] Indian J Dermatol Venereol Leprol. 2003 Jan-Feb;69(1):16-8 [17642815.001]
  • [Cites] Int J Dermatol. 2000 Nov;39(11):872 [11123455.001]
  • [Cites] Clin Dermatol. 1998 Jan-Feb;16(1):109-11 [9472440.001]
  • [Cites] Environ Int. 2014 Feb;63:101-13 [24275707.001]
  • [Cites] Int J STD AIDS. 1998 Apr;9(4):231-3 [9598752.001]
  • [Cites] Indian J Dermatol Venereol Leprol. 1999 Nov-Dec;65(6):258-60 [20921679.001]
  • [Cites] Mycopathologia. 1986 Oct;96(1):45-51 [3796710.001]
  • (PMID = 28216726.001).
  • [ISSN] 1998-3611
  • [Journal-full-title] Indian journal of dermatology
  • [ISO-abbreviation] Indian J Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Climate / desert dermatoses / environment / infections / water
  •  go-up   go-down


59. Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A: Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4&lt;sup&gt;+&lt;/sup&gt; T Cells. Front Immunol; 2017;8:197

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T Cells.
  • Nonetheless, a growing body of evidence indicates that CD4<sup>+</sup> T cells can also exert a direct effector activity, which depends on intrinsic cytotoxic properties acquired and carried out along with the evolution of several pathogenic infections.
  • This review aims at summarizing currently available data about functional and therapeutic relevance of cytotoxic CD4<sup>+</sup> T cells in the context of viral infections and virus-driven tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2005 Nov 1;106(9):3166-74 [16014568.001]
  • [Cites] Nat Immunol. 2008 Oct;9(10):1122-30 [18776904.001]
  • [Cites] J Virol. 2015 Aug;89(15):7494-505 [25972560.001]
  • [Cites] Curr Opin Virol. 2016 Aug;19:99 [27619790.001]
  • [Cites] J Immunol. 2004 Aug 1;173(3):1834-41 [15265915.001]
  • [Cites] Eur J Immunol. 2013 Nov;43(11):2886-95 [23921569.001]
  • [Cites] J Virol. 2014 Dec;88(24):14232-40 [25275131.001]
  • [Cites] Cell Host Microbe. 2015 Mar 11;17(3):295-300 [25766291.001]
  • [Cites] J Gen Virol. 2002 Dec;83(Pt 12):3023-33 [12466479.001]
  • [Cites] Annu Rev Immunol. 2008;26:741-66 [18173374.001]
  • [Cites] J Exp Med. 2007 Aug 6;204(8):1849-61 [17635957.001]
  • [Cites] Nat Immunol. 2013 Mar;14(3):281-9 [23334788.001]
  • [Cites] PLoS One. 2016 May 02;11(5):e0154815 [27136203.001]
  • [Cites] J Immunol. 2004 Jan 1;172(1):525-31 [14688363.001]
  • [Cites] Nat Immunol. 2009 Jun;10(6):636-46 [19412183.001]
  • [Cites] Int J Cancer. 2008 Dec 15;123(12):2824-31 [18781564.001]
  • [Cites] Nature. 1988 Dec 1;336(6198):484-7 [2461519.001]
  • [Cites] Int Rev Immunol. 2010 Aug;29(4):371-402 [20635880.001]
  • [Cites] Nat Med. 2012 Jan 29;18(2):274-80 [22286307.001]
  • [Cites] J Burn Care Res. 2013 Nov-Dec;34(6):628-32 [24043233.001]
  • [Cites] J Immunol. 2011 Oct 1;187(7):3555-64 [21880986.001]
  • [Cites] J Virol. 2004 May;78(9):4463-77 [15078927.001]
  • [Cites] J Clin Oncol. 2007 Jun 20;25(18):2586-93 [17577038.001]
  • [Cites] Eur J Immunol. 2011 Jun;41(6):1652-62 [21469116.001]
  • [Cites] Immunity. 2009 May;30(5):646-55 [19464987.001]
  • [Cites] J Immunol. 2009 Jun 1;182(11):7131-45 [19454710.001]
  • [Cites] Br J Cancer. 2005 Jul 25;93(2):248-59 [15986031.001]
  • [Cites] Immunology. 2009 Sep;128(1):83-91 [19689738.001]
  • [Cites] J Exp Med. 2016 Sep 19;213(10):2065-80 [27621419.001]
  • [Cites] N Engl J Med. 1995 Apr 20;332(16):1065-9 [7898524.001]
  • [Cites] J Infect Dis. 2013 Jan 1;207(1):80-8 [23100562.001]
  • [Cites] Nature. 1984 Mar 22-28;308(5957):365-7 [6608693.001]
  • [Cites] PLoS One. 2014 Jan 21;9(1):e86348 [24466045.001]
  • [Cites] Front Immunol. 2013 May 13;4:105 [23717308.001]
  • [Cites] Cancer Res. 2008 Feb 1;68(3):901-8 [18245493.001]
  • [Cites] J Clin Invest. 2001 Jan;107(1):121-30 [11134187.001]
  • [Cites] Haematologica. 2010 Oct;95(10):1769-77 [20421267.001]
  • [Cites] J Virol. 2013 Nov;87(21):11884-93 [23986597.001]
  • [Cites] Immunology. 2010 Sep;131(1):89-98 [20545782.001]
  • [Cites] Nat Rev Immunol. 2015 Nov;15(11):705-16 [26449178.001]
  • [Cites] Sci Transl Med. 2012 Feb 29;4(123):123ra25 [22378925.001]
  • [Cites] Int Immunol. 1998 Aug;10(8):1149-57 [9723701.001]
  • [Cites] Clin Exp Immunol. 2008 Aug;153(2):231-9 [18549439.001]
  • [Cites] PLoS One. 2015 Feb 09;10(2):e0115582 [25665096.001]
  • [Cites] Blood. 2010 Sep 30;116(13):2245-52 [20562330.001]
  • [Cites] Clin Cancer Res. 2008 Jan 1;14(1):178-87 [18172269.001]
  • [Cites] Vaccine. 2015 Aug 20;33(35):4247-54 [25858855.001]
  • [Cites] J Immunother. 2012 Apr;35(3):254-66 [22421943.001]
  • [Cites] J Virol. 2009 Apr;83(8):3719-33 [19176632.001]
  • [Cites] Virus Res. 2014 Jun 24;185:53-63 [24675275.001]
  • [Cites] Arthritis Res Ther. 2003;5(5):R292-300 [12932293.001]
  • [Cites] N Engl J Med. 1997 Oct 30;337(18):1267-74 [9345075.001]
  • [Cites] J Intern Med. 2010 May;267(5):483-501 [20433576.001]
  • [Cites] Immunol Lett. 2012 May 30;144(1-2):7-15 [22425747.001]
  • [Cites] J Virol. 2009 Sep;83(17):8722-32 [19553327.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1577-86 [15735048.001]
  • [Cites] Nature. 2005 Apr 28;434(7037):1093-7 [15793563.001]
  • [Cites] J Clin Invest. 2002 Feb;109(4):431-5 [11854312.001]
  • [Cites] Nature. 1992 Jun 25;357(6380):702-4 [1614517.001]
  • [Cites] J Gen Virol. 2007 Mar;88(Pt 3):803-13 [17325352.001]
  • [Cites] J Virol. 2001 Jul;75(14):6359-66 [11413302.001]
  • [Cites] J Immunol. 2012 May 15;188(10):5166-76 [22529301.001]
  • [Cites] J Virol. 2015 Oct 21;90(2):650-8 [26491148.001]
  • [Cites] Nat Immunol. 2005 Mar;6(3):287-94 [15711549.001]
  • [Cites] Nat Med. 2010 Oct;16(10):1147-51 [20890291.001]
  • [Cites] J Exp Med. 2008 Aug 4;205(8):1789-96 [18625749.001]
  • [Cites] Immunology. 2016 Feb;147(2):165-77 [26489873.001]
  • [Cites] BMC Immunol. 2014 Sep 24;15:36 [25245659.001]
  • [Cites] Science. 2010 Feb 26;327(5969):1098-102 [20185720.001]
  • [Cites] J Infect Dis. 2010 Oct 15;202(8):1200-11 [20822453.001]
  • [Cites] Int J Oncol. 2003 Jun;22(6):1397-402 [12739010.001]
  • [Cites] J Immunol. 2005 Sep 15;175(6):3603-13 [16148104.001]
  • [Cites] Nat Immunol. 2009 Aug;10(8):864-71 [19578368.001]
  • [Cites] Science. 1997 Nov 21;278(5342):1447-50 [9367954.001]
  • [Cites] Blood. 2004 Mar 15;103(6):2238-47 [14645006.001]
  • [Cites] J Virol. 2005 Apr;79(8):4896-907 [15795275.001]
  • [Cites] Immunology. 2005 Aug;115(4):451-61 [16011514.001]
  • [Cites] PLoS Pathog. 2016 Sep 08;12(9):e1005832 [27606804.001]
  • [Cites] J Immunol. 2002 Jun 1;168(11):5954-8 [12023402.001]
  • [Cites] J Exp Med. 2000 May 15;191(10):1649-60 [10811859.001]
  • [Cites] Semin Immunol. 2013 Nov 15;25(4):249-51 [24262948.001]
  • [Cites] N Engl J Med. 1983 Jul 7;309(1):13-7 [6602294.001]
  • [Cites] J Exp Med. 2006 Dec 25;203(13):2865-77 [17158960.001]
  • [Cites] Hepatology. 2013 Jul;58(1):139-49 [22961630.001]
  • [Cites] J Virol. 2007 Aug;81(16):8468-76 [17553885.001]
  • [Cites] Nat Immunol. 2008 Dec;9(12):1341-6 [18931678.001]
  • [Cites] J Hepatol. 1997 Mar;26(3):503-7 [9075656.001]
  • [Cites] Blood. 2009 Jul 23;114(4):807-15 [19443664.001]
  • [Cites] Curr Opin Rheumatol. 2006 Sep;18(5):462-7 [16896283.001]
  • [Cites] Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20248-53 [24277853.001]
  • [Cites] Science. 2003 Oct 24;302(5645):659-62 [14576438.001]
  • [Cites] Nature. 1987 Jul 23-29;328(6128):348-51 [3496542.001]
  • [Cites] Semin Cancer Biol. 2008 Dec;18(6):397-408 [18977445.001]
  • [Cites] Semin Immunol. 2006 Apr;18(2):120-7 [16464609.001]
  • [Cites] Curr Opin Immunol. 2008 Jun;20(3):339-43 [18440213.001]
  • [Cites] Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20748-53 [22143798.001]
  • [Cites] J Exp Med. 1999 May 3;189(9):1451-60 [10224285.001]
  • [Cites] Expert Rev Vaccines. 2010 Dec;9(12):1453-63 [21105780.001]
  • [Cites] J Biomed Biotechnol. 2011;2011:954602 [22174559.001]
  • [Cites] Science. 2005 Jan 28;307(5709):593-6 [15591165.001]
  • [Cites] J Immunol. 2011 Jul 1;187(1):92-101 [21622860.001]
  • [Cites] J Exp Med. 1989 Apr 1;169(4):1199-212 [2564415.001]
  • [Cites] PLoS Pathog. 2009 Dec;5(12):e1000699 [20019813.001]
  • [Cites] Oncol Rep. 2013 Aug;30(2):993-9 [23754319.001]
  • [Cites] Arthritis Rheum. 1998 Dec;41(12):2108-16 [9870867.001]
  • [Cites] Nat Immunol. 2010 May;11(5):442-8 [20383150.001]
  • [Cites] Int J Cancer. 2015 Jan 1;136(1):212-24 [24824905.001]
  • [Cites] J Exp Med. 2009 Jun 8;206(6):1253-72 [19487423.001]
  • [Cites] Clin Cancer Res. 2007 Apr 15;13(8):2479-87 [17438108.001]
  • [Cites] J Virol. 2012 Jun;86(12):6792-803 [22491469.001]
  • [Cites] Proc Natl Acad Sci U S A. 1982 Apr;79(7):2365-9 [6980419.001]
  • [Cites] Nat Rev Immunol. 2009 Nov;9(11):757-66 [19855402.001]
  • [Cites] Nat Rev Immunol. 2012 Nov;12 (11):799-804 [23059426.001]
  • [Cites] Haematologica. 2004 Apr;89(4):435-43 [15075077.001]
  • [Cites] J Clin Invest. 2000 Feb;105(4):541-8 [10683384.001]
  • [Cites] J Leukoc Biol. 2010 Apr;87(4):569-73 [20053708.001]
  • [Cites] Immunology. 2011 Mar;132(3):326-39 [21214539.001]
  • [Cites] Int J Cancer. 2006 Feb 15;118(4):950-6 [16152582.001]
  • [Cites] Front Immunol. 2016 Apr 11;7:136 [27148257.001]
  • [Cites] Nat Rev Immunol. 2013 Sep;13(9):666-78 [23907446.001]
  • [Cites] Virology. 2001 Aug 15;287(1):79-88 [11504544.001]
  • [Cites] Nat Immunol. 2013 Mar;14(3):271-80 [23334789.001]
  • [Cites] J Immunol. 2014 Dec 15;193(12):5827-34 [25378595.001]
  • [Cites] J Virol. 2001 Dec;75(23):11449-56 [11689626.001]
  • [Cites] J Immunol. 2015 Oct 1;195(7):3190-7 [26297758.001]
  • [Cites] J Immunol. 2010 May 15;184(10):5895-902 [20385879.001]
  • [Cites] Nat Immunol. 2010 Aug;11(8):674-80 [20644573.001]
  • [Cites] Semin Immunol. 2013 Nov 15;25(4):252-62 [24183700.001]
  • [Cites] Blood. 2002 May 1;99(9):3302-9 [11964297.001]
  • [Cites] Clin Dev Immunol. 2012;2012:925135 [22474485.001]
  • [Cites] Semin Immunol. 2011 Oct;23(5):360-7 [21963088.001]
  • [Cites] Eur J Immunol. 1990 Apr;20(4):847-54 [2112094.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9791-6 [19478057.001]
  • [Cites] Science. 2013 Nov 22;342(6161):976-9 [24264991.001]
  • [Cites] Immunity. 2011 Nov 23;35(5):733-45 [22118525.001]
  • [Cites] Nat Rev Immunol. 2009 Feb;9(2):91-105 [19151746.001]
  • [Cites] J Clin Oncol. 2013 Jan 1;31(1):39-48 [23169501.001]
  • [Cites] Immunogenetics. 2002 Nov;54(8):527-42 [12439615.001]
  • [Cites] Cancer Res. 2002 Dec 15;62(24):7195-9 [12499257.001]
  • [Cites] J Immunother. 2003 May-Jun;26(3):212-21 [12806275.001]
  • [Cites] Immunity. 2008 Nov 14;29(5):720-33 [18951048.001]
  • [Cites] J Exp Med. 2013 May 6;210(5):933-49 [23569328.001]
  • [Cites] J Immunol. 2015 Oct 15;195(8):3803-15 [26363059.001]
  • [Cites] J Exp Med. 2004 May 17;199(10):1301-4 [15148332.001]
  • [Cites] Cancer Immunol Res. 2016 May;4(5):431-40 [27009165.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1123-31 [17468341.001]
  • [Cites] HPB (Oxford). 2012 Aug;14 (8):500-5 [22762397.001]
  • [Cites] J Immunol. 2008 Feb 1;180(3):1643-54 [18209060.001]
  • [Cites] J Virol. 2007 May;81(9):4766-75 [17314172.001]
  • [Cites] J Exp Med. 2005 Oct 17;202(8):1109-19 [16216889.001]
  • [Cites] Nat Rev Cancer. 2002 May;2(5):342-50 [12044010.001]
  • [Cites] Cell Immunol. 2010;262(2):89-95 [20236628.001]
  • [Cites] Clin Transplant. 2007 Mar-Apr;21(2):149-58 [17425738.001]
  • [Cites] J Virol. 2003 Nov;77(22):12088-104 [14581546.001]
  • [Cites] Nat Immunol. 2006 Jul;7(7):755-62 [16732291.001]
  • [Cites] Curr Opin Rheumatol. 2007 Jul;19(4):340-5 [17551363.001]
  • [Cites] PLoS One. 2014 Feb 20;9(2):e89010 [24586481.001]
  • [Cites] Blood. 2003 Apr 1;101(7):2686-92 [12411292.001]
  • [Cites] Nat Rev Immunol. 2004 Jul;4(7):529-40 [15229472.001]
  • [Cites] Eur J Immunol. 2005 Mar;35(3):806-15 [15719368.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9 [3872457.001]
  • [Cites] Nat Med. 2006 Oct;12(10):1198-202 [16917489.001]
  • [Cites] J Biomed Sci. 2013 Aug 16;20:60 [23947399.001]
  • [Cites] J Immunol. 1986 Apr 1;136(7):2348-57 [2419430.001]
  • [Cites] PLoS Pathog. 2011 Dec;7(12):e1002455 [22216005.001]
  • [Cites] Science. 1986 Dec 19;234(4783):1563-6 [2431484.001]
  • [Cites] Blood. 2005 Sep 1;106(5):1660-7 [15905189.001]
  • [Cites] J Exp Med. 2012 Jan 16;209(1):61-75 [22213804.001]
  • [Cites] Hum Vaccin Immunother. 2014;10(6):1688-99 [24643207.001]
  • [Cites] Immunol Res. 2008;41(2):87-102 [18172584.001]
  • [Cites] Nat Immunol. 2013 Mar;14(3):199-201 [23416670.001]
  • [Cites] Infect Dis Obstet Gynecol. 2013;2013:540850 [24023507.001]
  • [Cites] Curr Opin Virol. 2016 Feb;16:132-42 [26974887.001]
  • [Cites] Hepatology. 2003 May;37(5):1189-98 [12717401.001]
  • [Cites] J Virol. 1998 Nov;72(11):8682-9 [9765409.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):483-8 [12010863.001]
  • [Cites] Hepatology. 2000 Jun;31(6):1371-3 [10827165.001]
  • [Cites] Liver Cancer. 2012 Nov;1(3-4):226-37 [24159587.001]
  • [Cites] J Infect Dis. 2015 Feb 1;211(3):405-15 [25139018.001]
  • [Cites] J Viral Hepat. 2010 Oct;17(10):705-13 [20002303.001]
  • [Cites] Semin Immunol. 2013 Nov 15;25(4):273-81 [24246226.001]
  • [Cites] J Exp Med. 2008 Aug 4;205(8):1763-73 [18663124.001]
  • [Cites] J Virol. 2013 Jun;87(11):6306-13 [23536666.001]
  • [Cites] J Virol. 2008 Apr;82(8):3903-11 [18272580.001]
  • [Cites] Eur J Immunol. 2001 Mar;31(3):947-58 [11241300.001]
  • [Cites] Curr Top Microbiol Immunol. 2015;391:325-53 [26428380.001]
  • [Cites] J Exp Med. 1992 Dec 1;176(6):1763-7 [1460431.001]
  • [Cites] J Virol. 2001 Jul;75(14):6367-74 [11413303.001]
  • [Cites] J Virol. 2009 May;83(9):4700-3 [19244319.001]
  • [Cites] J Viral Hepat. 2006 Aug;13(8):505-14 [16901280.001]
  • [Cites] Nat Immunol. 2010 Aug;11(8):666-73 [20644572.001]
  • [Cites] J Clin Invest. 2004 Aug;114(4):542-50 [15314691.001]
  • [Cites] PLoS One. 2013;8(4):e60420 [23565245.001]
  • [Cites] Int J Cancer. 2009 Apr 1;124(7):1721-6 [19089927.001]
  • [Cites] J Exp Med. 2004 Apr 5;199(7):905-15 [15067030.001]
  • [Cites] J Virol. 2004 Aug;78(16):8844-51 [15280492.001]
  • [Cites] Clin Exp Immunol. 1990 Mar;79(3):409-15 [1690617.001]
  • [Cites] Nat Commun. 2014 Nov 05;5:5377 [25369785.001]
  • [Cites] J Immunol. 2016 Jun 15;196(12):4848-56 [27260768.001]
  • [Cites] J Immunother. 2007 Feb-Mar;30(2):215-26 [17471168.001]
  • [Cites] N Engl J Med. 2009 Dec 3;361(23):2209-20 [19843557.001]
  • [Cites] J Immunol. 2011 Sep 1;187(5):2093-100 [21788446.001]
  • [Cites] N Engl J Med. 2009 Nov 5;361(19):1838-47 [19890126.001]
  • [Cites] J Immunol. 2002 Aug 15;169(4):2172-9 [12165547.001]
  • [Cites] Front Immunol. 2016 Mar 09;7:93 [27014272.001]
  • [Cites] Cell Immunol. 2009;257(1-2):69-79 [19338979.001]
  • [Cites] Int J Cancer. 2011 Jan 15;128(2):379-89 [20473854.001]
  • [Cites] PLoS One. 2007 Jul 04;2(7):e583 [17611619.001]
  • [Cites] Hepatology. 2002 May;35(5):1225-36 [11981773.001]
  • [Cites] Cancer Sci. 2008 Aug;99(8):1633-42 [18754877.001]
  • [Cites] J Immunol. 2007 Nov 15;179(10):7176-83 [17982110.001]
  • [Cites] Sci Rep. 2016 Jan 18;6:19227 [26778409.001]
  • [Cites] Curr Top Microbiol Immunol. 2008;325:417-70 [18637519.001]
  • [Cites] Immunology. 2015 Oct;146(2):185-93 [26190355.001]
  • [Cites] Nat Med. 1996 Mar;2(3):338-42 [8612235.001]
  • [Cites] J Clin Immunol. 2012 Dec;32(6):1305-16 [22797815.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):246-51 [17200302.001]
  • [Cites] PLoS Med. 2007 Mar 27;4(3):e96 [17388662.001]
  • [Cites] Immunity. 2005 Mar;22(3):329-41 [15780990.001]
  • [Cites] J Virol. 2009 Aug;83(15):7668-77 [19457989.001]
  • [Cites] Clin Transl Immunology. 2014 Oct 31;3(10):e27 [25505955.001]
  • [Cites] Clin Exp Immunol. 2004 Oct;138(1):10-3 [15373899.001]
  • [Cites] Transplant Proc. 1991 Jun;23(3 Suppl 3):90-6 [1648843.001]
  • [Cites] AIDS. 2010 Apr 24;24(7):947-57 [20179574.001]
  • [Cites] J Exp Med. 2016 Jan 11;213(1):123-38 [26694968.001]
  • [Cites] J Exp Med. 2006 Apr 17;203(4):995-1006 [16549597.001]
  • [Cites] Immunology. 2015 Jan;144(1):1-10 [25093579.001]
  • [Cites] Clin Cancer Res. 2008 Jan 1;14(1):169-77 [18172268.001]
  • (PMID = 28289418.001).
  • [Journal-full-title] Frontiers in immunology
  • [ISO-abbreviation] Front Immunol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; CD4+ T cells / cytotoxicity / immunotherapy / viral infection / virus-driven tumors
  •  go-up   go-down


60. Crosby CM, Barry MA: Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors. Genes (Basel); 2017 Feb 18;8(2)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While RC-Ad are more potent, they run the real risk of causing adenovirus infections in vector recipients and those that administer them.
  • To gain the benefits of transgene amplification, but avoid the risk of Ad infections, we developed "single cycle" Ad (SC-Ad) vectors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2014 Dec;88(24):14426-39 [25297994.001]
  • [Cites] Adv Virus Res. 2008;72:77-126 [19081489.001]
  • [Cites] Hum Gene Ther. 2010 Jun;21(6):739-49 [20331369.001]
  • [Cites] Curr Gene Ther. 2011 Aug;11(4):241-58 [21453281.001]
  • [Cites] Curr Opin Virol. 2011 Dec;1(6):519-25 [22328912.001]
  • [Cites] Methods Mol Med. 2007;130:169-83 [17401172.001]
  • [Cites] J Virol. 2015 Mar;89(6):3412-6 [25552715.001]
  • [Cites] Biochem Pharmacol. 1990 Nov 15;40(10):2353-62 [2244936.001]
  • [Cites] Br J Cancer. 1972 Aug;26(4):239-57 [4561027.001]
  • [Cites] Nat Med. 1997 Jul;3(7):808-11 [9212113.001]
  • [Cites] J Virol. 2015 Jan;89(1):669-75 [25355873.001]
  • [Cites] Clin Vaccine Immunol. 2012 May;19(5):629-37 [22441384.001]
  • [Cites] PLoS One. 2009;4(3):e5059 [19333387.001]
  • [Cites] J Virol. 2014 Jan;88(2):974-81 [24198409.001]
  • [Cites] Cancer Res. 2008 Jul 15;68(14):5896-904 [18632644.001]
  • [Cites] J Virol. 2006 Apr;80(7):3549-58 [16537623.001]
  • [Cites] J Virol. 2017 Jan 3;91(2):null [27807231.001]
  • [Cites] J Virol. 2012 Apr;86(8):4644-57 [22345466.001]
  • [Cites] J Immunol. 1975 Sep;115(3):844-7 [807647.001]
  • [Cites] Hepatology. 2006 Feb;43(2 Suppl 1):S54-62 [16447271.001]
  • [Cites] Virology. 2014 Aug;462-463:158-65 [24996029.001]
  • [Cites] J Virol. 2013 Apr;87(7):3678-86 [23325678.001]
  • [Cites] Virology. 2009 Nov 25;394(2):311-20 [19765790.001]
  • (PMID = 28218713.001).
  • [Journal-full-title] Genes
  • [ISO-abbreviation] Genes (Basel)
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI096967; United States / NCI NIH HHS / CA / R01 CA136945
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; adenovirus / animal models / cancer therapy / genome replication / replication-competent / replication-defective / vaccines
  •  go-up   go-down


61. Ahmed H, Ali S, Afzal MS, Khan AA, Raza H, Shah ZH, Simsek S: Why more research needs to be done on echinococcosis in Pakistan. Infect Dis Poverty; 2017 Jul 03;6(1):90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The country has a meagre annual budget for health, which is being spent on known infections such as polio, dengue fever and hepatic viral infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Parasit Dis. 2014 Mar;38(1):73-6 [24505182.001]
  • [Cites] Infect Dis Poverty. 2014 Jan 29;3(1):3 [24475907.001]
  • [Cites] Parasitology. 2002 Oct;125(Pt 4):367-73 [12403325.001]
  • [Cites] Acta Trop. 2015 Jan;141(Pt B):235-43 [24686096.001]
  • [Cites] PLoS Negl Trop Dis. 2009;3(2):e319 [19238190.001]
  • [Cites] Cases J. 2009 Jan 18;2(1):62 [19149905.001]
  • [Cites] Parasit Vectors. 2011 Jun 14;4:106 [21672216.001]
  • [Cites] J Pak Med Assoc. 1989 Dec;39(12):320-1 [2517436.001]
  • [Cites] Niger J Surg. 2012 Jan;18(1):2-7 [24027383.001]
  • [Cites] Parasitol Int. 2006;55 Suppl:S221-5 [16338167.001]
  • [Cites] Surg Neurol Int. 2015 Jul 29;6:125 [26257983.001]
  • [Cites] J Urol. 2000 Mar;163(3):896-8 [10688003.001]
  • [Cites] Vet Parasitol. 2002 Apr 30;105(2):161-71 [11900930.001]
  • [Cites] Infect Dis Poverty. 2013 Aug 01;2(1):16 [23915395.001]
  • [Cites] J Radiol Case Rep. 2009;3(5):25-31 [22470661.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):71-3 [17591016.001]
  • [Cites] PLoS One. 2015 Jul 17;10 (7):e0132731 [26186219.001]
  • [Cites] Infect Dis